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Overview 
This study describes the molecular epidemiology of Mycobacterium tuberculosis 
strains with the Beijing genotype.  This genotype has received clinical prominence 
due to its global distribution and the hypothesis that these strains have acquired the 
ability to evade the protective effect of BCG vaccination, spread more readily, acquire 
drug resistance and cause severe forms of disease.  Molecular biological techniques 
were used in a series of studies to elucidate the genetic evolutionary mechanisms 
underlying the success of this genotype in Cape Town, South Africa.  
 
Using a collection of 40 different markers it was possible for the first time to construct 
a phylogenetic history of Beijing genotype strains.  This phylogeny was characterized 
by the consecutive evolution of 7 sublineages.  Analysis of epidemiological data in 
relation to these sublineages showed an association between more recently evolved 
Beijing strains and an increased ability to transmit and cause disease.  From these 
findings it was hypothesized that the pathogenic characteristics
 
of the Beijing 
genotype were not conserved but rather that strains
 
representative of the different 
sublineages had evolved unique properties.  In order to determine whether these so-
called unique properties were associated with either the host population or the genetic 
background of strains from sublineage 7, a meta-analysis of published Mycobacterial 
Interspersed Repetitive-Unit (MIRU) typing data (East Asia) was compared with 
MIRU typing data from the South African strains in the context of their phylogenetic 
histories.  This study showed that Beijing genotype strains in South Africa originated 
in East Asia following their introduction during the early 18
th
 century.  A significant 
association was observed between the frequency of occurrence
 
of strains from defined 
Beijing sublineages and the human population
 
from whom they were cultured (p < 
0.0001).  Based on these findings it was proposed that either the host population 
(South African) had selected for a particular Beijing sublineage (i.e. sublineage 7) or 
that strains from that sublineage had adapted to be more successful in the South 
African population. 
 
In a subsequent study, using the methodology developed in the above studies, it was 
shown that strains from the ancestrally positioned lineage (termed “atypical” Beijing 
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genotype) were over-represented in drug resistant isolates in the Eastern Cape region.  
This contradicts current dogma which suggests that “atypical” Beijing genotype 
strains are attenuated in their ability to transmit.  However, this phenomenon may be 
ameliorated in immune-compromised patients as review of the clinical records 
showed that transmission was associated with HIV co-infection.  These findings 
highlight the need to improve tuberculosis control in vulnerable populations as strains 
which would normally not contribute significantly to the epidemic now become a 
cause for concern especially if they are associated with drug resistance.  
 
To improve our understanding of the evolution of the Beijing genotype, the genomic 
stability of an additional 27 polymorphic markers were analysed.  These markers have 
recently been proposed as the new standard in molecular epidemiological studies and 
were based on MIRU-Variable Number Tandem-Repeats (VNTR) sequences. 
Superimposition of the MIRU-VNTR data onto the phylogenetic tree showed 
excellent concordance thereby demonstrating that these alleles were largely stable 
over time.  It is currently not known how the alleles that do change could influence 
pathogenicity.  The results of this study also demonstrated discordance between 
strains defined by IS6110 DNA fingerprinting and those defined by MIRU-VNTR 
typing thereby demonstrating that these markers evolve independently and at different 
rates.  Furthermore, the MIRU-VNTR typing method was unable to predict 
transmission of drug resistant strains which contradict previous reports from low 
incidence settings.  This has significant implications for the use of this typing method 
in high incidence settings.  
 
Using an improved PCR-based method it was possible for the first time, to identify 
the 5 most prominent phylogenetic lineages in primary cultures of adult tuberculosis 
patients resident in a high HIV/TB co-infection setting.  The results of this study 
showed that 15% of the study population was infected with two or more strains and 
Beijing genotype strains were over-represented in these mixed infections.  
Furthermore, drug susceptibility tests showed that one patient was co-infected with 
both a drug sensitive and a drug resistant strain.  Since mixed infections have been 
implicated in treatment failure, these findings demonstrate the epidemiological 
importance of detecting mixed infections in vulnerable populations.  This PCR-based 
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method was further applied to cultures of paediatric tuberculosis patients to classify 
strains which spoligotyping was unable to define.  The result of this study showed 
three mixed infections which otherwise would have been missed. 
 
In order to determine whether clinical disease presentation of patients infected with 
strains of the Beijing genotype were different from that of patients infected with non-
Beijing genotype strains, clinical and demographic data of these two groups were 
analysed.  This study showed that patients infected with strains of the Beijing 
genotype were highly infectious as defined by the increased bacterial load in sputum 
specimens.  However, this finding could not be validated by lung pathology according 
to chest radiographs of infected patients. 
  vi 
Oorsig 
Hierdie studie beskryf die molekulêre epidemiologie van Mycobacterium tuberculosis 
rasse met die Beijing genotipe.  Hierdie genotipe is van groot kliniese belang weens 
hul globale verspreiding en die hipotese dat hierdie rasse die vermoë ontwikkel het 
om die beskermende effek van BCG vaksinasie te vermy, om meer geredelik te 
versprei, middelweerstandigheid te ontwikkel en erger vorms van siekte te 
veroorsaak.  Molekulêre biologiese tegnieke is gebruik in ‘n reeks studies om die 
genetiese evolusionêre meganismes onderliggend tot die sukses van hierdie genotipe 
in Kaapstad, Suid-Afrika te verklaar. 
 
Deur ‘n versameling van 40 verskillende merkers te gebruik, was dit moontlik om vir 
die eerste keer ‘n filogenetiese stamboom van die Beijing ras genotipe te skep.  
Hierdie filogenie word gekenmerk deur die opeenvolgende evolusie van 7 ras 
sublyne.  Met die analise van epidemiologiese data in verhouding tot hierdie ras 
sublyne, is ‘n assosiasie tussen die mees onlangs ontwikkelde Beijing rasse en die 
verhoogde vermoë om te versprei en siekte te veroorsaak, getoon.  Vanweë hierdie 
bevindinge, is ‘n hipotese daargestel dat die patogeniese kenmerke van die Beijing 
genotipe nie in alle raslyne voorkom nie, maar eerder dat verteenwoordigende rasse 
van die verskillende sublyne unieke eienskappe deur evolusie ontwikkel het.  ‘n Meta-
analise van gepubliseerde MIRU tipering data van Oos-Asië is vergelyk met MIRU 
tipering data van Suid-Afrikaanse rasse in die konteks van hul filogenetiese 
geskiedenis om te bepaal watter van hierdie sogenoemde unieke eienskappe 
geassosieer is met die gasheerpopulasie en watter eienskappe geassosieer is met die 
genetiese agtergrond van die sublyn 7 rasse.  Hierdie studie het getoon dat die Beijing 
ras genotipe van Suid-Afrika hul oorsprong gekry het van Oos-Asië en vir die eerste 
keer waargeneem is in die vroeë 18de eeu.  ‘n Betekenisvolle assosiasie is 
waargeneem tussen die frekwensie waarteen die rasse van ‘n bepaalde Beijing sublyn 
voorkom en die menslike populasie van wie hulle geïsoleer is (p < 0.0001).  Gebaseer 
op hierdie bevindinge is dit voorgestel dat die menslike populasie (Suid-Afrikaners) 
vir ‘n spesifieke Beijing sublyn geselekteer het (bv. Sublyn 7) of dat rasse van hierdie 
sublyn aangepas het om meer suksesvol te wees in die Suid-Afrikaanse populasie.
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In ‘n daaropvolgende studie is, deur gebruik te maak van die metodiek wat ontwikkel 
is vir die bogenoemde studies, getoon dat die voorouerlike sublyn (bekend as 
die“atipiese” Beijing genotipe) die mees verteenwoordigende sublyn was onder 
middelweerstandige isolate van die Oos-Kaap gebied.  Dit is teenstrydig met die 
bestaande dogma wat bepaal dat die “atipiese” Beijing genotipe rasse hulle vermoë 
om te versprei verloor het.  Hierdie verskynsel kan egter versterk word in immuun 
inkompetente pasiënte aangesien hersiening van die kliniese rekords aangedui het dat 
verspreiding geassosieer was met HIV ko-infeksie.  Hierdie bevindinge bring die 
behoefte om TB beheer in vatbare populasies te verbeter, na vore, omrede rasse wat 
gewoonlik `n onbetekenisvolle bydrae tot die epidemie lewer, nou ‘n rede vir kommer 
is veral as hulle met middelweerstandigheid geassosieer is. 
 
Om ons insig rakende die evolusie van die Beijing genotipe te verbeter, is die 
genomiese stabiliteit van ‘n addisionele 27 polimorfiese merkers geanaliseer. Daar is 
onlangs voorgestel dat hierdie merkers, wat gebaseer is op MIRU-VNTR volgordes, 
die nuwe standaard vir molekulêre studies is.  Die MIRU-VNTR data is op die 
filogenetiese boom geplaas en het uitstekende ooreenstemming getoon wat die allele 
se stabiliteit oor tyd gedemonstreer het.  Dit is tans nie duidelik hoe van die allele wat 
wel verander, die patogenisiteit beïnvloed nie.  Die resultate van die studie wys ook 
onenigheid tussen rasse wat deur IS6110 DNA tipering gedefinieer is en dié wat deur 
MIRU-VNTR tipering gedefinieer is.  Dit impliseer dus dat die evolusie van merkers 
onafhanklik van mekaar plaasvind en teen verskillende tempos.  Verder was die 
MIRU-VNTR tipering metode nie in staat om verspreiding van middelweerstandige 
rasse te voorspel nie, wat teenstrydig is met vorige verslae waar lae insidensie 
omgewings bestudeer is.  Dit het noemenswaardige implikasies vir die gebruik van 
hierdie tipering metode in hoë insidensie omgewings.  
 
‘n Verbeterde PKR-gebaseerde metode is vir die eerste keer gebruik om die 5 mees 
prominente filogenetiese sublyne in primêre kulture van volwasse tuberkulose 
pasiënte van ‘n hoë MIV/TB ko-infeksie omgewing, te identifiseer.  Die resultate van 
hierdie studie het gewys dat 15% van die studiepopulasie geïnfekteer is met twee of 
meer rasse en dat die Beijing genotipe ras die meeste voorgekom het in gemengde 
infeksies.  Verder het middelweerstandige toetse gewys dat een pasiënt geïnfekteer 
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was met beide ‘n middelsensitiewe en ‘n middelweerstandige ras.  Gemengde 
infeksies is al vantevore gekoppel aan onsuksesvolle behandeling en dus demonstreer 
hierdie bevindinge die epidemiologiese belang van die opsporing van gemengde 
infeksies in vatbare populasies.  Hierdie PKR-gebaseerde metode is verder gebruik 
om rasse wat voorkom in kulture van pediatriese pasiënte, wat spoligotipering nie kon 
klassifiseer nie, te klassifiseer.  Die resultate het drie gemengde infeksies gewys wat 
sonder die PKR-gebaseerde metode, nie geïdentifiseer sou gewees het. 
 
Om te bepaal of die kliniese beeld van pasiënte wat geïnfekteer is met rasse van die 
Beijing genotipe verskil van dié van pasiënte wat geïnfekteer is met rasse van die nie-
Beijing genotipe, is die kliniese en demografiese data van die twee groepe pasiënte 
geanaliseer.  Hierdie studie wys dat pasiënte wat geïnfekteer is met rasse van die 
Beijing genotipe hoogs aansteeklik is (gedefinieer op grond van hoë bakteriële lading 
in sputum monsters).  Hierdie bevindinge kon egter nie met behulp van long patologie 
op borskas X-strale bevestig word nie. 
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Preface 
Prior to the advent of molecular epidemiological strain typing tools it was thought that 
Mycobacterium tuberculosis was a ubiquitous bacillus responsible for the global 
tuberculosis epidemic.  This view has changed with the development of IS6110 DNA 
fingerprinting which showed that the tuberculosis epidemic was composed of 
numerous different Mycobacterium tuberculosis strains.  Analysis of molecular 
epidemiological data subsequently showed the over-representation of certain strains 
and that these strains were often associated with major outbreaks.  This led to the 
hypothesis that these strains have evolved unique properties of hyper-transmissibility 
and increased virulence which could manifest with unique clinical features.  Beijing 
strains represent such an aggressively emerging genotype.  This genotype has been 
extensively studied and the research findings are reviewed in chapter 1.  Subsequent 
chapters describe the phenotypic and genotypic characteristics of the Beijing genotype 
strains circulating in Cape Town, South Africa, using molecular genotyping methods 
in association with clinical and demographic data. 
 
In chapter 2, 40 genetic loci were analysed in a collection of Beijing genotype strains 
in order to reconstruct their evolutionary history and to determine whether pathogenic 
characteristics were associated with defined sublineages.  This study described 7 
independently evolving sublineages of which the most recently evolved sublineage 
was associated with increased pathogenicity.  Using the methodology developed it 
was possible to show a different distribution of strains among the different 
sublineages in a different host population.  Rarely observed strains, known not to 
transmit, were over-represented compared to frequently observed strains.  This was 
explained by different host immune factors between the different host populations.   
 
In chapter 3 the Mycobacterial Interspersed Repetitive-Unit (MIRU) typing method 
was used to show that the frequency of occurrence of strains from a defined Beijing 
sublineage was associated with the human host population from whom they were 
isolated.  This suggested that either, 1) strains of a defined sublineage have evolved a 
higher level of pathogenicity in response to the immunity presented by a novel host
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 population or 2) that a certain host population was more vulnerable to strains from 
that sublineage.  
 
Chapter 4 describes the evolutionary characteristics of a further 27 MIRU-Variable-
Number Tandem-Repeats (VNTR) loci in strains of the Beijing genotype.  This study 
showed that these loci were evolving at a rate slower than IS6110 and therefore were 
less informative as molecular epidemiological markers.  However, we note that the 
evolution of these MIRU-VNTR loci allowed for the accurate grouping of Beijing 
genotype strains into their respective phylogenetic lineages.  
 
In chapter 5, clinical isolates were subjected to a PCR-based method to classify them 
into one of the 5 most prominent phylogenetic lineages of Mycobacterium 
tuberculosis.  This methodology allowed for the quantification of the extent of mixed 
infections and thereby showed that strains of the Beijing genotype were more 
frequently associated with mixed infections than the other genotypes tested in this 
study.  Again, this supports the notion that strains of the Beijing genotype have 
evolved unique properties which either allowed superinfection (vulnerability of a 
distinct host population to a defined Beijing sublineage) or strains from a defined 
Beijing sublineage have selected for a distinct host population.  This PCR-based 
genotyping method was instrumental in grouping strains cultured from paediatric 
patients, thereby allowing the demonstration that the Beijing and Haarlem genotypes 
were associated with drug resistance.   
 
In chapter 6, clinical and demographic data of tuberculosis patients infected with 
Beijing and non-Beijing genotype strains respectively were analysed to determine 
whether differences in clinical presentation in relationship to Beijing and non-Beijing 
genotype strains circulating in Cape Town, South Africa existed.  In this study, 
patients with positive-smear disease were more often infected with strains of the 
Beijing genotype.   
 
This series of studies have substantially enhanced our understanding of the influence 
of genetic strain variation on disease outcome.  These findings could help future drug, 
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vaccine and diagnostic development in an attempt to limit tuberculosis transmission 
and the perpetuation of the TB epidemic. 
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1.1 The tuberculosis epidemic 
 
In 1882, Robert Koch announced the discovery that Mycobacterium tuberculosis (M. 
tuberculosis) is the principal causative agent of human tuberculosis (TB).  M. 
tuberculosis is a member of a closely related group of organisms known as the M. 
tuberculosis complex (MTBC); other species within the MTBC (e.g. M. microtti, M. 
caprae and M. pinnipedi) primarily known to cause disease in animals are also known 
to cause disease in humans.  After Koch’s discovery, research was directed towards 
the development of anti-TB drugs and vaccines to eliminate TB.  However, despite 
any advances, 126 years later more people die from TB than ever before and in 1993 
the World Health Organisation (WHO) declared TB a public health emergency.   
 
It is important to note that a third of the world’s population is estimated to be infected 
with M. tuberculosis and up to 9 million TB cases are diagnosed annually, resulting in 
over three million deaths every year (1).  This makes TB the infectious disease with 
the highest adult mortality rate.  TB accounts for more than a quarter of all 
preventable adult deaths in developing countries and for a third of HIV/AIDS related 
deaths.  Individuals with undiagnosed or untreated TB are thought to infect 10 to 15 
of their contacts each year of which 5 to 10 percent will develop disease in the 
following 2 years, thereby perpetuating the epidemic (2).  Factors that probably 
influence the worldwide prevalence are the escalating numbers of HIV/AIDS cases, 
emergence of drug-resistant TB (especially multidrug-resistance (MDR) and 
extensively drug-resistance (XDR)), the increase in population mobility and failure to 
implement effective TB control.  In order to combat the global TB epidemic, the 
WHO has been focusing on a strategy of political commitment, case detection, 
directly observed treatment, an uninterrupted drug supply and standardized reporting 
(so called Direct Observed Short-Course Therapy System (DOTS)) which is currently 
implemented in 182 countries worldwide (3).  
 
1.2 Characteristics of the tubercle bacillus 
The tubercle bacillus is a highly successful pathogen.  It has the ability to persist in a 
dormant state within the host for extended periods, despite the presence of host 
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immune cells specialised to kill intracellular bacteria (termed latent infection), to 
manifest disease in a variety of ways (duration of disease, severity and anatomic 
distribution (from self-limiting pulmonary infection to extrapulmonary infection and 
disseminated disease)) and to manifest disease in different human host populations 
(some geographical areas are more affected than others).  However, despite ongoing 
research, the mechanisms governing pathogenicity and the factors influencing the 
degree of disease variability remain largely unknown.  Several host factors (i.e. 
malnutrition, alcoholism, homelessness, overcrowding, genetic predisposition (i.e. 
polymorphism in natural resistance-associated macrophage proteins (NRAMPs), Toll-
like receptors and vitamin D receptor) and occupational lung disease) and 
environmental factors (i.e. exposure to environmental mycobacteria) have been 
suggested.  However, there is substantial evidence to suggest that bacterial factors i.e. 
genetic variation in the mycobacterium, also contribute to the variability of disease 
presentation, frequency of transmission and treatment outcome (4 567).  For example, 
a more recent animal study, which infected guinea pigs with both laboratory strains 
(H37Rv and Erdman) and clinical isolates, found that guinea pigs infected with 
laboratory strains of M. tuberculosis, showed less lung parenchymal lesions than 
guinea pigs infected with various clinical isolates (8).  Clinical isolates showed rapid 
and progressive disease with extensive pulmonary and extrapulmonary lesion necrosis 
including lymph node lesion cavitations, a rare event in animals infected with 
laboratory strains of M. tuberculosis (8).   
 
1.3 Using molecular genotyping methods to identify strains 
Members of the MTBC are defined by unique genetic characteristics, although they 
show highly conserved genomes with 99.9% of the DNA sequence being shared.  The 
use of molecular genotyping methods has made it possible to identify and classify 
members of the MTBC according to these unique genetic characteristics.   
 
In 1992, DNA repeat sequences (Polymorphic GC-rich sequence (PGRS)) marked the 
advent of molecular epidemiology, since this genetic marker was able to discriminate 
among TB isolates causing disease in different patients (9).  Thereafter, the method of 
IS6110 Restriction Fragment Length Polymorphism (RFLP) was developed (10).  
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This method is based on the detection of the insertion sequence IS6110; an insertion 
element containing 1,355-base pairs (bp) integrated into different sites in the M. 
tuberculosis genome.  These “jumping” elements have been shown to be involved in 
gene disruption or gene regulation and, along with their positional polymorphism, can 
either be deleted from or replicated in different positions in the genome leading to 
highly variable IS6110 copy numbers (ranging between 0 and 25 copies).  The 
internationally standardised method of IS6110 RFLP analysis requires digestion of 
chromosomal DNA with the restriction enzyme PvuII, separation of the restricted 
DNA fragments by electrophoresis in an agarose gel, Southern blotting, hybridisation 
with a labelled DNA probe matching the sequence of IS6110 and detection of the 
labelled probes by autoradiography.  The resulting IS6110 RFLP (banding pattern) is 
characteristic of a specific M. tuberculosis strain.  Studies have shown IS6110 to 
evolve fast enough to differentiate distant epidemiological events and yet slow 
enough to accurately define recent epidemiological events (11, 12).  These properties 
make IS6110 RFLP a useful marker for strain genotyping.  However, this method has 
a number of limitations that hinders its use: it requires large amounts of good quality 
DNA which requires time consuming culturing, it cannot accurately differentiate low 
copy number strains, it is labour intensive, expensive and inter-laboratory 
comparisons are complicated due to the complexity of standardising methodology and 
interpretation of the fingerprints obtained.  Nevertheless, IS6110 RFLP fingerprinting 
has provided a foundation for much of our current understanding of the transmission 
dynamics of M. tuberculosis in different study settings (13), as well as the ability to 
distinguish between endogenous reactivation and exogenous re-infection in recurrent 
TB cases (14), identification of outbreaks, confirmation of laboratory cross-
contamination, to identify where transmission occurs (i.e. household) and helped to 
define the global population structure of M. tuberculosis strains in different 
geographical settings. 
 
In order to circumvent the limitations associated with IS6110 RFLP, two PCR-based 
molecular typing methods, have been developed, namely spoligotyping (15) and 
mycobacterial interspersed repetitive-unit–variable-number tandem-repeat (MIRU-
VNTR) typing (16, 17).  Spoligotyping is a PCR-based method that determines the 
structure of the direct repeat (DR) locus in the genome of M. tuberculosis.  The DR 
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locus contains direct repeats of 36-bp which are interspersed with unique non-
repetitive spacer sequences varying from 35 to 41 bps in size; together termed the 
direct variable repeat (DVR) (18).  Variability in the DR locus most likely occurs 
through homologous recombination between neighbouring or distant direct repeats, 
IS-mediated transposition and single nucleotide polymorphisms (SNPs).  The 
presence or absence of DVRs is determined by amplification of the DVRs and 
subsequent hybridisation to a membrane containing 43 different DVR sequences.  M. 
tuberculosis strains are defined by the absence or presence of these 43 DVRs.  
Spoligotyping is faster and simpler than IS6110 RFLP fingerprinting, requires small 
amounts of DNA and can be performed on crude DNA extracted from clinical 
samples, thus avoiding the time intensive work associated with the slow growth of 
these bacteria and is able to discriminate among isolates with fewer than 5 IS6110 
copy numbers.  Nevertheless, this method requires a special apparatus and reagents 
for hybridisation and signal detection, has a lower overall discriminatory power than 
IS6110 RFLP and is incapable of accurately defining transmission events leading to 
an over-estimation of transmission events.  A further limitation of spoligotyping is the 
observation that the DR locus may undergo convergent evolution, leading to 
epidemiologically unrelated strains sharing identical spoligotype patterns.  However, 
despite these limitations, spoligotyping provides an overview of the population 
structure of M. tuberculosis strains in different geographical settings, since strains 
which have evolved from a common ancestor can be grouped into evolutionary 
lineages according to unique spoligotype signatures (19).  An international database 
of spoligotypes of M. tuberculosis has been created, termed SpolD.  This database 
contains spoligotype data from numerous settings throughout the world and thereby 
serves as an extremely important reference that consistently documents the global 
population structure (20, 21).  MIRU-VNTR typing is based on the characterisation of 
different tandem DNA repeats scattered in various intergenic regions (loci) in the 
mycobacterial genome.  These repeat sequences can either expand or contract due to 
changes in the number of repeats at each genomic locus.  This is then converted into a 
numerical code which can be used to define a strain.  Since many independent loci are 
assessed, it has been suggested that this method is more appropriate for phylogenetic 
analysis, however, the resulting trees are not always concordant with SNP-based 
phylogenetic studies (22).  Unlike IS6110 RFLP, this method can be automated 
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making this genotyping technique less labour intensive than IS6110 RFLP with more 
reproducible results and straightforward inter-laboratory comparison of data.  Various 
studies using MIRU-VNTR-based typing have shown that this technique has a 
discriminatory power similar to that of IS6110 RFLP fingerprinting which could 
further be enhanced when combined with spoligotyping.   
 
1.4 The genetic diversity among strains 
Initial phylogenetic analysis of M. tuberculosis grouped strains into 3 principal 
genetic groups (PGG) according to 2 non-synonomous single nucleotide 
polymorphisms (nsSNPS): codon 463 of the katG gene and codon 95 of the gyrA 
gene (23, 24).  Epidemiological analysis of strains within these 3 PGGs suggested that 
PGG1 strains were more pathogenic as measured by their frequency of transmission.  
These PGGs were preserved when additional nsSNPs were used to further refine the 
phylogeny of M. tuberculosis.  Filliol and colleagues suggested that M. tuberculosis 
strains could be divided into 6 phylogenetic distinct groups, of which 2 groups could 
be further subdivided into 5 subgroups, resulting in a combination of 9 SNP cluster 
groups (SCGs) (22).  In contrast, Gutacker and colleagues identified 8 major groups 
of M. tuberculosis without subgroups, as well as a three-branch tree rather than a four-
branch tree as obtained by Filliol et al (25).  Both studies showed all of the M. 
tuberculosis SCGs to be distinct and deeply branched.  When traditional genotyping 
methods (spoligotyping and MIRU typing) were superimposed on these phylogenies 
there was a large degree of concordance with spoligotyping with the exception of 
some families found in PGG2.  MIRU typing, however, appeared to be the least 
successful method to assign isolates to their respective SCGs (22).  Accordingly, the 
traditional genotyping methods cannot be exploited to study the global phylogeny of 
M. tuberculosis.  Tsolaki and Hirsch proposed the use of long sequence 
polymorphisms (LSPs) to define the phylogeny of M. tuberculosis based on the 
understanding that homologous recombination between strains was not observed in 
M. tuberculosis and thus the analysis of genomic deletions would provide a robust 
phylogeny given the absence of parallel evolution (homoplasy) (26).  Using this 
technique, Gagneux et al (2006) defined the global phylogeny of M. tuberculosis in 
which strains were grouped into 6 six major lineages: Indo-Oceanic, East Asian, East 
African-Indian, Euro-American, West African I and II (27).  The authors also noted 
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that the major lineages displayed a strong degree of geographic confinement 
indicative of host-pathogen compatibility.  This notion was further supported by Reed 
et al (2009) who demonstrated a relationship between bacterial lineage and patient 
origin (28).  However, this concept was at first controversial and limited in 
(geographical) scope.  We therefore explored this in order to validate the concept in 
an entirely independent population.  Our study conducted in South Africa used 
genetic information to reconstruct the evolutionary history of strains of the Beijing 
genotype found in this study setting; we found that the Beijing strain genotype could 
be divided into 7 sublineages (29).  In a follow-up study we compared the frequency 
of occurrence of different bacterial sublineages circulating in Cape Town, South 
Africa and East-Asia.  We found a significant association between the frequency of 
occurrence of strains of a defined bacterial sublineage and the human population they 
were isolated from (30).  The success (frequency and/or association with more severe 
disease presentation) of certain strain genotypes in defined host populations has 
prompted the hypothesis that these genotypes have evolved unique properties 
enabling them to spread and cause disease more readily.  However, the relationship 
between genomic evolution and changes in pathogenicity remains to be described. 
 
1.5 Distribution and dominance of strain genotypes 
The fourth international spoligotyping database, SpolDB4, was constructed to 
determine the global population structure, transmission and evolution of the MTBC 
(31).  This database represents 39 295 isolates collected from patients resident in 141 
countries.  Isolates classified according to spoligotyping, were grouped into clades or 
lineages based on defined spoligotype signatures which were recognised using 
specialised computerised software.  In total, strains representative of 62 evolutionary 
lineages have been identified and it is evident that these lineages are not evenly 
distributed.  M. tuberculosis strains from the Beijing evolutionary lineage were found 
to be present in the largest number of countries (13% of global isolates) (Table 1), 
suggesting that this evolutionary lineage may have evolved unique properties which 
has allowed global spread (clonal expansion).  This differs from many other M. 
tuberculosis lineages, which are restricted to a defined geographical location (usually 
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the country of origin i.e. East-African Indian (EAI), X-family, Central Asian strain 1 
(CAS1) -Delhi) (Table 2). 
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Table 1:  Total number of clinical isolates collected from different countries with 
their respective number of Beijing genotype strains isolated according to SpolDB4 
(31) 
Country of isolation of clinical 
isolates 
Total number of clinical 
isolates collected 
Total number of Beijing 
genotype strains 
isolated (%) 
AFRICA 1 491 137 (9.2) 
Guinea-Bissau 217 1 
Kenya 71 6 
Libya 54 3 
Morocco 127 1 
Mozambique 28 2 
Malawi 122 1 
Senegal 69 8 
Sierra Leone 3 4 
South Africa 564 106 
Zimbabwe 247 5 
CENTRAL AMERICA 1 232 34 (2.8) 
Cuba 239 27 
Guadeloupe 232 1 
Haiti 375 3 
Mexico 386 3 
EUROPE 11 393 813 (7.1) 
Austria 1 456 25 
Belgium 517 14 
Czech Republic 393 14 
Germany 574 19 
Denmark 281 18 
Estonia 115 50 
Finland 347 4 
France 2 265 40 
United Kingdom 1523 11 
Italy 934 26 
Latvia 138 76 
Netherlands 973 25 
Poland 227 9 
Portugal 336 4 
Russia 986 446 
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Sweden 328 32 
FAR-EAST ASIA 2 600 1 120 (43.1) 
China 145 46 
Indonesia 344 153 
Japan 138 101 
Korea 4 2 
Myanmar 20 11 
Mongolia 19 10 
Malaysia 598 250 
Philippines 237 12 
Singapore 4 2 
Thailand 302 135 
Vietnam 789 398 
MIDDLE-EAST-CENTRAL 
ASIA 
2 422 441 (18.2) 
Armenia 119 51 
Azerbaijan 71 53 
Bangladesh 676 123 
Georgia 272 65 
India 483 35 
Iran 110 10 
Israel 15 15 
Kazakhstan 55 38 
Madagascar 395 22 
Mauritius 21 10 
Pakistan 90 5 
Reunion Island 16 8 
Saudi Arabia 99 6 
NORTH AMERICA 9 149 1 380 (15.1) 
Canada 266 4 
USA unspecified 1 690 
USA, Alabama 3 
USA, New York 5 948 
USA, Texas 1 242 
1 376 
OCEANIA 187 46 (24.6) 
Australia 36 42 
New Zealand 151 4 
SOUTH AMERICA 2 471 16 (0.65) 
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Table 2:  Distribution of strains other than the M. tuberculosis Beijing genotype in 
different countries (31) 
Country of 
isolation of 
clinical isolates 
Haarlem LAM T family EAI 
CAS1 -
Delhi 
X family 
Africa 
Most 
frequent 
Most 
frequent 
Most 
frequent 
¯ 
Less 
frequent 
¯ 
Central America 25% 
Most 
frequent 
Most 
frequent 
¯ 
Less 
frequent 
11.9% 
Europe 25% 
Most 
frequent 
Most 
frequent 
¯ 
Less 
frequent 
¯ 
Far-East Asia ¯ ¯ ¯ 33.8% 
Less 
frequent 
¯ 
Middle-East-
Central Asia 
¯ ¯ ¯ 24.3% 75% ¯ 
North America ¯ ¯ ¯ ¯ 
Less 
frequent 
21.5% 
Oceania ¯ ¯ ¯ 22.9% 
Less 
frequent 
¯ 
South America 
Most 
frequent 
50% 
Most 
frequent 
¯ ¯ ¯ 
 
Abbreviations:  LAM - Latino- American and Mediterranean; EAI - East-African-Indian; CAS1-Delhi 
– Central Asian strain 1 – Delhi 
 
1.6 Beijing strain genotype 
The Beijing strain genotype was first identified by van Soolingen et al (1995) after 
analysing M. tuberculosis isolates from TB patients resident in the People’s Republic 
of China and Mongolia (32).  A comparison between IS6110 RFLP fingerprints from 
the East Asian region showed that strains with this genotype were more frequently 
observed in East-Asia compared to more distant regions, suggesting that these strains 
Argentina 1 150 3 
Brazil 842 2 
French Guiana 375 6 
Peru 96 4 
Suriname 8 1 
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may have originated and spread from the Beijing area to other regions and thus the 
naming of the evolutionary lineage as Beijing.  Van Soolingen and colleagues 
hypothesised that the success of this genotype was due to their ability to avoid the 
protective effect of Mycobacterium bovis bacilli Calmette-Guérin (BCG) vaccination.  
Furthermore, they suggested that the Beijing strains represented an aggressively 
emerging genotype that has successfully and effectively disseminated from its country 
of origin to neighbouring and distant regions (32).  Subsequently, numerous studies 
have focused on the analysis of strains representative of the Beijing genotype.  
According to SNP-based analysis, Beijing genotype strains are members of PGG1 
(23), Spoligotype S00034 or ST1 (15), Lineage 1 (33) and Cluster II (25) while 
according to LSP-based analysis they form part of the East-Asian lineage (27).  These 
characteristics have been used to identify members of the Beijing genotype with the 
view to discovering unique characteristics associated with their global success. This 
will be the focus of this review from this point. 
Articles were collected with reference to studies that were applicable to the 
M.tuberculosis Beijing strain genotype. The articles were selected through searches 
of Pubmed, searching the Internet and checking references in the respective Beijing 
strain genotype articles (the reference list was investigated for further appropriate 
studies).  The full text of a minor amount of articles was not available (mostly due to 
articles being published in a foreign language) and therefore only the abstract could 
be reviewed and were only included if it contained sufficient information.  The full 
text of one article and specific results that were not included in another article, were 
directly requested from the respective authors.  One article was not available on 
Pubmed and was manually searched from a medical library.  The terms “Beijing 
strain genotype and Mycobacterium tuberculosis” and “HN878” (a clinical isolate 
with the Beijing genotype) were entered into the search fields of Pubmed and the 
Internet (using Google).  The articles selected included different study designs 
(population-based cross-sectional studies, reviews, prospective and retrospective 
studies, pilot studies, descriptive studies, case-control studies and surveillance 
studies), study settings, experimental models and ranged from the year 1995 when the 
Beijing strain family was first identified up till the most recent published articles 
(2009).  Articles were included that contained information about any of the different 
pathogenic characteristics (i.e. drug resistance, host immune response) that have 
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been hypothesised to be unique to the Beijing strain genotype and could explain the 
reason for the success of this genotype.  Therefore, articles that reported 
characteristics i.e. drug resistance or immune response activation for M. tuberculosis 
in general without referring specifically to the Beijing strain genotype were excluded.  
The included articles defined the Beijing strain genotype either according to IS6110 
RFLP fingerprinting and/or spoligotyping.  The term “Beijing strain genotype” used 
in the review refers to Beijing, Beijing-like, W strains and W-like strains unless 
otherwise stated.  The term “non-Beijing strain” refers to strains other than the 
Beijing, Beijing-like, W strain and W-like strain genotypes.  The initial search in 
Pubmed revealed a hundred and ninety three articles from the year 1995 to 2009 
which included 5 reviews.  However, 3 reviews upon search were excluded because 
they were written in foreign languages.  Articles were excluded that did not report the 
relevant information required for this review (i.e. drug resistance data was analysed 
during the study period but not reported in the article).   
 
2.1 Epidemiology of the Beijing strain genotype   
To date, the most frequently observed strain genotype of M. tuberculosis causing 
disease globally is the Beijing strain genotype.  Strains of the Beijing genotype have 
definitive molecular characteristics (Table 3) which differentiate them from all other 
M. tuberculosis strain genotypes.  Although they display a variety of multi-copy (15-
26) IS6110 RFLP patterns, they are genetically related to each other based on several 
independent genetic markers (Table 3).  The Beijing strain genotype can be divided 
into two groups (which share the characteristic spoligotype pattern consisting of at 
least 3 of the last 9 spacers) according to the absence or presence of an IS6110 
insertion in the NFT region.  Strains with this insertion were termed “typical” as these 
were often observed in different geographical settings.  In addition, these strains show 
similar IS6110 RFLP patterns along with mutations in the putative mutator genes.  
Strains lacking this insertion were termed “atypical” as they were relatively rarely 
observed and demonstrate more diverse IS6110 RFLP patterns, with no mutations in 
the putative mutator genes.  The atypical Beijing strains have been shown to position 
near the root of this monophyletic lineage and thereby are suggested to be the 
progenitor to the typical Beijing strains.  The reason for the difference in the 
frequency of the atypical and typical strains remains to be determined but it has been 
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suggested to reflect differences in pathogenicity (presumably caused by underlying 
genetic differences).  Using comparative whole-genome hybridization, Tsolaki et al 
(2005) showed that this genotype could be further divided into 4 or 5 subgroups 
according to LSPs and demonstrated a phylogenetic relationship between the 
subgroups (34).  More recently, the Beijing genotype phylogeny was reconstructed 
based on a combination of sSNPs, SNPs in mismatch repair genes, IS6110 insertion 
points and genomic deletions (regions of difference).  This phylogeny was shown to 
be highly congruent with the “gold standard” phylogenetic tree based on sSNPs.  
 
A 
total of 7 independently evolving
 
Beijing sublineages were identified suggesting that 
pathogenic characteristics of Beijing genotype strains are not conserved but rather that 
strains within the Beijing genotype have evolved unique pathogenic characteristics 
(29). 
 
Table 3: Main molecular characteristics defining the Beijing strain genotype  
 
Unique to the Beijing strain genotype 
 
1. A1 insertion of an IS6110 element  in the origin of replication 
     (intergenic dnaN-dnaN region) (35) 
2. Spoligotype S00034 (characterised by deletions of spacers 1-34 and presence of 
most of the spacers 35-43) (36) 
3. Presence of a 3.5-kb PvuII fragment carrying IS1081 (37) 
4. One and two IS6110 copy(ies) in the NTF chromosomal region for atypical and 
typical strains respectively (3538) 
5. Similar IS6110 multiband profile (15-26 bands) that show >80% similarity  
6. Deletion in region of difference 105 (34) 
7. Deletion in Rv0927c and SNP in Rv0927c-pstS3 intergenic spacer (39) 
8. Overexpression of DosR regulon with concomitant accumulation of TAG (40) 
9. Mutation in Rv2629 (41) 
 
Shared by other strain genotypes 
 
1. Principal genetic group 1 (katG codon 463 CTG (Leu) and gyrA codon 95 ACC 
(Thr) (23) 
2. Intact pks 15/1 gene (42) 
3. TLR2 T597C polymorphism (43) 
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Their success has been attributed to their ability to cause a number of outbreaks in 
institutional, nosocomial (44, 45) and community settings (46), and their association 
with MDR (47), indicates their substantial contribution to the TB epidemic.  The 
Beijing strain genotype has also been associated with exogenous re-infection, 
treatment relapse and treatment failure (48), febrile response during early stages of 
treatment (6) and HIV (49).  In addition, associations with modulation or suppression 
of the host immune response (inhibition of apoptosis of infected macrophages (50), 
diminished production of IL-2, IFN-γ, TNF-α and elevated levels of IL-10 and IL-18) 
(51), decreased expression of certain antigens (heat shock protein of 65-kDa, 
phosphate transport subunit S and 47-kDa protein) (52), distinct expression of 
proteins that are associated with virulence (i.e. α-crystallin) (52) and the production of 
a highly bioactive lipid (a polyketide synthase-derived phenolic glycolipid) (42) have 
been found.  Recently, strains of the Beijing genotype have also been associated with 
zoonotic transmission (53). 
 
2.2 Mycobacterium bovis bacilli Calmette-Guérin (BCG) vaccine 
To date, M. bovis BCG remains the only agent used to vaccinate children against TB.  
It is successful in reducing the risk of developing the disseminated form of TB, 
especially meningitis, during early childhood.  However, reports on its protective 
effect against adult pulmonary TB have been inconsistent and in some cases 
conflicting.  An earlier meta-analysis of studies of the efficacy of BCG concluded that 
geographic location was the major contributor as this accounted for 41% of the 
between-study variance (54).  Factors associated with varying protective efficacy 
included prevalence of nontuberculous mycobacterium (NTM), the level of socio-
economic development (i.e. population density, capacity for case detection in studies, 
housing and nutrition), differences in vaccination schedules, differences in climate 
(which can influence conditions for storage of BCG, exposure to sunlight, and levels 
of Vitamin D in humans), host genetics and virulence of local endemic strains of M. 
tuberculosis (54 - 56).  An alternative view, proposed by Hart and colleagues, 
suggested that strain differences between BCG preparations were responsible for most 
of the observed variation in efficacy of the BCG vaccine (55 - 57).   
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Van Soolingen et al (1995) hypothesised that the dissemination of the strains of the 
Beijing genotype could have been secondary to widespread BCG vaccine use 
(selective pressure) after their observation that high rates of BCG vaccination was a 
common factor for all countries in South-East Asia where strains with the Beijing 
genotype are highly prevalent (32).  However, a dissimilar trend in the distribution of 
Beijing genotype strains was found in South America where BCG vaccination has 
been implemented since at least 1929 (58).  Two possible explanations for the 
observed trend were reported:  (1) the available data on the distribution of strains in 
these countries are incomplete, therefore it is not known whether or not other new 
successful strains are already circulating in some communities; and (2) transmission 
of TB in communities in South American countries may be low compared to South-
east Asia, in which case clonal expansion of new strains may take a longer time 
compared to communities of high transmission (57).  Subsequently, numerous studies 
have attempted to determine whether an association existed between the use of the 
BCG vaccine and the emergence of the Beijing strain genotype.  These findings are 
summarised in Table 4.   
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Table 4:  Comparison of studies that found an association with the spread of the 
Beijing strain genotype and BCG vaccination and studies that did not find any 
associations 
BCG vaccination 
Studies that found an association with the 
Beijing strain genotype and the study 
population investigated 
Studies that found no association with the 
Beijing strain genotype and the study 
population investigated 
Van Soolingen et 
al, 1995 (32) 
Human population of 
China and Mongolia 
Anh et al, 2000 (59) Human population of 
Vietnam 
Tuyen et al, 2000 
(60)  
Human population of 
Vietnam 
Van Crevel et al, 
2001 (6) 
Human population of 
Indonesia 
Lopez et al, 2003 
(61)  
mouse model of 
pulmonary TB 
Shi et al, 2007 (62) Human population of 
Tibet 
Castañon-Arreola 
et al, 2004 (63) 
Mouse model of 
pulmonary TB 
Jeon et al, 2008 (64) 
 
Mouse model of 
pulmonary TB 
Grode et al, 2005 
(65) 
Mouse model of 
pulmonary TB 
  
Tsenova et al, 
2007 (66) 
Rabbit model of 
TBM 
  
Kremer et al, 2004 
(67) 
Human population of 
Vietnam and Hong 
Kong 
  
 
In Vietnam, where BCG vaccination is not uniformly practiced, strains of the Beijing 
genotype were more commonly associated with vaccinated patients than non-
vaccinated patients (60).  Subsequently, Kremer et al (2004) also showed that BCG 
vaccinated individuals from Vietnam, Hong Kong and the Netherlands were 
significantly more often infected with strains of the Beijing genotype than non-
Beijing genotype strains (68).  However, some studies failed to demonstrate an 
association between BCG vaccination and the spread of strains with the Beijing 
genotype in Vietnam, Indonesia, Tibet and various regions of the USA respectively 
(6, 59, 62).  On the other hand, one of these studies did find an association between 
age and infection and strains of the Beijing genotype suggesting that the prevalence of 
the Beijing strain genotype rather suggests a cohort effect of BCG vaccination than 
reduced sensitivity to BCG vaccine-induced immunity of the Beijing strain genotype 
as postulated by others (59). 
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Studies conducted in different animal models collectively showed that although BCG 
conferred a significant protection against Beijing and non-Beijing genotype strains, 
the protective effect was the lowest for the Beijing strain genotype (61, 63, 65, 66).  
However, when mice vaccinated with a recombinant BCG (experimental BCG over-
expressing the 38-kDa antigen of M. tuberculosis or experimental BCG secreting 
listeriolysin of Listeria moncytogenesis which enables the latter to escape from the 
phagosomes of infected host cells), were challenged with strains of the Beijing 
genotype, protection was restored (63, 65).  In contrast, some animal studies could not 
find a strain-specific resistance to BCG-induced protective immunity (64).  The 
authors showed that levels of BCG-induced immunity against a classic laboratory 
strain, 4 Beijing clinical isolates and 4 non-Beijing strains to be generally similar (64).  
These discrepant results were attributed to the use of different animal TB infection 
models, M. tuberculosis challenge methods, lung pathology analyses and the nature of 
the strains and their inability to induce protective immunity (63 - 66).  Furthermore, 
the different production methods of BCG can present mycobacterial strain 
preparations with contrasting immunogenic activities because of different ratios of 
live and dead organisms, different bacterial concentrations and altered surface 
composition, which may explain the reason that some results did not correlate with 
previous findings.   
 
In summary, although it has been hypothesised that strains of the Beijing genotype 
have acquired mechanisms to circumvent BCG-induced immunity, the association 
with BCG vaccination and the emergence of strains of the Beijing genotype remains 
inconclusive.  Therefore, the possibility that differences in strains of M. tuberculosis 
might influence the variation in BCG efficacy, cannot completely be ignored. 
 
2.3 Drug resistance 
Resistance to one or more of the anti-TB drugs is a major public health concern, 
which increases TB case numbers and has a severe impact on morbidity and mortality.  
According to the WHO, the drug resistance epidemic has reached alarming 
proportions, with more than 490 000 MDR cases and 40 000 XDR cases being 
diagnosed each year (69).  
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M. tuberculosis usually develops drug resistance as the result from genomic mutations 
(in the form of nsSNPs, deletions or insertions) in specific resistance-determining 
regions of target genes or their promoters (70).  Resistance-conferring mutations 
occur spontaneously at a very low frequency and are selected by inadequate therapy 
(due to poor patient treatment adherence, unavailability or poor quality of drugs) or 
sub-therapeutic drug levels (due to drug malabsorption or low drug bioavailability).  
Drug-resistant cases may then infect close contacts within the community.  This is 
probably exacerbated by prolonged diagnostic delay and failure to ensure optimal 
treatment (46, 71).  Routine culture-based methods for drug susceptibility testing 
(DST) are slow, expensive and rarely available in resource-limited settings.  The fact 
that it often takes several weeks to produce a result, delays the institution of effective 
treatment, thereby increasing the risk that drug-resistant bacilli will be transmitted to 
contacts (71, 72).  In addition, patients may receive inappropriate therapy that 
amplifies resistance and further compromises the chance of a successful treatment 
outcome (73, 74). 
 
All TB strains can develop drug resistance, however, a number of studies have 
suggested that the genetic background of the M. tuberculosis strain may define how 
frequently resistance is acquired and/or propagated.  Numerous molecular 
epidemiological studies, done in various geographical settings, have suggested an 
association between drug resistance and MDR-TB, and the Beijing strain genotype 
(see appendix C).  This association held true in areas where the proportion of the 
Beijing strain genotype was increasing (epidemic).  This prompted the hypothesis that 
this genotype had the ability to acquire drug resistance more readily than other M. 
tuberculosis genotypes.  To address this hypothesis, Rad et al (2003) suggested that 
mutations in putative mutator (mut) genes (which encode DNA repair enzymes) may 
play a role in defining the frequency at which drug resistance is acquired in Beijing 
genotype strains.  Analysis of the mut genes in 55 Beijing isolates identified missense 
alterations in the mutT4 (Rv3908), mutT2 and ogt genes.  The authors suggested that 
these polymorphisms could play a role in the acquisition of drug resistance, since they 
were unique to strains of the Beijing genotype (75).  However these findings are 
controversial, as drug resistance has been noted in both Beijing and non-Beijing 
genotype strains without mutations in the putative mutator genes (29, 76).  
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Subsequent genetic studies have aimed to describe additional mutations in DNA 
repair genes in order to substantiate the hypothesis of a Beijing mutator phenotype 
(77, 78). However, the concept of a mutator phenotype was not supported when the 
frequency of spontaneous mutations was calculated using the Luria-Delbrück 
fluctuation method (79).  The authors found that the rate of spontaneous mutations 
was the same in Beijing, non-Beijing and laboratory strains.   
 
Comparative studies have suggested that mutations in rpoB (confers rifampicin 
resistance) and katG (confers isoniazid resistance) may define the frequency at which 
drug resistance is acquired in Beijing genotype strains (80, 81).  These studies showed 
that Beijing genotype strains with an rpoB codon 531 and a katG codon 315 mutation 
occurred more frequently than MDR non-Beijing genotype strains with similar point 
mutations (80, 81).  However, no association with a specific mutation and different M. 
tuberculosis strain genotypes could be found in studies analysing the prevalence of 
rpoB mutations in South-East Asia (82) or rpoB and katG mutations in Latvia (83) 
and England (84).  Thus, it has been suggested that the regional differences in the 
selection of drug resistance-conferring mutations may either be associated with the 
increased capacity of Beijing genotype strains in different settings to acquire these 
mutations or simply reflects the efficacy of the TB control program in different 
countries (i.e. transmission) (81).  Alternatively, the association of drug resistance 
with a specific genotype may be related to the pathogenicity of that genotype, which 
in turn will be defined by the genetic background.  For example, strains with a Beijing 
genotype may develop resistance at the same frequency as strains with a non-Beijing 
genotype, although the former spread more efficiently giving an impression that they 
acquired resistance more readily e.g., MDR-TB outbreak of Beijing genotype strains 
in the United States and in the Samara region of Russia where two-thirds of TB 
isolates in prisoners and civilians were infected with the Beijing strain genotype (44).  
However, this hypothesis contradicts the dogma that the evolution of drug resistance 
has an associated fitness cost.  This may be explained by compensatory mutations 
which ameliorate the fitness cost associated with resistance (85, 86).  Thus, it is 
possible that Beijing genotype strains are able to accumulate compensatory mutations 
more readily than non-Beijing genotype strains thereby allowing resistant forms to 
spread.  An alternative explanation may be that the genetic background of the Beijing 
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genotype strains confers a high level of fitness when compared to other genotype 
strains (87).  Thus, when the Beijing genotype strains acquire resistance the high 
intrinsic level of fitness offsets the fitness cost associated with the acquisition of 
resistance.  This was supported by a recent molecular epidemiological study which 
showed that drug-resistant Beijing genotype strains were able to spread and cause 
disease more readily than drug-resistant non-Beijing genotype strains (87).  An 
alternative explanation is that the Beijing genotype is dominant in areas where MDR-
TB rates are high, as this was the first genotype to develop resistance due to 
incomplete treatment regimens and thereby has had the greatest opportunity to spread 
(85, 88, 89).  The observations that the Beijing strain genotype is associated with drug 
resistance have important implications for TB control.  Failure to implement rapid 
diagnostics, improve infection control measures, screen contacts and ensure treatment 
adherence in these settings will mean that the drug-resistant TB epidemic could 
continue to increase.  
 
2.4 Virulence  
Historically, virulence in mycobacteria has been defined as the ability of the 
mycobacterium to invade, survive and multiply within host macrophages, the ability 
to induce a granulomatous inflammatory response and the ability to overcome host 
defences and persist in the host tissue in a dormant state (even for years).  However, 
virulence in mycobacteria can also be modified by intrinsic factors of the host; 
avirulent microbes have been noted to become virulent in immune-incompetent hosts 
(i.e. HIV, steroid therapy).  Virulence of mycobacteria has also been quantified in the 
laboratory; in the majority of mouse model studies, virulence has been measured as 
the time and inoculum size required to kill the host, number of colony-forming units 
(CFUs) in the lung homogenates, lung histopathology and the host’s defence 
mechanism (delayed-type hypersensitivity (DTH) reaction).  Virulence according to 
epidemiological studies has been measured as the number of secondary infections 
caused by an index case (90), the ratio of active to latent infections (91), the 
propensity to cause cavitatory disease (92) and the ability to disseminate or to cause 
extrapulmonary infection (93).   
Chapter 1 
 23 
After inhalation of viable M. tuberculosis bacilli by an immune-competent 
mycobacterium-naïve host, the innate immune response of the host is activated with 
the aim of killing the bacilli.  However, this is not true for all infected hosts and 
different scenarios exist (Figure 1):  1) in some infected hosts the bacilli will be killed 
while in others the bacilli will either persist in a latent form or multiply leading to 
active disease, 2) in some infected hosts the bacilli will actively multiply in the 
primary infection area while in others, the bacilli will spread to secondary infection 
areas and multiply, 3) in vaccinated hosts, some will develop active disease and others 
latent disease and 4) in hosts with latent disease, some will never develop active 
disease while others will develop active disease when the host’s immune system is 
compromised.  
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Figure 1: The response after exposure to an intracellular pathogen   
 
 
 
The reasons for the observed discrepancy are not well understood however, there is 
substantial evidence that host genetics could influence the susceptibility to develop 
TB disease (94).  Furthermore, studies have shown that M. tuberculosis has developed 
intricate mechanisms to suppress the protective host immune response thereby 
enhancing their ability to survive, multiply inside human macrophages and 
subsequently to cause active disease (95, 96).  However, these intricate mechanisms 
have not been identified in all M. tuberculosis strains, suggesting that different strains 
exhibit dissimilar pathogenesis leading to different disease outcomes (97).   
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Much work has been done evaluating M. tuberculosis strain-related differences to try 
to disclose the mechanisms by which strains may suppress the immune response 
leading to immunopathology.  Thus far, various studies have identified a number of 
possible so-called virulence factors that may play a significant role (42, 50).  
However, it is not yet clear how these virulence factors enable mycobacteria to grow 
within its host, to withstand within-host and between-host environmental stresses, to 
disseminate and to infect a new host.   
 
Molecular epidemiological studies have shown that certain strain genotypes are over-
represented, suggesting either host-pathogen compatibility or that the genotype has 
evolved unique properties enhancing pathogenicity and virulence.  To date, most 
studies have focussed on the Beijing strain genotype as it has been associated with 
numerous outbreaks worldwide (47) and thus, it has been suggested that the Beijing 
genotype strain has evolved various mechanisms which enable evasion of the 
protective host immune response and disease progression.  To test this hypothesis, 
many in vivo and in vitro TB infection studies have been conducted to analyse the role 
played by different M. tuberculosis strain genotypes in the development of TB in the 
host.  Time to death and organ bacterial load are the most widely used measures, with 
histopathology and immune parameters studied mainly in the explanation of potential 
mechanisms underlying the observed virulence.   
 
Earlier studies using infection models in human macrophages found that Beijing 
genotype strains grew significantly faster than non-Beijing genotype strains.  In this 
study, the Beijing genotype strains caused 25% of TB cases in Los Angeles while the 
non-Beijing genotype strain was isolated from a diseased patient who had positive 
sputum for acid-fast bacilli and had contact with many persons at homeless shelters 
but did not generate secondary cases.  Based on these findings, the authors suggested 
that the Beijing genotype strains had an enhanced ability to avoid host defences (95).  
Subsequent studies confirmed a higher growth rate associated with strains of the 
Beijing genotype (98, 99).  To determine whether rapid growth in macrophages was 
characteristic of all Beijing genotype strains, Theus et al (2007) infected macrophages 
with various Beijing genotype strains and found a series of growth phenotypes:  three 
of the Beijing strains grew significantly more slowly than the other Beijing strains, 
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with Beijing strain 210 growing the fastest.  They concluded that rapid growth in 
macrophages is not a common characteristic of all Beijing genotype strains and that 
few Beijing genotype strains are as virulent as Beijing strain 210 (100). 
 
In an attempt to determine the mechanism underlying growth rate, numerous in vitro 
TB infection studies have analysed the ability of Beijing and non-Beijing genotype 
strains to differentially induce cytokines (Table 5).  
 
Table 5: Differential cytokine responses to infection with different M. tuberculosis 
genotype strains 
Publications Beijing strain 
genotype 
Non-Beijing strain 
genotype 
Zhang et al,1999 (95) TNF-α, IL-6, IL-10 and IL-12 equally induced 
Engele et al, 2002 (101) ↑TNF-α ↓ TNF-α 
Manca et al, 2004 (102) ↓ TNF-α, IL-12 
↑IL-4, IL-13 
↑TNF-α 
↓IL-4, IL-13 
Chacón-Salinas et al, 2005 
(97) 
↑TNF-α, IL-12, IL-1ß 
↓IL-10 
↓TNF-α, IL-12, IL-1ß 
↑IL-10 
Wong et al, 2007 (103) Not determined ↓ TNF-α 
Rocha-Ramirez et al, 2007 
(43) 
↑TNF-α, IL-10 ↓ TNF-α, IL-10 
 
From Table 5 it is evident that the respective studies produced different and often 
conflicting results.  A possible explanation for the discordant results reported by 
Manca et al (2004) could be related to the genetic background of the strains used, as it 
has been shown that different Beijing genotype strains can induce different host 
immune responses in vivo (102).  The diverse findings of Rocha-Ramirez et al (2007) 
and Chacon-Salinas et al (2005) may be explained by the use of lipid fractions and 
whole bacteria respectively to infect macrophages (43, 97).  Interestingly, the strains 
that Wong et al (2007) defined as hypervirulent were non-Beijing genotype strains 
isolated from patients with a more severe form of TB infection however, these strains 
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induced similar cytokine levels as non-Beijing genotype strains used in other studies 
(103).  When macrophages were infected with Beijing and non-Beijing genotype 
strains with similar drug resistance profiles (MDR), the highest death of macrophages 
were observed with infection of strains with the Beijing genotype (96).  The outcome 
of infection with Beijing and non-Beijing genotype strains on programmatic cell death 
of macrophages has also been investigated since induction of macrophage apoptosis 
accompanies reduced bacterial counts therefore, containing the disease by the host’s 
defence mechanism.  The authors found that strains with the Beijing genotype 
induced a lower extent of macrophage apoptosis, permitting higher bacillary growth.  
This finding was based on lower expression of IFN-γ, TNF-α and iNOS levels by 
Beijing genotype strains which subsequently reduces NO production and apoptosis 
(50). 
 
In an attempt to address the influence of different M. tuberculosis strain genotypes on 
host immune response, a number of different measures of virulence (survival, lung 
pathology, bacterial load, DTH response) have also been studied in animal TB 
infection models (mice, rabbits, guinea pigs).  Comparative survival studies in mice 
conducted by Manca et al (2001) revealed that strains of the Beijing genotype are of 
unusually high virulence as mice died more rapidly than mice infected with non-
Beijing genotype strains.  This was attributed to the decreased ability of spleen and 
draining lymph node cells of mice to proliferate and produce IFN-γ in response to M. 
tuberculosis antigens (105).  This was supported by follow-up studies which found 
that strains of the Beijing genotype induced the highest mortality in mice compared to 
mice infected with non-Beijing genotype strains (61, 106).  In an extensive study by 
Dormans et al (2004), the survival, lung pathology, bacterial load and DTH responses 
of BALB/c mice after intratracheal infection with 19 different MTBC strains 
(including 3 Beijing strains) of 11 major strain genotypes were evaluated.  They found 
that 2 of the 3 Beijing genotype strains were highly virulent indicated by short 
survival time associated with high CFU counts, while one Beijing genotype strain was 
less virulent, therefore suggesting that not all Beijing genotype strains are 
hypervirulent (104). 
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A study conducted in a guinea pig model used the extent of extrapulmonary lesions 
and necrosis and time of death as an indicator for virulence and found similar results 
for Beijing and non-Beijing genotype strains (107).   
 
In a study conducted by Barczak et al (2005), mice were simultaneously infected with 
different concentrations of both Beijing and non-Beijing genotype strains and 
observed for mycobacterial growth kinetics, strain proportions during infection and 
mouse survival (108).  They revealed that Beijing genotype strains were the most 
dominant virulent phenotype even when they only made up 4% of the mixed 
infection.  In fact, the simultaneous presence of a non-Beijing and Beijing genotype 
strain in infected lungs of mice did not appear to influence the outcome of infection in 
mice.  This was explained by the inefficient activation of infected macrophages by 
Beijing genotype strains rather than inherent differences of strains to overcome 
macrophage defence mechanisms.  Similarly, Tsenova et al (2005) showed in 
tuberculosis meningitis (TBM) rabbit models that the innate immune response to 
infection with one strain did not appear to affect the innate immune response to the 
other strain during co-infection.  This was based on the observation that macrophages 
infected with Beijing genotype strains breached the blood brain barrier and seeded to 
the lungs more efficiently than macrophages infected with non-Beijing genotype 
strains (109). 
 
In contrast to macrophage infection studies, in vivo infection in mouse models showed 
that strains of the Beijing genotype failed to induce a Th1-type host immune response 
with subsequent failure to contain Beijing genotype associated disease.  They 
observed a decreased induction of IL-12 and IFN-γ mRNA and increased early 
production of INF-α mRNA in Beijing-infected mouse lungs (51, 102, 105).  It has 
been suggested that M. tuberculosis strains that induce higher levels of type 1 IFN 
may be more virulent because the development of the IL-12 dependent Th1-type 
response is reduced (105, 110).  However, contradictory results in animal models 
have also been observed.  Sun et al (2006) found the Th1-type immune responses to 
be similar in patients infected with Beijing and non-Beijing genotype strains but 
strains with a non-Beijing genotype activated more Th2-type immune responses 
compared to Beijing genotype strains as evidenced by increased IL-4 expression 
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(111).  Some studies found that strains of the Beijing genotype induced a transient 
increase in TNF-α and iNOS mRNA expression compared to non-Beijing genotype 
strains that on the other hand induced a high and sustained TNF-α and iNOS mRNA 
expression (61, 112).  This was further supported by Ordway et al (2007) who found 
evidence that initially within the first 2 weeks after infection strains of the Beijing 
genotype induced a strong Th1-type immune response.  This was characterised by a 
significant IFN-γ and TNF-α production which subsequently declined rapidly.  The 
subsequent reduction in Th1-type immunity was further associated with the rapid 
emergence of a CD4
+
CD25
+
FoxP3
+
CD223
+
IL-10
+
 regulatory T cell population.  
However, with non-Beijing strain infections, the presence of T regulatory cells was 
not associated with the inhibition of the early acquired immune response by reduced 
IFN-γ levels (113). 
 
It has been hypothesised that M. tuberculosis has evolved a number of mechanisms to 
reduce recognition by the host innate immune system and to reduce a tendency to 
stimulate cytokine responses: 
 
Phenolic glycolipid (PGL):  Studies of aerosol infection in mice have observed an 
increase in time to death between animals infected with a Beijing genotype strain 
compared to strains with the non-Beijing genotype.  The increased virulence of the 
Beijing strain genotype was associated with the production of a polyketide synthase 
derived phenolic glycolipid, which dose-dependently reduces the production of Th1-
type cytokines (TNF-α, IL-6 and IL-12) by macrophages (42, 51, 102, 105, 109).  A 
7-bp deletion of the polyketide synthase gene cluster pks1-15 which gives rise to a 
frameshift mutation has been associated with the inability of non-Beijing genotype 
strains to synthesise PGL (114).  Growth of wild-type Beijing strains and Beijing 
strains with the mutant pks1-15 in mouse lungs and spleens were similar as well as 
bacterial titres at time of death of mice.  However, median survival times of mutant -
infected mice were 90 days longer than those of mice infected with the wild-type 
Beijing strains (51).  Therefore inactivation of pks1-15 inhibited production of 
Beijing-specific lipids as well as reduced virulence to that of non-Beijing strains.  On 
the other hand, when human peripheral blood monocytes were infected with a non-
Beijing strain transformed with the functional pks1-15 gene, growth was similar in the 
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mutant non-Beijing strain compared to the wild-type non-Beijing strain suggesting 
that PGL did not influence growth of M. tuberculosis (115).  To determine whether 
the pks1-15 gene were responsible for successful transmission of a M. tuberculosis 
strain in California, USA, differences in the pks1-15 locus sequence between the 
outbreak strain and unique strains were compared.  They found that the outbreak 
strain had the same frameshift mutation in the pks1-15 locus as found in non-Beijing 
strains while the unique strains shared the same pks1-15 sequence found in Beijing 
strains.  Therefore, pks1-15 gene could not explain the outbreak of this strain in the 
study setting (116).  It is possible that other molecular mechanisms could be 
responsible for their success as suggested by some authors (40, 115).  They showed 
that some Beijing strains that possess the intact pks1-15 gene were deficient in PGL 
synthesis indicating that not all members of this genotype are producers of this lipid 
(40).  However, regardless of the strain’s ability to produce PGL, all clinical isolates 
have been reported to be virulent and have likely adapted mechanisms to survive in 
their respective niches (115). 
 
Genotyping studies showed that the pks1-15 gene was intact in all Beijing genotype 
strains tested, but mutated in non-Beijing genotype strains (42, 114).  This was further 
supported by subsequent studies that found the intact pks1-15 gene in almost all of the 
Beijing genotype strains (34, 117, 118).  However, the intact region was also found in 
PGG 1 non-Beijing strains isolated from patients with severe manifestations of TB 
such as TBM, as well as from those with lung disease (117, 118).  This suggests that 
although PGL are involved in the hypervirulence of the PGL-producing strains, they 
are not a unique characteristic of the Beijing strain genotype.  However, according to 
Sinisimer et al, (2008) although the lipid’s cytokine-modulatory function is active in 
non-Beijing genotype strains, this does not necessarily confer hypervirulence in non-
Beijing genotype strains (115).  When a laboratory non-Beijing strain was 
transformed with a functional pks1-15 gene, it elicited lesser amounts of particular 
cytokines than its parental strain.  However, the cytokines differentially induced were 
not the same as previously observed to be differentially elicited by a Beijing strain 
and its PGL mutant Beijing strain (42).  The mutant Beijing strain induced higher 
levels of IL-12 compared to the wild-type Beijing strain while the mutant and wild-
type non-Beijing strains induced similar levels of IL-12.  Hence, the hypervirulence of 
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the Beijing genotype strain was suggested to be attributed to its failure to induce a 
strong Th1-type immune response including inducing lower levels of IL-12.  Thus, it 
is possible that by affecting the ability of Beijing genotype strains to induce IL-12, 
PGL induces a hypervirulence phenotype in infected animal models.  This suggests 
that the ability of PGL to modulate the host cytokine response is likely dependent on 
the background of the strain in which it is produced.  In addition, the recombinant 
non-Beijing strain was not more virulent in the mouse or rabbit model of infection, as 
judged by bacillary growth in lungs, dissemination of bacilli to other tissues, gross 
pathology and survival.  In fact, the recombinant non-Beijing strain was even less 
virulent.  In contrast, the virulence of Beijing strains in rabbits were increased 
compared to the PGL-deficient mutant Beijing strain, further supporting the 
hypothesis that the effect of PGL on virulence in different animal models may be 
strain dependent (109).  Collective data therefore conclude that, while PGL is an 
important virulence factor for the Beijing genotype strain only, it probably acts 
synergistically with other protein and/or lipid virulence factors, also present in other 
M. tuberculosis strains (115).  
 
Antigen expression:  Differences in antigen expression levels between Beijing and 
non-Beijing genotype strains have been proposed as a mechanism which may assist 
strains of the Beijing genotype to minimise recognition by the host immune response, 
thereby facilitating the increased prevalence of the Beijing genotype strains (52, 119).  
Strains of the Beijing genotype were found to have increased expression of α-
crystallin (M.tuberculosis virulence factor (120)) and decreased expression of Hsp65, 
PstS1 (B- and T-cell stimulant), and the 47kDa protein compared to the non-Beijing 
genotype strains which may allow strains of the Beijing genotype to evade the host 
immune response (121).  In accordance, Rindi et al (2007) found the expression of the 
ppe44 gene to be significantly higher in Beijing strains than non-Beijing strains and 
concluded that differential expression of ppe genes could influence the host’s immune 
responsiveness (119). 
 
Sigma factor, Sig A and the eis gene:  Wu et al (2004) proposed that the upregulation 
of the principal sigma factor, SigA in Beijing genotype strains, enhances growth in 
macrophages and in the lungs of mice during the initial phase of infection (122).  
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They found that strains with the Beijing genotype had higher sigA mRNA levels and 
higher intracellular growth rates compared to non-Beijing genotype strains.  
Furthermore, SigA was also upregulated in Beijing strains during growth in 
macrophages compared with growth in broth.  In contrast, sigA mRNA levels in non-
Beijing strains did not change under these conditions (122).  Follow-up studies 
demonstrated that the expression of eis (elicits higher levels of IL-10 than TNF-α 
secretion therefore manipulating the host TNF-α/IL-10 axis to its advantage by 
inducing a state of localised immunosuppression in the host) was enhanced 12-fold in 
the Beijing strains compared to the non-Beijing strains when grown in a human 
monocyte cell line, whereas the expression was the same when the strains were grown 
in vitro (123).  They also showed that SigA binds to the promoter region of eis and is 
responsible for the upregulation of eis expression in Beijing genotype strains.  They 
concluded that eis may contribute to the enhanced growth of the Beijing genotype 
strains in human macrophages.  This was further supported by a subsequent study 
where increased IL-10 and decreased TNF-α production driven by eis, and possibly 
other M. tuberculosis antigens, was proposed to possibly contribute to the intracellular 
survival of the pathogen by suppressing host cell apoptosis during mycobacterial 
infection (124). 
 
Dormancy regulon genes (dosR, Rv3130c, hspX, fdxA and narX):  Reed and 
colleagues have demonstrated that strains of the Beijing genotype have a basal level 
of transcription for several dormancy regulon genes (known to be involved in the 
adaptive response of M. tuberculosis to hypoxia and reactive nitrogen intermediates) 
that is up to 50-fold higher than that of non-Beijing genotype strains (40).  Similarly, 
the level of the Rv3130c transcript was 10-fold higher in Beijing than non-Beijing 
genotype strains under standard growth conditions (Rv3130c which encodes a 
Triacylglycerol (TAG) synthase whose activity is induced in response to hypoxia and 
NO treatment).  This suggests that the Beijing genotype strain has the ability to 
accumulate fatty acids in the form of TAG which is a readily available source of 
energy during anaerobic conditions (i.e. latency).  The constitutive accumulation of 
TAG by strains of the Beijing genotype supports the hypothesis that these strains are 
more adept than strains of the non-Beijing genotype at altering their metabolism to 
that required for survival within host tissues.  While the role of the DosR regulon and 
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TAG in human TB remains to be explored, the study by Reed et al (2007) represents 
the description of a series of phenomena that occur uniquely within members of a 
single M. tuberculosis genotype (40). 
 
Toll-like receptor 2 (TLR2) gene:  Caws et al (2008) recently identified a relationship 
between bacterial and host genotype in TB for the first time.  They observed a 
polymorphism in the TLR2 gene and an association with disease caused by the 
Beijing genotype strain (7).  Therefore, they hypothesised that polymorphisms in 
genes responsible for the innate immune response to infection may influence the 
host’s response to infection and may result in increased susceptibility to disease from 
some bacterial lineages but not others.  However, the Beijing genotype’s own ability 
to subvert the host innate immune response and subsequently make the host more 
susceptible to TB could not be excluded. 
 
2.5 Clinical presentation 
To determine whether a correlation existed between mycobacterial genotype and 
clinical presentation and outcome (phenotype), many studies have integrated 
molecular data (Beijing and non-Beijing genotype strains) with clinical information 
(chest X-ray (CXR) features, symptoms and signs, age, smear grading, treatment 
category, disease site and co-morbid diseases).  Table 6 summarises these findings.  
From Table 6 it is evident that a high degree of variability exists between the different 
studies which may be due to the host population in which the study was performed 
(including HIV status), the power of the different studies and diagnostic delay 
(masking extent of disease). Thus it is not possible to conclusively demonstrate a 
universal association between the Beijing strain genotype and clinical presentation.   
 
Table 6:  Correlation between phenotype and the Beijing genotype 
Phenotype Association with the Beijing 
genotype 
No association with the Beijing 
genotype 
Pre-treatment CXR findings Van Rie et al, 1999 (46) 
Drobniewski et al, 2005 
(125) 
Borgdorff et al, 2004 (126) 
Van Crevel et al, 2001 (6) 
Thwaites et al, 2008 (127) 
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Feng et al, 2008 (128) 
Kong et al, 2007 (93) 
Sun et al, 2006 (110) 
 
Progression to disease De Jong et al, 2008 (129) 
Thwaites et al, 2008 (127) 
Sapozhnikova et al, 2003 
(130) 
 
- 
Febrile response during early 
stages of treatment 
 
Van Crevel et al, 2001 (6) - 
Symptoms:  Night sweats - Drobniewski et al, 2005 (125) 
Sun et al, 2006 (110) 
 
Duration of disease 
symptoms prior to TB 
diagnosis 
 
Thwaites et al, 2008 (127) 
Sun et al, 2006 (131) 
Van Crevel et al, 2001 (6) 
Younger age (<65) Thwaites et al, 2008 (127) 
Anh et al, 2000 (59) 
Lillebaek et al, 2003 (132) 
Van Rie et al, 1999 (46) 
Kubica et al, 2004 (133) 
Borgdorff et al, 2003 (134) 
Moss et al, 1997 (135) 
Caminero et al, 2001 (5) 
Jou et al, 2005 (136) 
Drobniewski et al, 2005 
(125) 
Li et al, 2005 (137) 
Kong et al, 2007 (93) 
 
Van Crevel et al, 2001 (6) 
Borgdorff et al, 2004 (126) 
Sun et al, 2006 (111) 
Glynn et al, 2002 (47) 
Dale et al, 2005 (138) 
Tracevska et al, 2003 (83)  
Chan et al, 2001 (139) 
Bifani et al, 1999 (36) 
Prodinger et al, 2001 (140) 
Palittapongarnpim et al, 1997 
(141)  
Krüüner et al, 2001 (142) 
Previous TB treatment Feng et al, 2008 (128) 
Drobniewski et al,2005 (125) 
 
Borgdorff et al, 2004 (126) 
Toungoussova et al, 2002 (143) 
Lillebaek et al, 2003 (132) 
Glynn et al, 2005 (144) 
 
Extrapulmonary disease Kong et al, 2007 (93) 
 
Feng et al, 2008 (128) 
Borgdorff et al, 2004 (126) 
Chapter 1 
 35 
Caws et al, 2008 (7) 
Lillebaek et al, 2003 (132) 
Dale et al, 2005 (138) 
Glynn et al, 2005 (144) 
Hasan et al, 2006 (145) 
Nicol et al, 2005 (146) 
 
Smear positivity - 
 
Feng et al, 2008 (128) 
Borgdorff et al, 2004 (126) 
Glynn et al, 2005 (144) 
Van Crevel et al, 2001 (6) 
Kong et al, 2007 (93) 
 
Treatment failure and 
disease relapse 
Lan et al, 2003 (48) 
Sun et al, 2006 (111)  
 
Feng et al, 2008 (128) 
 
Clustering Cox et al, 2005 (147) Kong et al, 2007 (93) 
 
Previous imprisonment Drobniewski et al, 2005 
(125) 
 
Cox et al, 2005 (147) 
HIV status Caws et al, 2006 (49) Drobniewski et al, 2005 (125) 
Palittapongarnpim et al, 1997 
(141)  
 
 
3.1 Conclusion 
A prominent theme emerging from studies in the present review is that the genetic 
background of M. tuberculosis strains may influence the risk of disease progression.  
Based on the data accumulated it is clear that virulence of the Beijing strain genotype 
is not determined by a single characteristic but is the result of a unique, intricate, 
dynamic interaction between host and the pathogen that is encoded by the pathogen’s 
genome.  The association between genetic diversity and differential induction of the 
host immune response, drug resistance patterns and clinical or pathogenic features 
emphasizes the importance of continued investigation into the genetic mechanisms 
underlying the phenotypic and genotypic characteristics of different M. tuberculosis 
strains.  Advances in knowledge regarding the Beijing strain genotype will enhance 
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our understanding of the contribution of pathogenic factors which define disease 
progression following infection.  This in turn may enable the development and 
assessment of new interventions.  In future, these findings could help to direct drug 
and vaccine development towards targeting critical virulence factors and could also 
enable the development of new diagnostic tests to identify persons at risk for 
developing active disease.  The latter should in turn guide TB control programs 
towards high risk patients who are in need of preventative therapy or prompt 
diagnosis thereby limiting transmission and the perpetuation of the TB epidemic. 
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Abstract 
This study aimed to reconstruct the evolutionary history of
 
Beijing strains of 
Mycobacterium tuberculosis and to test the
 
hypothesis that evolution has influenced 
the ability of the
 
Beijing strains within the different Beijing sublineages to
 
spread 
and cause disease.  A PCR-based method was used to analyze
 
the genome structure 
of 40 different loci in 325 Beijing isolates
 
collected from new and retreatment 
tuberculosis patients from
 
an urban setting and 270 Beijing isolates collected from 
high-risk
 
tuberculosis patients from a rural setting in the Western Cape,
 
South 
Africa.  The resulting data were subjected to phylogenetic
 
analysis using the 
neighbor joining algorithm.  Phylogenetic
 
reconstructions were highly congruent 
with the "gold standard"
 
phylogenetic tree based on synonymous single-nucleotide 
polymorphisms,
 
thereby allowing a prediction of the order in which the evolutionary
 
events had occurred.  A total of seven independently evolving
 
Beijing sublineages 
were identified.  Analysis of epidemiological
 
data in relation to the Beijing 
sublineage suggested an association
 
between recent evolutionary change and 
frequency of occurrence
 
in an urban population (p < 0.001) as well as in the rural
 
population (p < 0.001).  This concept was further supported
 
by an association 
between more recently evolved Beijing strains
 
and an increased ability to transmit 
and to cause disease (odds
 
ratio, 5.82; 95% confidence interval, 3.13 to 10.82 [p <
 
0.001]). An association between Beijing sublineage and demographic
 
and clinical 
parameters and drug resistance could not be demonstrated.
  
From these data, we 
suggest that the pathogenic characteristics
 
of Beijing strains are not conserved but 
rather that strains
 
within individual lineages have evolved unique pathogenic 
characteristics. 
Introduction 
From molecular epidemiological data, it has been hypothesized
 
that Beijing strains 
of Mycobacterium tuberculosis have evolved
 
unique properties (10), including the 
abilities to evade the
 
protective effect of Mycobacterium bovis BCG vaccination 
(23),
 
to disseminate more efficiently than non-Beijing strains (4),
 
and to acquire 
drug resistance more frequently as the consequence
 
of single-nucleotide 
polymorphisms (SNPs) in the mismatch repair
 
genes (15).  In some studies, disease 
caused by a Beijing strain
 
has been associated with treatment relapse (16), while in 
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another
 
study a febrile response was noted during the earlier stages
 
of treatment of 
tuberculosis caused by a Beijing strain (21). 
 
However, studies of chest radiography 
data have not been able
 
to consistently demonstrate differences between the 
pathogenic
 
characteristics of Beijing and non-Beijing strains (5, 7, 17).
  
It is 
currently not known whether these results can be explained
 
by different pathogenic 
characteristics among different Beijing
 
strains, as a recent study has shown that 
extrathoracic tuberculosis
 
was associated with only a subset of Beijing strains (12).
  
M. tuberculosis strains with a Beijing genotype are members
 
of principal genetic 
group 1 and are characterized by a distinct
 
spoligotype pattern, closely related 
IS6110 DNA fingerprints,
 
identical variable-number tandem repeat sequences, and 
an IS6110
 
insertion in the NTF 1 region (Rv0001:Rv0002) (10).  Comparative
 
genomics have shown that Beijing strains have evolved through
 
mechanisms 
including IS6110 transposition (2), SNPs in the mismatch
 
repair genes (15), deletion 
of chromosomal domains (regions
 
of difference [RDs]) (19), and synonymous 
SNP(sSNPs) (9).
  
An evolutionary scenario based on mutations in the mismatch
 
repair genes mutT2 and mutT4 and ogt genes has suggested the
 
absence of these 
mutations in the ancestral Beijing strains
 
(15).  Subsequent mutations in the mutT4 
gene (codon 48) and
 
ogt gene (codon 37) or ogt and mutT2 genes (codons 12 and 
58,
 
respectively) generated two independently evolving subgroups
 
(15).  Mapping of 
the RD domains showed that the Beijing strain
 
family is a monophyletic clade, with 
four distinct evolutionary
 
branches defined by the RD105, RD181, RD150, and 
RD142 deletions,
 
respectively (19).  Phylogenetic analysis according to sSNPs
 
supported the monophyletic clade structure and suggested 11
 
Beijing sequence types 
(STs) (9).  However, the order in which
 
all of the above evolutionary events 
occurred remained to be
 
determined.
  
 
In this study we aimed to reconstruct the evolutionary history
 
of Beijing strains from 
the Western Cape, South Africa, through
 
the analysis of the genomic structure of 40 
different loci.
  
This phylogeny was used to test the hypothesis that evolution
 
has 
influenced the ability of the Beijing strains within the
 
different Beijing sublineages 
to spread and cause disease.
  
 
Chapter 2 
 59 
Material and methods 
Urban setting  
As part of an ongoing molecular epidemiological study, an attempt
 
was made to 
collect sputum samples at diagnosis from all new
 
and retreatment tuberculosis cases 
who attended primary health
 
care clinics and who were resident in an 
epidemiological field
 
site in Cape Town, Western Cape, South Africa (3), during the
 
period January 1993 to December 2004.  Sputum smear microscopy
 
(fluorescent 
staining) and/or culture (BACTEC 460, MGIT 960,
 
or Löwenstein-Jensen medium) 
was performed by the National
 
Health Laboratory Service or the Stellenbosch 
University laboratories
 
to confirm the presence of M. tuberculosis.  Clinical and 
demographic
 
data including previous history of tuberculosis, gender and
 
age, smear 
positivity, and drug susceptibility test results
 
(if requested) were recorded in a 
database.  Chest radiography
 
was not done routinely and therefore was not included 
in this
 
study. A case was considered as smear positive if any sputum
 
sample, 
collected within the first 2 months after diagnosis,
 
was found to be smear-positive.  
Human immunodeficiency virus
 
(HIV) testing was not routinely done in the initial 
years of
 
this study although a recent survey of 366 new adult smear-positive
 
tuberculosis cases (2000 to 2002) in this epidemiological field
 
site showed that 10% 
were HIV positive.
  
Rural setting 
Sputum isolates were routinely collected at diagnosis from all
 
high-risk tuberculosis 
patients (patients whose sputum failed
 
to convert after the intensive phase of therapy 
or patients
 
who had previously been treated with antituberculosis drugs)
 
who were 
attending primary health care clinics and who were
 
resident in the Boland, 
Overberg, Karoo, and Southern Cape region
 
of the Western Cape, South Africa, 
during the period February
 
2003 to August 2004.  This region is located 150 to 500 
km northeast
 
of the epidemiological field site in Cape Town.  Sputum smear
 
microscopy (fluorescent staining) and/or culture (BACTEC 460,
 
MGIT 960, or 
Löwenstein-Jensen medium) was performed by
 
the National Health Laboratory 
Service or the Stellenbosch University
 
laboratories to confirm the presence of M. 
tuberculosis.  Clinical
 
and demographic data including previous history of 
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tuberculosis,
 
gender and age, smear positivity, and drug susceptibility test
 
results 
were recorded in a database. A survey of 384 tuberculosis
 
retreatment patients (2003 
to 2004) in this study setting showed
 
that 13% were HIV coinfected.  This study 
setting was included
 
to enable a comparison of the M. tuberculosis strain population
 
structures in two independent communities.
 
This study was approved by the Ethics 
Committee (Institutional
 
Review Board) of Stellenbosch University.
  
Drug susceptibility testing 
Drug susceptibility testing was done by the National Health
 
Laboratory Service, 
using the indirect proportion method on
 
Middlebrook medium containing critical 
concentrations of 0.2
 
µg/ml isoniazid and 30 µg/ml rifampin.  In this study
 
drug 
resistance was defined as resistance to either isoniazid
 
or rifampin or a combination 
of isoniazid and rifampin (multidrug-resistant
 
[MDR] tuberculosis). Drug 
susceptibility testing for other resistance
 
markers was not routinely done.
  
Genotypic classification 
Sputum isolates from patients resident in the urban epidemiological
 
field site were 
subcultured on Löwenstein-Jensen medium
 
and genotyped by IS6110 DNA 
fingerprinting (22) and spoligotyping
 
according to internationally standardized 
methods (11).  Sputum
 
isolates from patients resident in the rural setting were 
cultured
 
on BACTEC 12B medium, and a boiled aliquot was genotyped by
 
spoligotyping according to internationally standardized methods
 
(11).  Subcultures 
of the isolates from the rural setting were
 
not available for IS6110 DNA 
fingerprinting.
  
Isolates were classified as members of the Beijing genotype
 
if they 
had the characteristic Beijing spoligotype (10).  Only
 
the first M. tuberculosis 
isolate from each case with a Beijing
 
strain was included for subsequent genetic 
analysis.
 
 
Genomic comparison 
Each Beijing strain from each patient was subjected to PCR amplification
 
in a 
reaction mixture containing 0.2 µg DNA template,
 
5 µl Q buffer, 2.5 µl 10x buffer, 
2 µl 25
 
mM MgCl2, 4 µl 10 mM deoxynucleoside triphosphates, 1
 
µl of each primer 
(50 pmol/µl) (Table 1), and 0.125
 
µl HotStarTaq DNA polymerase (QIAGEN, 
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Germany) and made
 
up to 25 µl with H2O.  Primers 1 to 22 (Table 1) were used
 
in 
combination with the universal forward primer and the internal
 
control primers to 
determine the presence or absence of IS6110
 
elements at specific chromosomal loci 
(2).  Primer sets 23 to
 
26 (Table 1) was used to determine the presence or absence of
 
SNPs in the mutT2 (codon 58), mutT4 (codon 48), and ogt (codons
 
12 and 37) genes 
(15) by the amplification refractory mutation
 
system method.  Primer sets 27 to 30 
(Table 1) was used to determine
 
whether RDs (RD105, RD181, RD150, and 
RD142) (19) were present
 
or absent.  Primer sets 31 to 40 (Table 1) was used to 
determine
 
the presence or absence of sSNPs at chromosomal positions 797736,
 
909166, 1477596, 1548149, 1692069, 1892017, 2376135, 2532616,
 
2825581, and 
4137829 (9) relative to the H37Rv whole-genome
 
sequence (6) by the amplification 
refractory mutation system
 
method.  Amplification was initiated by incubation at 
95°C
 
for 15 min, followed by 35 to 45 cycles at 94°C for 1 min,
 
annealing 
temperature (Table 1) for 1 min, and 72°C for
 
1 min.  After the last cycle, the 
samples were incubated at 72°C
 
for 10 min.  PCR amplification products were 
electrophoretically
 
fractionated in 3.0% agarose in 1x Tris-buffered EDTA, pH 8.3,
 
at 6 V/cm for 4 h and visualized by staining with ethidium bromide.
 
The existence 
of a mutational event was determined by the presence
 
or absence and the size of the 
respective PCR product. 
Table 1: Primer sequences  
 
Primer Set Primer Name
 e
 Sequence (5’ to 3’) Tm 
(ºC)
f
 
 Internal control  TCC CAG TGA CGT TGC CTT C 62 
 Internal control  GAG CAG CAG TGG AAT TTC GC 62 
 Universal Forward TTC AAC CAT CGC CGC CTC TAC 62 
1 IS21-1(1262963)
a
 GTC GCC GGA GTT GAA GAA GCT GAA CC 62 
2 IS21-2 (absent)a CGA TCA ATG TTC CGC CTA ATT GAA CC 62 
3 IS21-3 (3797825)
a
 AAT GCA GAC GAC GCG ACG ATT GAA CC 62 
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4 IS21-4 (1592)a CAG CGA CAC TCA CAG CCA ATT GAA CC 62 
5 IS21-5 (1543972)
a
 CTG CAC CGC GCG CAA CGA GGT GAA CC 62 
6 IS21-6 (2263627)
a
 TCC AGG CAC CAG CAT CAA GGT GAA CC 62 
7 IS21-7 (2038898)a CGT TTG TGG GTG TCC GGT ATT GAA CC 62 
8 IS21-8 (2367677)
a
 TGT CGC CAG TTA CGC ACG AGT GAA CC 62 
9 IS21-9 (3549199)
a
 CGC GGA GCC GTC GGC CGC GGT GAA CC 62 
10 IS21-10 (888990)a TGA GGG GGT GTT GAG GTT GGT GAA CC 62 
11 IS21-11 (3379025)
a
 GGG TTT TAA AAA AGT CGC TGT GAA CC 62 
12 IS21-12 (3127932)a GAT GGC ACG GCC GAC CTG AAT GAA CC 62 
13 IS21-13 (3547342)a GAC CGC GGT TGG GTG GAC ATT GAA CC 62 
14 IS21-14 (3378553)
a
 CCC GCG CCT GCG CAA TTG GCT GAA CC 62 
15 IS21-15 (3844681) a GCG ATG TGG ATT GTG TCG GGT GAA CC 62 
16 IS21-16 (1986638)a ATC TGT TCA TCT CCG ACC TGT GAA CC 62 
17 IS21-17 (absent)
a
 CGC GCG GTT CGA ATA CGG TGT GAA CCC 62 
18 IS21-18 (2163649)a TAC CAG CGA CGT TAA ACG GAT GAA CC 62 
19 IS21-19 (3493910)a GAA CCC CGG CTC CGC CTC GAT GAA CC 62 
20 IS21-20 (1657015)
a
 GAG GCT CCT TTC GAC CGC GTT GAA CC 62 
21 IS21-21 (2366892)a GCG TGA TGT GCA CCA TAG TGT GAA CC 62 
22 IS21-22 (2634022) a GGT GCG GGG TCG GGG CCG TTT GAA CC 62 
23 mutT2(58)
b
 wt F  AGA GCT CGC CGA AGA ACC GG 70 
23 mutT2(58)b mut F  AGA GCT CGC CGA AGA ACC GC 70 
23 mutT2(58
b
) R AAG CAG ATG CAC GCG ATA GG 70 
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24 mutT4(48)b  F AGC CGA GAA TCA CAT GGA CG  68 
24 mutT4(48)
b
 wt R CGA GGT GAG CGG GAT CG 68 
24 mutT4(48)
 b
 mut R CGA GGT GAG CGG GAT CC 68 
25 ogt(12)b F CCG CAG GAG AAG ATC GCA T 68 
25 ogt(12)
b
 wt R GCC CGG CCA GGG TTA ATA GC 68 
25 ogt(12)
b
 mut R GCC CGG CCA GGG TTA ATA GT 68 
26 ogt(37)b F CCA TCG GGC CAT TAA CCC T 66 
26 ogt(37)
b
 wt R TCG GGT GTC CAG TGT GCG C 66 
26 ogt(37)b mut R TCG GGT GTC CAG TGT GCG A 66 
27 RD105c F ACA GCG CGG GTC ATA TCA C 62 
27 RD105
c
 int GCA ACA CCC GCT TGT CTT TG 62 
27 RD105c R AAC CAG CTC CTC GAC GCT ATC 62 
28 RD142c F CCG GTG GTA CGG GTA TTT CC 62 
28 RD142
c
 int GCT CGA GCA TGA TCA GCA AAG 62 
28 RD142c R TAG CAC CAG TAC CGG ATG TCC 62 
29 RD150c F AGT GCT GGC AAT AGC GGT TG 62 
29 RD150
c
 int CAC CGG CAC TTA CCA TCT CG 62 
29 RD150c R CCA GCA CTT GTT GCA ACT TCG 62 
30 RD181c F AAA TCC GCC CAT ACC CGT C 62 
30 RD181
c
 R AGC TTC GAC TGG CCA TAG GC 62 
31 797736d wt F CAG CTC ATC TGT TGA TGT TC 66 
31 797736
d
 mut F CAG CTC ATC TGT TGA TGT TT 66 
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31 797736d R ACG CCA TAA GCA CCT TCA CAC 66 
32 909166
d
 wt F CAC GTT TGA CCG GAT CCC GC 69 
32 909166
d
 mut F CAC GTT TGA CCG GAT CCC GT 69 
32 909166d R CGT CCC AAG GAG CAG TCA AG 69 
33 1477596
d
 wt F GCC CGG CCA GGG TTA ATA GC 69 
33 1477596
d
 mut F GCC CGG CCA GGG TTA ATA GT 69 
33 1477596d R CCG GTA AAC CAA TGG CCA C 69 
34 1548149
d
 F CGA CGT GAC ATG GCT GGA TT 68 
34 1548149d wt R CCG ACA ACG TCA GCG ATA CC 68 
34 1548149d mut R CCG ACA ACG TCA GCG ATA CT 68 
35 1692069
d
 F CGA CCC GTG ATC GCA TGT A 69 
35 1692069d wt R CAC CGA GCT CAC CGG CCT TT 69 
35 1692069d mut R CAC CGA GCT CAC CGG CCT TC 69 
36 1892017
d
 wt F CCA CGT TTC TTG ATG CCT AT 66 
36 1892017d mut F CCA CGT TTC TTG ATG CCT AC 66 
36 1892017d R TAT CGA GGC CGA CGA AAG G 66 
37 2376135
d
 wt F GTT GAT GTA TAT CGC GGA CA 66 
37 2376135d mut F GTT GAT GTA TAT CGC GGA CG 66 
37 2376135d R GCC GCC GAA TTA GAA CAG C 66 
38 2532616
d
 F CTG CTT CGA CAC CTT TAA CGC 72 
38 2532616d wt R ATG CCC AAC GCC GCA GTG GGC 72 
38 2532616
d
 mut R ATG CCC AAC GCC GCA GTG GGT 72 
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39 2825581d wt F TGA CGG TCG GAT TCT TGG GT 68 
39 2825581
d
 mut F TGA CGG TCG GAT TCT TGG GG 68 
39 2825581
d
 R AGC CCA CGA GAT ACT GAG CG 68 
40 4137829d wt F AGA TGG CCT ACC GGA TCA CC 69 
40 4137829
d
 mut F AGA TGG CCT ACC GGA TCA CT 69 
40 4137829
d
 R GAC GCA GTC GCA ACA GTT CAC 69 
 
a  chromosomal position of IS6110 insertion sites (2). 
b 
codon positions of SNPs in the mismatch repair genes (15) 
c 
regions of difference (RD) (19) 
d chromosomal positions of sSNPs  (9)  
e
 F – forward primer; R – reverse primer; int – internal primer; wt – wild-type and mut - mutant  
f 
Tm, annealing temperature
. 
 
Phylogenetic analysis 
The evolutionary state(s) for the SNPs in the mismatch repair
 
genes and the 11 
Beijing ST sSNPs was assigned according to
 
the DNA sequence of H37Rv (6).  
IS6110 insertion sites were assigned
 
according to the absence or presence of an 
IS6110 element at
 
a specific chromosomal site (IS6110 insertions at positions
 
3547342 and 3378553 were excluded from the final analysis as
 
they showed a high 
degree of homoplasy).  The RDs were assigned
 
according to their absence or 
presence.  The complete set of
 
evolutionary states for the different mutational events 
or subsets
 
thereof was subjected to phylogenetic analysis using the neighbor
 
joining 
algorithm (PAUP* 4.0; Phylogenetic Analysis Using Parsimony
 
[*Other Methods], 
version 4b10; Sinauer Associates, Sunderland,
 
MA).  Bootstrapping was performed 
to establish a degree of statistical
 
support for branch nodes (8).  A consensus tree 
rooted to M.
 
bovis was generated using the program Contree (PAUP* 4.0).  Only
 
branches which occurred in >50% of the bootstrap trees were
 
included in the final 
tree. Each branch was defined as a Beijing
 
sublineage.
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Statistical analysis 
The z test for proportions was used for testing frequency of
 
occurrence of cases in 
the respective Beijing sublineages.  The
 
Fisher exact test was used to determine the 
association between
 
Beijing sublineage and gender, new versus retreatment cases,
 
smear positivity within 2 months of diagnosis, drug resistance
 
(for patients resident 
in either the urban or the rural setting),
 
and IS6110 clustering (urban setting only).  
In all cases, a
 
P value of 0.05 was used as the cutoff level for significance.
  
Results 
Genotyping showed that 325/1,525 patients (21%) from the urban
 
epidemiological 
field site in Cape Town and 270/904 patients
 
(30%) from the rural setting in the 
Boland, Overberg, Karoo,
 
and Southern Cape regions of the Western Cape had 
tuberculosis
 
with an M. tuberculosis Beijing strain.  Drug susceptibility
 
testing 
showed that of the patients with Beijing strains, 50
 
(15%) from the urban setting and 
63 (23%) from the rural setting
 
had drug-resistant tuberculosis.
  
 
Phylogenetic analysis according to the neighbor joining algorithm
 
grouped the 
Beijing strains from the two settings into four
 
STs, ST11, ST19, ST22, and a novel 
ST (Beijing sublineages 6
 
and 7) (Figure 1, left).  The evolutionary history of these 
STs
 
was further resolved according to SNPs in the mismatch repair
 
genes, mutations 
induced by IS6110 insertion, and the structure
 
of the RDs (Figure 1, right).  This 
phylogenetic tree was statistically
 
robust, and the predicted evolutionary order was 
congruent with
 
the tree based only on sSNPs (compare left and right sides of
 
Figure 
1).  This phylogeny demonstrates that the Beijing genotype
 
is a monophyletic clade, 
defined by the RD105 deletion; IS6110
 
insertions at chromosome positions 1592, 
1986638, 3127932, 3549199,
 
and 3844681; and an sSNP at position 1548149 
(Figure 1, right).
  
Subsequent evolution divided the Beijing strains into seven
 
Beijing sublineages (Figure 1, right) according to RDs (19), sSNPs
 
(9), SNPs in the 
mismatch repair genes (15), and IS6110 insertions
 
(2).  The evolutionary order 
suggests that the RD181 deletion
 
and the mutT4 (codon 48) SNP occurred before 
ST19, while the
 
SNPs in the mutT2 and ogt mismatch repair genes occurred after
 
ST19 and before ST10.  Beijing sublineages 3 to 6 were distinguished
 
by a 
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combination of specific IS6110 insertions and/or sSNPs,
 
while Beijing sublineage 7 
was characterized by the RD150 deletion. 
 
The overall topology of the tree suggests 
divergent evolution,
 
and this is supported by the increasing complexity in the 
IS6110
 
banding patterns between Beijing sublineage 1 (closest to the
 
ancestor) and 
Beijing sublineage 7 (most distant from the ancestor)
 
isolates from the urban setting 
(Figure 2). 
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Figure 1: The evolutionary history of M. tuberculosis Beijing strains from an urban and a rural setting 
in the Western Cape, South Africa.  (Left) Phylogenetic reconstruction based on sSNPs (9) using the 
bootstrapping and neighbor joining algorithms (PAUP* 4.0).  The tree was rooted to M. bovis.  
Bootstrap values are given at internal nodes.  The chromosomal positions of the predominant sSNPs 
are given at the nodes where they occur.  All branches with a zero length were collapsed. (Right) 
Phylogenetic reconstruction based on sSNPs (9), SNPs in mismatch repair genes (15), IS6110 insertion 
points (2), and RDs (19) using the bootstrapping and neighbor joining algorithms (PAUP* 4.0). The 
tree was rooted to M. bovis. Bootstrap values are given at internal nodes. The respective evolutionary 
events are indicated at nodes where they occur (the order in which these events occurred is unknown). 
All branches with a zero length were collapsed. The scale indicates the number of steps per unit length. 
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Figure 2: IS6110 DNA fingerprints of M. tuberculosis Beijing strains from the urban setting.  M. 
tuberculosis isolates were classified by IS6110 DNA fingerprinting according to the internationally 
standardized method (22). The DNA fingerprints from representative isolates are grouped according to 
their Beijing sublineage.  Only a single representative of each IS6110 DNA fingerprint is shown.  
Beijing strains with STs ST03, ST08, ST10, ST17, ST50, ST25,
 
ST26, and ST27; strains with the 
RD142 deletion; and strains
 
with IS6110 insertions at positions 2038898, 2163649, and 2367677
 
were 
absent from this study setting although Beijing strains with these evolutionary events have been 
described elsewhere
 
(2, 9, 15, 19).  In order to determine whether the evolutionary process had altered
 
the ability of drug-sensitive Beijing strains to spread and
 
cause disease, the frequency of occurrence of 
strains from the more recently evolved Beijing sublineage 7 was compared to that of strains belonging 
to the more distantly evolved Beijing sublineages
 
2 to 6.  
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This analysis showed an overabundance of Beijing sublineage
 
7 strains in the urban 
population (Table 2) (p < 0.001 from
 
the z test for the hypothesis that proportion of 
sublineage
 
7 cases = 0.14) as well as in the rural population (Table 3)
 
(p < 0.001 
from the z test for the hypothesis that proportion
 
of sublineage 7 cases = 0.14).  In 
addition, strain clustering
 
according to IS6110 DNA fingerprinting in the urban 
community
 
was strongly associated with the Beijing sublineage 7 (Table
 
2) (odds 
ratio, 5.82; 95% confidence interval, 3.13 to 10.82
 
[p < 0.001]) (A similar analysis 
could not be done for isolates
 
from the rural setting as cultures were not available for 
DNA
 
fingerprinting).   Together, this suggests that strains from sublineage
 
7 have 
evolved a phenotype which allows them to transmit and
 
cause disease more 
frequently than strains from sublineages
 
2 to 6. 
 
To determine whether the frequency of occurrence of drug-susceptible
 
strains could 
be explained by either a demographic or a clinical
 
phenomenon, the demographic 
and clinical data from patients
 
(in both settings) were compared according to their 
strains'
 
Beijing sublineage.  No association could be shown between Beijing
 
sublineage and age, gender, previous history of tuberculosis,
 
and smear positivity 
within the first 2 months following diagnosis.
  
 
To determine whether evolution has altered the ability of the
 
Beijing sublineages to 
acquire drug resistance, phenotypic drug
 
susceptibility data were compared 
according to the respective
 
strains' Beijing sublineage.  The results from the 50 
patients
 
resident in the urban setting showed no association between
 
the Beijing 
sublineage and the number of strains with drug resistance
 
(Table 2).  However, a 
high level of transmission of resistant
 
strains was seen in Beijing sublineage 5, 
which was associated
 
with MDR tuberculosis (Table 2).  Similarly, the high number
 
of drug-resistant tuberculosis cases seen with Beijing sublineages
 
6 and 7 in the rural 
setting was associated with MDR tuberculosis
 
(Table 3). 
 
In this study we have used genetic information to predict evolutionary
 
relationships 
between strains within the Beijing evolutionary
 
lineage in order to test the 
hypothesis that the evolutionary
 
process has altered the ability of these strains to 
spread and
 
cause disease.  According to the phylogenetic prediction we demonstrate
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that the Beijing strain family is a monophyletic clade which
 
could be divided into 
seven sublineages.  The predicted evolutionary
 
order was congruent with the "gold 
standard" tree based on sSNPs
 
(9).  The observation that many of the evolutionary 
events have
 
also been described for Beijing isolates from different geographical
 
regions suggests that these evolutionary events occurred in
 
the distant past and that 
the resulting progeny (including both
 
distantly and more recently evolved clones) 
were subsequently
 
imported into South Africa (13).
  
 
Discussion 
In this study, cases with a sublineage 7 strain were over-represented,
 
suggesting that 
the evolutionary process has had a positive
 
influence on the strain's ability to spread 
and cause disease. This concept was further supported by an association between
 
sublineage 7 and transmissibility.  Similarly, in a previous
 
study, a significant 
association was observed between extrathoracic
 
tuberculosis and a subset of Beijing 
strains characterized by
 
either RD142 or RD150 deletion (12).  Together these data 
support
 
the hypothesis that phenotypic differences may exist within
 
the Beijing 
strain family (7, 19).  Molecular epidemiological
 
studies also support the notion that 
the more recently evolved
 
strains (termed typical Beijing strains) are adapted to 
spread
 
and cause disease, given their frequency of occurrence, in comparison
 
to 
distantly evolved strains (termed atypical Beijing strains)
 
(14, 18).  However, factors 
including social behavior which could
 
lead to the spread of sublineage 7 strains were 
not investigated
 
in this study.  An alternative explanation for the high frequency
 
of 
occurrence of the Beijing sublineage 7 strains in South Africa
 
could be a strong 
founder effect.  However, comparison between
 
Beijing genotypes from South Africa 
and East Asia showed that
 
at least nine different Beijing founder strains were 
introduced
 
into South Africa (data not shown).  The spectrum of founder
 
strains is 
likely to reflect that in East Asia at the time of
 
importation into South Africa since 
the East Asia immigrants
 
were derived from many different locations throughout the 
region.  Thus, it is probable that the subsequent spread of sublineage
 
7 in South 
Africa represents evolutionary selection of an individual
 
sublineage rather than a 
founder effect.
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The observation of a changing epidemiological picture concurrent
 
with the 
accumulation of evolutionary events cannot be linked
 
to the sSNPs analyzed as these 
events are thought to be largely
 
neutral (9).  Conversely, mutation in the mismatch 
repair genes
 
(15), IS6110 integration (2), and chromosomal deletions (19)
 
may 
influence the strains' ability to spread and cause disease
 
by altering or eliminating 
gene function.  Mutation in the mismatch
 
repair genes has been hypothesized to 
enhance the ability of
 
the Beijing strains to acquire drug resistance (15).  IS6110
 
insertion is thought to influence the characteristics of the
 
Beijing strains by altering 
the function of genes by either
 
causing knockouts or disrupting or enhancing 
promoter activity
 
(2).  The accumulation of chromosomal deletions has been 
suggested
 
to contribute to an altered virulence in the Beijing strain
 
family (19), and 
in a previous study, the analysis of 100 M.
 
tuberculosis strains suggested an 
association between deletion
 
and an altered phenotype (20).  In our study the most 
pathogenic
 
strains, as measured by their frequency of occurrence, were
 
associated 
with the accumulation of deletions, including RD150.
  
The true extent of 
chromosomal evolution within the Beijing
 
strain family almost certainly extends 
beyond the evolutionary
 
events tested in this study, and the influence of such events
 
on the phenotype of different strains remains to be determined.
  
 
Our study design differs from previous studies as we analyzed
 
intrastrain family 
phenotypic-genotypic correlations compared
 
to interstrain family phenotypic-
genotypic correlations (5,
 
7, 16, 17, 21).  In our study, the analysis of patient 
demographic
 
and clinical data failed to demonstrate an association with
 
any of the 
Beijing strain sublineages. This implies that the
 
appearance of secondary cases 
occurs independently of the proportion
 
of infectious (smear-positive) cases in the 
different sublineages,
 
thereby suggesting that the characteristics of the strains from
 
the different sublineages could be the key factors influencing
 
the ability to spread 
and cause disease.
  
 
We noted the presence of drug resistance in all of the Beijing
 
sublineages and noted 
that the frequency of occurrence of the
 
drug resistance phenotype was not associated 
with the most recently
 
evolved Beijing sublineage.  The absence of spread of drug 
resistance
 
in the most recently evolved Beijing sublineage could be explained
 
by the 
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fitness cost as a result of the acquisition of mutations
 
in the genes conferring drug 
resistance (1).  The high number
 
of resistant cases in sublineage 5 (urban setting) 
and sublineages
 
6 and 7 (rural settings) was associated with MDR tuberculosis
 
and 
clearly indicates that MDR tuberculosis can spread within
 
communities if not 
managed and treated appropriately.
  
 
In summary, we suggest that the pathogenic characteristics of
 
M. tuberculosis strains 
are not conserved within defined strain
 
families but rather that individual lineages 
within strain families
 
have evolved unique pathogenic characteristics.
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Abstract
 
The fitness cost associated with the evolution of resistance to rifampin in 
Mycobacterium tuberculosis may be different in clinical isolates compared to in vitro-
generated mutants. An atypical Beijing strain (attenuated phenotype) demonstrated 
the ability to spread despite acquiring resistance to rifampin.  Transmission was 
linked to human immunodeficiency virus co-infection (p = 0.029), raising concern for 
the spread of drug resistance in vulnerable populations. 
Text 
The fitness of Mycobacterium tuberculosis strains circulating in a community is 
possibly the driving force perpetuating the tuberculosis epidemic.  This is particularly 
true for the spread of drug resistance, since it has been suggested that the evolution of 
drug resistance has a fitness cost resulting in the overall attenuation of the pathogen 
(1).  This phenomenon has been demonstrated during the spontaneous in vitro 
evolution of resistance to rifampin, where a direct correlation was observed between 
the frequency at which a specific non-synonymous single nucleotide polymorphism 
(nsSNP) occurred and the fitness of the mutant clone (4).  That study showed that 
rarely observed nsSNPs had a high fitness cost, whereas frequently observed nsSNPs 
had a low fitness cost.  These results correlated well with the frequency of nsSNPs 
observed in rifampin-resistant clinical isolates (4).   
Molecular epidemiological studies have suggested that certain M. tuberculosis 
genotypes are more successful than others (3, 5).  Accordingly, it has been 
hypothesized that the Beijing genotype is a high fitness genotype, possibly as a result 
of the evolution of unique properties (2, 11, 16).  Strains with the Beijing genotype 
can be broadly grouped as typical or atypical according to the presence or absence, 
respectively, of an IS6110 insertion in the NTF region of the M. tuberculosis genome 
(9).  Phylogenetic analysis has provided evidence that these two genotypes are 
derived from a common progenitor (6); however, they demonstrate vastly different 
epidemiological characteristics, since strains with the atypical Beijing genotype are 
only rarely observed (9, 14).  This has prompted speculation that atypical Beijing 
strains have lower fitness than typical Beijing strains. We hypothesize that rifampin 
resistance causing nsSNPs that have a fitness cost would only be rarely observed in 
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M. tuberculosis strains with an atypical Beijing genotype unless epidemiological 
factors favouring their spread were present.   
 
To test this hypothesis, sputum specimens were collected from retreatment cases 
attending health care clinics or referral hospitals in two provinces in South Africa.  
Each specimen was subjected to routine culture-based drug susceptibility testing for 
isoniazid and rifampin. During the period from January 2001 to October 2004, 312 
rifampin-resistant cases were identified from the Western Cape (WC) region (12), 
while during the period from September 2003 to May 2004, 117 rifampin resistant 
cases were identified from the Eastern Cape (EC) region. DNA sequence analysis of 
the rifampin resistance determining region (RRDR) of the rpoB gene (13) showed that 
>90% of rifampin-resistant isolates had an nsSNP in the RRDR region.  Of the 30 
nsSNPs identified, 25 nsSNPs appeared at a frequency consistent with frequencies 
reported in in vitro-generated rifampin-resistant mutants (4, 7, 10) (Table 1).  The 
frequency of appearance of the remaining five nsSNPs was discordant compared to 
the in vitro-generated rifampin resistant mutants (Table 1).  The nsSNPs at codons 
516 (GAC→GTC and GAC→TAC) and 533 (CTG→CCG) were significantly under-
represented in the in vitro-generated rifampin resistant mutants, while nsSNPs at 
codon 522 (TCG→TTG) and codon 526 (CAC→CGC) were significantly over-
represented in the in vitro-generated rifampin-resistant mutants (Table 1).  This 
suggests that the nsSNPs at codons 516 (GAC→GTC and GAC→TAC) and 533 
(CTG→CCG) had a lower fitness cost in clinical isolates compared to in vitro-
generated rifampin resistant mutants. Conversely, the nsSNPs at codons 522 
(TCG→TTG) and 526 (CAC→CGC) appear to have a high fitness cost in clinical 
isolates.  
C
h
a
p
te
r 
2
 
 
8
2
T
a
b
le
 1
: 
D
is
tr
ib
u
ti
o
n
 o
f 
n
sS
N
P
s 
co
n
fe
rr
in
g
 r
es
is
ta
n
ce
 t
o
 r
if
am
p
in
 i
n
 c
li
n
ic
al
 i
so
la
te
s 
fr
o
m
 t
h
e 
W
C
 a
n
d
 E
C
 r
eg
io
n
s 
o
f 
S
o
u
th
 A
fr
ic
aa
 
 
 
 
 
 
 
W
es
te
rn
 C
a
p
e 
R
IF
R
 
 
E
a
st
er
n
 C
a
p
e 
R
IF
R
 
 
 
 
 
 
B
ei
ji
n
g
 (
n
=
1
1
6
) 
 
B
ei
ji
n
g
 (
n
=
5
9
) 
 
 
 
 
 
 
C
o
d
o
n
 
W
T
 
 
M
u
t 
In
 v
it
ro
 
R
IF
R
 
st
u
d
ie
s 
co
m
b
in
ed
a
  
(n
=
3
6
8
) 
 
A
ll
 
(n
=
3
1
2
) 
N
o
n
-
B
ei
ji
n
g
 
(n
=
1
9
6
) 
T
y
p
ic
a
l 
(n
=
1
0
1
) 
A
ty
p
ic
a
l 
(n
=
1
5
) 
 
A
ll
 
(n
=
1
1
7
) 
N
o
n
-B
ei
ji
n
g
 
(n
=
5
8
) 
T
y
p
ic
a
l 
(n
=
1
4
) 
A
ty
p
ic
a
l 
(n
=
4
5
) 
4
9
0
 
C
A
G
 
→
 
C
A
A
 
 
 
1
 
1
 
 
 
 
 
 
 
 
5
1
1
 
C
T
G
 
→
 
C
C
G
 
 
 
3
 
 
2
 
1
 
 
3
 
 
3
 
 
5
1
2
 
C
A
A
 
→
 
A
A
A
 
 
 
3
 
3
 
 
 
 
 
 
 
 
C
A
A
 
→
 
A
A
A
 
2
 
 
4
 
4
 
 
 
 
 
 
 
 
C
A
A
 
→
 
C
C
A
 
 
 
1
 
 
 
1
 
 
 
 
 
 
C
A
A
 
→
 
G
A
A
 
4
 
 
 
 
 
 
 
 
 
 
 
5
1
3
 
C
A
A
 
→
 
C
T
A
 
2
 
 
 
 
 
 
 
 
 
 
 
G
A
C
 
→
 
G
T
C
 
3
b
 
 
1
5
 
7
 
5
 
3
 
 
2
9
 
1
 
1
 
2
7
 
G
A
C
 
→
 
T
A
C
 
 
 
1
5
 
1
3
 
1
 
1
 
 
6
 
2
 
1
 
3
 
G
A
C
 
→
 
T
T
C
 
 
 
1
 
1
 
 
 
 
 
 
 
 
5
1
6
 
G
A
C
 
→
 
G
G
C
 
 
 
1
 
 
1
 
 
 
 
 
 
 
5
1
9
 
A
A
C
 
→
 
A
A
G
 
1
 
 
 
 
 
 
 
 
 
 
 
5
2
2
 
T
C
G
 
→
 
T
T
G
 
4
6
c  
 
 
 
 
 
 
 
 
 
 
C
A
C
 
→
 
A
A
C
 
 
 
3
 
1
 
1
 
1
 
 
1
 
1
 
 
 
C
A
C
 
→
 
C
T
C
 
1
 
 
5
 
4
 
1
 
 
 
1
 
 
1
 
 
C
A
C
 
→
 
T
A
C
 
5
8
 
 
1
9
 
1
4
 
5
 
 
 
6
 
3
 
1
 
2
 
C
A
C
 
→
 
G
A
C
 
1
8
 
 
8
 
7
 
1
 
 
 
 
 
 
 
C
A
C
 
→
 
G
C
C
 
 
 
2
 
2
 
 
 
 
 
 
 
 
C
A
C
 
→
 
T
G
C
 
 
 
1
 
1
 
 
 
 
 
 
 
 
C
A
C
 
→
 
C
G
C
 
5
7
c  
 
1
 
1
 
 
 
 
 
 
 
 
5
2
6
 
C
A
C
 
→
 
C
C
C
 
4
 
 
 
 
 
 
 
 
 
 
 
5
2
9
 
C
G
A
 
→
 
C
C
A
 
1
 
 
 
 
 
 
 
 
 
 
 
C
h
a
p
te
r 
2
 
 
8
3
C
G
A
 
→
 
C
A
A
 
1
 
 
 
 
 
 
 
 
 
 
 
C
G
A
 
→
 
G
G
A
 
1
 
 
 
 
 
 
 
 
 
 
 
T
C
G
 
→
 
T
G
G
 
1
7
 
 
8
 
2
 
3
 
3
 
 
2
 
2
 
 
 
T
C
G
 
→
 
T
T
G
 
1
3
2
 
 
1
6
9
 
1
1
0
 
5
4
 
5
 
 
5
8
 
4
2
 
5
 
1
1
 
T
C
G
 
→
 
C
A
G
 
 
 
3
 
 
3
 
 
 
 
 
 
 
5
3
1
 
T
C
G
 
→
 
T
T
C
 
 
 
1
 
 
1
 
 
 
 
 
 
 
C
T
G
 
→
 
C
C
G
 
1
b
 
 
1
5
 
5
 
1
0
 
 
 
 
 
 
 
5
3
3
 
C
T
G
 
→
 
G
A
G
 
 
 
2
 
 
2
 
 
 
 
 
 
 
M
u
lt
ip
le
 
n
sS
N
P
s 
 
 
 
2
 
 
1
 
1
 
 
 
 
 
 
 
 
In
se
rt
io
n
s 
 
 
 
1
 
 
1
 
1
 
 
 
 
 
 
 
 
D
el
et
io
n
s 
 
 
 
1
5
d
 
 
2
 
2
 
 
 
 
 
 
 
 
n
sS
N
P
s 
a
b
se
n
t 
fr
o
m
 
R
R
D
R
 
 
 
 
1
 
 
2
7
 
1
6
 
1
1
 
 
 
1
1
 
7
 
2
 
2
 
 
a 
C
o
m
b
in
e
d
 d
at
a 
fr
o
m
 (
4
,7
,1
0
) 
b
 U
n
d
er
-r
ep
re
se
n
te
d
 i
n
 t
h
e 
in
 v
it
ro
-g
en
er
at
e
d
 r
if
am
p
ic
in
-r
es
is
ta
n
t 
m
u
ta
n
ts
 [
z-
te
st
 (
p
 <
 0
.0
0
1
)]
 
c 
O
v
er
-r
ep
re
se
n
te
d
 i
n
 t
h
e 
in
 v
it
ro
-g
en
er
at
ed
 r
if
am
p
ic
in
-r
es
is
ta
n
t 
m
u
ta
n
ts
 [
z-
te
st
 (
p
 <
 0
.0
0
1
)]
 
  
  
 d
 E
le
v
en
 d
if
fe
re
n
t 
d
el
et
io
n
 e
v
en
ts
 (
7
,1
0
) 
  
  
  
W
T
 =
 w
il
d
 t
y
p
e 
co
d
o
n
 s
eq
u
en
ce
, 
M
u
t 
- 
m
u
ta
n
t 
co
d
o
n
 s
e
q
u
e
n
ce
, 
R
IF
R
 -
 r
if
am
p
ic
in
-r
es
is
ta
n
t,
 R
R
D
R
 -
 r
if
am
p
ic
in
-r
es
is
ta
n
ce
 d
et
er
m
in
in
g
 r
e
g
io
n
  
 
Chapter 2 
 84 
In order to determine whether a relationship existed between strain genotype and the 
nsSNPs conferring rifampin resistance, the isolates from this study were classified as 
either Beijing or non-Beijing by spoligotyping (8).  The results showed that 116 
(37%) of the rifampin-resistant cases from the WC region and 59 (50%) of the 
rifampin-resistant cases from the EC region were infected with a Beijing genotype 
strain (Table 1).  Subclassification of the Beijing isolates as either typical or atypical 
(6) showed that the population structure of rifampin resistant Beijing strains was 
significantly different in the two study settings (Fisher exact test odds ratio = 21.6; 
95% confidence interval = 9.6 to 48.6, p < 0.0001) (Table 1). The nsSNP at codon 
516 (GAC→GTC) was associated with the atypical Beijing genotype from the EC 
(Fisher exact test odds ratio = 45; 95% confidence interval = 3.8 to 525, p < 0.0008), 
while the nsSNP at codon 533 was mostly found in isolates with the typical Beijing 
genotype from the WC (Table 1).  
 
IS6110 DNA fingerprinting (15) showed that isolates from the WC region with the 
typical Beijing genotype and either an nsSNP at codon 516 (GAC→GTC) or codon 
533 (CTG→CCG) were not clustered (5 of 5 banding patterns and 9 of 10 banding 
patterns, respectively), thereby suggesting that these nsSNPs had evolved 
independently and that the resulting clones were not transmitted.  In contrast, the 
isolates from the EC region with the atypical Beijing genotype and an nsSNP at codon 
516 (GAC→GTC) were clustered and also shared the rare -17 inhA promoter 
mutation (G→T) (data not shown), suggesting ongoing transmission. These isolates 
clustered with the atypical Beijing strains from the WC which had an nsSNP at codon 
516 (GAC→GTC) and the -17 inhA promoter mutation, suggesting interprovincial 
spread.  This finding was contrary to previous reports, which suggested that atypical 
Beijing strains are attenuated in their ability to transmit (9, 14), while the mutation at 
codon 516 (GAC→GTC) would have been expected to further compromise the ability 
of these strains to transmit unless compensatory mutations were present or the 
epidemiological context allowed transmission to occur.  Analysis of the host 
population in the EC region showed human immunodeficiency virus (HIV) 
coinfection to be a risk factor for the spread of the atypical Beijing strains (z-test for 
the hypothesis that a proportion of HIV-positive cases = 0.42, p < 0.029).  In contrast, 
the frequency of atypical Beijing strains was low in the WC region, which in turn has 
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a low incidence of HIV-tuberculosis coinfection (6).  This raises concern for the 
spread of all drug-resistant strains in vulnerable populations.  
 
In summary, greater vigilance is required to contain the drug-resistant tuberculosis 
epidemic in high-HIV-prevalence settings.  This can be achieved by the development 
and implementation of rapid diagnostics, the provision of appropriate therapy, 
ensuring treatment adherence, and intensified screening of contacts.  However, in 
order for diagnosis and treatment to be effective, it is essential that communities are 
educated to improve health-seeking behavior. 
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Abstract 
This study describes a comparative analysis of the Beijing mycobacterial
 
interspersed 
repetitive unit types of Mycobacterium tuberculosis
 
isolates from Cape Town, South 
Africa, and East Asia.  The results
 
show a significant association between the 
frequency of occurrence
 
of strains from defined Beijing sublineages and the human 
population
 
from whom they were cultured (p < 0.0001).
 
 
Text  
Mycobacterium tuberculosis strains with the Beijing genotype
 
have been shown to be 
globally widespread and are particularly
 
prevalent in East Asia, where over 80% of 
strains from the Beijing,
 
China region are of this genotype (5).  It has been 
hypothesized
 
that Beijing strains have evolved unique properties, including
 
the ability 
to evade the protective effect of Mycobacterium
 
bovis BCG vaccination (19) and the 
ability to spread more efficiently
 
than non-Beijing strains (2).  However, the clinical 
presentations
 
of patients with tuberculosis caused by a Beijing strain were
 
found to 
vary between different geographical settings (3-5,16).
  
Currently, it is not known 
whether the observed variability
 
in clinical presentation is a function of the Beijing 
strain
 
population found in particular geographical settings, is a function
 
of the genetic 
composition of the human population, or is a
 
function of a combination of these two 
variables.
  
This study aimed to test the hypothesis that host-pathogen compatibility
 
determined 
the Beijing strain population structure in different
 
host populations in different 
geographical settings.  Cultures
 
of M. tuberculosis isolates from patients of mixed 
ancestry
 
(14) who were resident in Cape Town, South Africa (20) were
 
classified as 
being of the Beijing genotype by spoligotyping
 
(10).  The Beijing strains were 
assigned to phylogenetic sublineages
 
as described previously (8) and were genotyped 
by mycobacterial
 
interspersed repetitive-unit (MIRU) typing (17).
 
 
During the study period (January 1993 to December 2004), 25
 
MIRU types were 
identified among 321 tuberculosis cases infected
 
with a Beijing strain (Table 1).  A 
comparison of the MIRU type
 
data for the Beijing strains from Cape Town and 
previously published
 
MIRU type data for the Beijing strains from East Asia (1, 9,
 
12, 
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13, 15, 18) showed that nine of the Beijing MIRU types (types
 
MT01, MT08, MT11, 
MT18, MT19, MT21, MT28, MT33, and MT54) were
 
shared between these 
geographical settings (Table 1).  This suggests
 
that the nine shared Beijing MIRU 
types represent founder strains
 
that were introduced into Cape Town from East Asia, 
as the latter
 
is thought to be the evolutionary origin of strains with a Beijing
 
genotype 
(5, 7, 12).  The definition of founder MIRU types was
 
supported by their 
disproportionately high number (n = 267)
 
compared to the number with non-founder 
MIRU types (n = 54) in
 
tuberculosis patients from Cape Town (z test for the 
hypothesis
 
that the proportion of types were founder MIRU types = 0.5;
 
p < 0.001). 
Superimposition of the Beijing MIRU type data onto the previously
 
described 
phylogenetic tree of the Beijing strain family (8)
 
provided a framework that could be 
used to predict the evolutionary
 
order in which the 25 Beijing MIRU types had 
evolved (Figure 1).
  
From this prediction, the Beijing MIRU types could be partitioned
 
into seven Beijing sublineages. The number of founder Beijing
 
MIRU types was 
variable among the different Beijing sublineages
 
(Figure 1). Twenty-four of the 
Beijing MIRU types were unique
 
to their respective sublineages, while the remaining 
Beijing
 
MIRU type (MT11) was shared by three different sublineages (sublineages
 
2, 
3, and 6) (Figure 1 and Table 1), suggesting that MT11 was
 
an ancestral Beijing 
MIRU type (12).
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Evolutionary scenario of Beijing MIRU types according to Beijing sublineage. Beijing 
MIRU types were grouped according to their respective Beijing sublineages (8), and the most 
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parsimonious evolutionary order was proposed. The Beijing MIRU types are indicated within each box. 
Founder Beijing MIRU types are indicated by bold boxes. Unknown Beijing MIRU types are indicated 
by "?." 
 
To determine the propensity of Beijing strains from the different
 
sublineages to spread 
in the human population in Cape Town,
 
the number of cases in circulation within each 
sublineage was
 
compared to the number of founder strains for that sublineage
 
(Table 
1). The number of representatives of these founder strains
 
was shown to be 
overrepresented in sublineage 7 (n = 233 cases
 
from one founder strain) compared 
with the numbers in sublineages
 
1 to 6 (n = 88 cases from eight founder strains) (z test 
for
 
the hypothesis that the proportion of sublineage 7 cases = 0.11;
 
p < 0.001).  In 
comparison, founder Beijing MIRU types MT01,
 
MT08, MT11, MT18, MT19, 
MT21, MT33, and MT54 were overrepresented
 
in the human population in East Asia 
(China, 73/130; Hong Kong,
 
108/211; Vietnam, 25/37; and Singapore, 45/56) 
compared to their
 
representation in Cape Town, South Africa (79/321) (Fisher's
 
exact 
test odds ratio [OR], 4.20; 95% confidence interval [CI],
 
3.06 to 5.77; p < 0.0001).
 
 
A significant association between the frequency of occurrence
 
of strains of defined 
Beijing sublineages and the human population
 
from whom they were isolated was 
observed (for sublineages 1
 
to 6, n = 88 for Cape Town and n = 253 for East Asia; for 
sublineage
 
7, n = 233 for Cape Town and n = 43 for East Asia; Fisher's
 
exact test OR, 
15.58; 95% CI, 10.38 to 23.38; p < 0.0001).
 
 
It is unlikely that these findings can be explained by multiple
 
importations of founder 
strains of sublineage 7 in preference
 
to founder strains of sublineages 1 to 6, given 
that immigrants
 
to South Africa came from many different geographical regions
 
in 
East Asia and that sublineage 7 founder strains are less
 
frequently observed in East 
Asia. Accordingly, we propose that
 
the situation in Cape Town represents an 
approximation to a
 
common starting point for all the founder strains introduced,
 
with 
those best adapted to the local population spreading most
 
efficiently.  This could be 
due to the innate characteristics
 
of the strains within defined Beijing sublineages or 
the local
 
host population.  Susceptibility to M. tuberculosis per se has
 
frequently been 
associated with the HLA genotype (11), and HLA
 
allele frequencies are known to 
differ widely between human
 
populations with different histories, with certain alleles 
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totally
 
absent in some populations.  Our conclusion differs from that
 
of Gagneux et al. 
(6), as we demonstrate that strains from a
 
defined sublineage (a subset of strains from 
an evolutionary
 
lineage) may have been selected by a human population in a defined
 
geographical setting.
 
 
In summary, the global success of the Beijing lineage may reflect
 
either the selection 
of defined sublineages in different geographical
 
settings by distinct human 
populations or the adaptation of
 
strains in a defined sublineage to spread more readily 
in a
 
distinct human population.  We acknowledge that these contrasting
 
conclusions 
cannot be easily distinguished with the available
 
data.  However, the emergence of a 
sublineage of Beijing strains
 
with increased pathogenicity may have important 
implications
 
for the Tuberculosis Control Program.  Early diagnosis and contact
 
tracing will be essential to curb the spread of these strains. 
 
Furthermore, it will be 
important to ensure that future vaccines
 
protect against these strains.
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Abstract 
IS6110 restriction fragment length polymorphism (RFLP) genotyping is the most 
widely used genotyping method to study the epidemiology of Mycobacterium 
tuberculosis.  However, due to the complexity of the IS6110 RFLP genotyping 
technique, and the interpretation of RFLP data, mycobacterial interspersed repetitive-
unit–variable-number tandem-repeat (MIRU-VNTR) genotyping has been proposed 
as the new genotyping standard.  This study aimed to determine the discriminatory 
power of different MIRU-VNTR locus combinations relative to IS6110 RFLP 
genotyping, using a collection of Beijing genotype M. tuberculosis strains with a well-
established phylogenetic history.  Clustering, diversity index, clustering concordance, 
concordance among unique genotypes, and divergent and convergent evolution were 
calculated for seven combinations of 27 different MIRU-VNTR loci and compared to 
IS6110 RFLP results.  Our results confirmed previous findings that MIRU-VNTR 
genotyping can be used to estimate the extent of recent or ongoing transmission. 
However, molecular epidemiological linking of cases varied ignificantly depending 
on the genotyping method used.  We conclude that IS6110 RFLP and MIRU-VNTR 
loci evolve independently and at different rates, which leads to discordance between 
transmission chains predicted by the respective genotyping methods.  Concordance 
between the two genotyping methods could be improved by the inclusion of genetic 
distance (GD) into the clustering formulae for some of the MIRU-VNTR loci 
combinations.  In summary, our findings differ from previous reports, which may be 
explained by the fact that in settings of low tuberculosis incidence, the genetic 
distance between epidemiologically unrelated isolates was sufficient to define a strain 
using either marker, whereas in settings of high incidence, continuous evolution and 
persistence of strains revealed the weaknesses inherent to these markers. 
Introduction 
Over the past 2 decades, molecular genotyping methods have enhanced our 
understanding of the epidemiology of tuberculosis (TB) in numerous geographical 
settings.  These methods have enabled geo-temporal tracking of Mycobacterium 
tuberculosis strains with the view to identifying source cases responsible for TB 
outbreaks (3), tracking of recent and ongoing disease transmission (31), 
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distinguishing between reinfection and relapse (28), evaluating the effectiveness of 
direct observed therapy short-course-based TB control programs (5,16), and 
identifying global genetic lineages (7).  Ideally, molecular genotyping tools should 
be inexpensive, highly discriminative, deliver rapid results, be straightforward to 
perform, and produce easily interpretable results that allow for accurate 
interlaboratory comparisons (universally comparable databases).  
 
Three genotyping methods are currently widely used in molecular epidemiological 
studies of TB: IS6110 restriction fragment length polymorphism (RFLP) genotyping 
(27), spoligotyping (14), and mycobacterial interspersed repetitive-unit–variable-
number tandem-repeat (MIRU-VNTR) genotyping (21, 22).  Currently, IS6110 RFLP 
genotyping is the most widely used genotyping method (27).  However, this method is 
time-consuming, laborious, and complex.  Furthermore, differences in application can 
make inter-laboratory comparisons difficult, and the data generated may have 
limitations (i.e., comparison of strains with high versus low IS6110 copy numbers).  
More recently, the validity of the calculation of IS6110 RFLP clustering, as a 
surrogate for transmission, has been questioned, as the IS6110 banding pattern may 
change during transmission (33, 35).  A nearest genetic distance model has been 
evaluated to incorporate IS6110 banding changes into the calculation of ongoing 
transmission (24).  The term “cluster” has also been questioned in studies which have 
compared contact tracing data with IS6110 RFLP data (4, 26).  In response, numerous 
studies have been conducted to try to identify alternative methods that have the ability 
to accurately describe epidemiological events in different settings at a similar 
discriminatory level to that of IS6110 RFLP genotyping. One of the most promising 
methods is MIRU-VNTR genotyping, a PCR-based method for detecting the number 
of tandem repeats at a given genetic locus.  Supply et al. (21) defined a set of 15 
MIRU-VNTR loci for molecular epidemiological investigations and a set of 24 
MIRU-VNTR loci for phylogenetic analysis of M. tuberculosis strains worldwide.  In 
support of this, another study concluded that this “real-time” MIRU-VNTR 
genotyping approach was highly applicable for population-based studies (18).  This 
view was reinforced by a study conducted in the Brussels region, where the authors 
concluded that a standardized MIRU-VNTR genotyping method could be a new 
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reference for epidemiological and phylogenetic screening of M. tuberculosis strains 
(2).   
A study from Japan (10) investigated the differentiation power of the proposed 15- 
and 24-loci MIRU-VNTR genotyping methods for strains with the Beijing genotype 
and concluded that the analyses of these loci were of limited use for discriminating 
strains of this genotype.  In their study they showed that VNTR loci 3820, 3232, and 
4120 were highly polymorphic in Beijing genotype strains and thus proposed the use 
of these loci to enhance the discriminatory power of the proposed 15-loci MIRU-
VNTR genotyping method. However, other studies have excluded these loci due to 
difficulties associated with the reproducibility of PCR amplification (15, 21, 36). 
Subsequently, a study in Hong Kong, which also examined strains of the Beijing 
genotype, showed that a different combination of 12 VNTR and QUB (Queen’s 
University of Belfast) loci gave a Hunter-Gaston discriminatory index value which 
was almost equal to that obtained in IS6110 RFLP genotyping (12, 13).  However, 
this was refuted by a more recent study from China which suggested that MIRU-
VNTR genotyping may over-estimate transmission in isolates with the Beijing 
genotype (11).  Collectively, these findings suggest that the selection of MIRU-VNTR 
loci for optimal differentiation of M. tuberculosis requires further validation in 
different geographical settings.  To date, the performance of the MIRU-VNTR 
genotyping method has not been evaluated in an epidemic setting, nor has it been 
tested within the context of a robust M. tuberculosis phylogeny.  
 
In this study the discriminatory power of different MIRUVNTR locus combinations 
was determined as previously described (8, 10, 21, 22) and compared to the IS6110 
RFLP genotyping method by using a collection of Beijing genotype M. tuberculosis 
strains with a well-established phylogenetic history (9).  The results are discussed in 
the context of concordance between the different genotyping methods in their abilities 
to define a strain and to accurately describe the epidemiology of TB in a high-
incidence setting. 
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Materials and methods 
Study population  
Sputum samples were collected during the period from January 1993 to December 
2004 from new and retreatment TB patients who were resident and attending health 
care clinics in an epidemiological field site in Cape Town, South Africa (31).  This 
study is part of a larger, long-term molecular epidemiological project which has been 
approved by the ethics committee of Stellenbosch University. 
IS6110 RFLP genotyping  
M. tuberculosis isolates were cultured on MGIT (Becton-Dickinson) or Löwenstein-
Jensen medium, and DNA was extracted as previously described (32).  Each isolate 
was classified by IS6110 RFLP genotyping (27) and spoligotyping (14) using 
internationally standardized protocols.  IS6110 RFLP patterns were analyzed using 
Gelcompar II (Applied-Maths, Sint-Martens-latem, Belgium) with tolerance settings 
allowing a 5% shift in lane position and a 0.6% variation in individual band position 
to compensate for minor technical errors.  Isolates were assigned as members of the 
Beijing genotype if they had the characteristic Beijing spoligotype (30).  Only the first 
M. tuberculosis isolate from each case was included for subsequent analysis.  Each 
Beijing isolate was grouped into one of seven phylogenetic sublineages according to 
40 different genetic markers, as previously described (9). 
DNA sequencing 
The DNA sequence of the katG, rpoB, embB, and rrs genes of isolates classified as 
members of the Beijing sublineage 5 were determined as previously described (19, 
25). 
MIRU-VNTR typing 
Twenty-seven MIRU-VNTR loci were amplified by PCR as described previously (8, 
10, 21, 22).  The number of repeats at each genomic locus was calculated according to 
the electrophoretic mobility of the corresponding PCR product (23). Alleles were 
assigned numerical values according to the number of repeats present in that genomic 
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locus.  Isolates were genotypically classified according to seven different MIRU-
VNTR locus combinations (Table 1). 
Table 1: MIRU-VNTR locus combinations  
 
MIRU-VNTR Locus Combinations 
 
12-MIRUa  
12-
MIRU + 
ETR A, 
B, C
b
 
12-MIRU 
+ hyper-
variable 
loci
e
  
15-
MIRU-
VNTR
c
 
15-
MIRU-
VNTR + 
hyper-
variable 
loci
d
 
24-MIRU-
VNTRc 
24-MIRU-
VNTR + 
hyper-variable 
loci
e
 
MIRU02 • • •   • • 
MIRU04 • • • • • • • 
MIRU10 • • • • • • • 
MIRU16 • • • • • • • 
MIRU20 • • •   • • 
MIRU23 • • •   • • 
MIRU24 • • •   • • 
MIRU26 • • • • • • • 
MIRU27 • • •   • • 
MIRU31 • • • • • • • 
MIRU39 • • •   • • 
MIRU40 • • • • • • • 
VNTR1955    • • • • 
VNTR2165/ETR-A  •  • • • • 
QUB11b    • • • • 
QUB26b    • • • • 
VNTR0424    • • • • 
VNTR2401    • • • • 
VNTR4156    • • • • 
VNTR3690    • • • • 
ETR-C  •  • • • • 
VNTR2347      • • 
ETR-B  •    • • 
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Mtub 34      • • 
QUB3232   •  •  • 
VNTR3820   •  •  • 
VNTR4120     •   •   • 
 
• locus included
    
a according to (22)  
b
 according to (7) 
c according to (21) 
d
 according to (9) 
e
 this study
 
 
 
Analytical calculations  
(i) Estimation of clustering:  A cluster (representing either recent or ongoing 
transmission or a <2-year interval) was defined as a series of isolates having the same 
genotype (IS6110 RFLP or MIRU-VNTR), while isolates with unique IS6110 RFLP 
or MIRU-VNTR genotypes were considered to represent reactivation or influx of 
disease into the study community (20).  Secondary analyses which incorporated the 
concept of evolution during transmission were done using data sets (genotypes 
according to IS6110 RFLP or a particular MIRU-VNTR locus combination) in which 
isolates separated by a single evolutionary event were combined into transmission 
chains with a genetic distance of 1 (24). 
 
(ii) Estimation of genetic diversity:  The genetic diversity for each individual 
MIRU-VNTR locus, each of the seven MIRU-VNTR locus combinations (Table 1), 
and the IS6110 RFLP fingerprints was calculated as h = 1 - ∑xi
2
[n/(n – 1)], where xi is 
the frequency of the ith allele at the locus, n is the number of isolates in the sample, 
and the term n/(n - 1) is a correction for bias in small samples (17). 
 
(iii) Estimation of matching and mismatching concordance:  Concordance 
between the IS6110 RFLP genotypes and the respective MIRU-VNTR genotypes was 
calculated as follows: each isolate was paired with every other isolate in the data set, 
and their genotypes (IS6110 RFLP and MIRU-VNTR) were scored as either a match 
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(identical) or mismatch (nonidentical).  Matching concordance between the respective 
genotyping methods was calculated according to the number of paired isolates having 
a match for both of the methods as a proportion of the total number of pairs having 
matching IS6110 RFLP genotypes.  This is a measure of agreement between two 
methods as to whether any two isolates form part of the same transmission chain. 
Mismatching concordance was calculated as the number of paired isolates having 
nonmatching genotypes for both of the methods as a proportion of the total number of 
pairs having nonmatching IS6110 RFLP genotypes.  This is a measure of agreement 
between two methods for any two isolates that do not form part of the same 
transmission chain. 
 
(iv) Estimation of concordance among unique genotypes:  Concordance between 
uniquely occurring IS6110 RFLP genotypes and the MIRU-VNTR genotypes was 
calculated as the proportion of isolates having unique IS6110 RFLP genotypes that 
also had unique MIRU-VNTR genotypes. 
 
(v) Estimation of number of convergent events:  Convergent evolution was 
identified by drawing connecting lines between each IS6110 RFLP genotype and each 
MIRU-VNTR genotype for which isolates were found to have that particular 
genotype combination (Figure 1).  Convergent evolution was defined, conservatively, 
as the existence of isolates representing each of the four possible combinations of two 
IS6110 RFLP genotypes (e.g., IS1 and IS2) and two MIRU-VNTR genotypes (e.g., 
M1 and M2) (Figure 1).  This scenario would only be possible if one of the MIRU-
VNTR genotypes had evolved more than once, assuming that the chance of IS6110 
RFLP genotype convergence was significantly lower than that of MIRU-VNTR 
genotype convergence. The validity of this method was confirmed by plotting the 
IS6110 RFLP genotypes onto a phylogenetic tree constructed using the MIRU-VNTR 
data in combination with a neighbor-joining algorithm (data not shown) (34). 
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Figure 1: An example of MIRU-VNTR (Mx) and IS6110 RFLP (ISx) genotypes. The connecting lines 
represent the MIRU-VNTR and IS6110 RFLP genotype combinations observed in M. tuberculosis 
isolates in the study setting. M1 and M2 are both linked to IS1 and IS2 and therefore represent a 
convergent event. Neither M3 nor M4 share common connections to more than one ISx with any other 
Mx. Their connecting lines therefore indicate simple, linear evolution. 
 
 (vi) Estimation of number of divergent events:  A divergent evolutionary event 
was scored for each MIRU-VNTR genotype which existed in combination with only 
one IS6110 RFLP genotype and where this IS6110 RFLP genotype was found in 
combination with more than one MIRU-VNTR genotype (Figure 2). This implies that 
the MIRU-VNTR genotype arose subsequent to the IS6110 RFLP genotype. A 
divergent event was also added for each convergent event, since a convergent event 
implies a prior divergent event. 
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Figure 2: IS6110 RFLP banding patterns of Beijing sublineage 5 isolates sharing identical katG, rpoB, 
embB, and rrs gene mutations. The isolate numbers are indicated in bold, while the IS6110-RFLP 
cluster numbers are indicated in standard text (these numbers correspond to the numbers given in data 
set S2 of the supplemental material). 
 
(vii) Sensitivity and specificity calculations:  The sensitivity and specificity (and 
positive and negative predictive values) of the IS6110 RFLP and respective MIRU-
VNTR genotyping methods were calculated using GraphPad Prism 5 software (La 
Jolla, CA) based on their ability to correctly identify an independently genotyped 
drug-resistant cluster. 
 
Results 
IS6110 RFLP genotyping identified 74 different strains among the 321 isolates with 
the Beijing spoligotype collected over a 12-year period (Table 2).  Of these strains, 
272 were grouped into 25 clusters (containing between 2 and 100 isolates), and 49 
were unique strains.  The overall percent clustering was calculated to be 84.7% using 
the n/T formula (1).  Each isolate was subsequently genotyped with 27 MIRU-VNTR 
loci and analyzed according to seven different MIRU-VNTR locus combinations 
(Table 1 and Supplemental data). The performance of these locus combinations, in 
relation to the IS6110 RFLP genotyping method, was determined either over a 12-
year period (Table 2) or over six consecutive 2-year periods (Table 3).  In both 
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analyses the traditional 12-MIRU loci genotyping method underestimated the number 
of genotypes (strains) identified and thereby overestimated the percentage of 
clustering (Tables 2 and 3).  The inclusion of exact tandem repeat (ETR) alleles A, B, 
and C to the 12-MIRU loci set did not significantly improve the number of strains 
detected or the estimate of clustering (Tables 2 and 3).  Analysis of the isolates using 
the newly proposed 15- and 24-MIRU-VNTR locus combinations increased the 
number of strains identified; however, the discriminatory power of these locus 
combinations remained lower than that observed using IS6110 RFLP genotyping 
(Tables 2 and 3).  Consequently, these locus combinations over-estimated clustering.  
The addition of the VNTR loci 3232, 4120, and 3820 to the 12-, 15-, and 24-MIRU-
VNTR locus combinations increased the number of strains detected and thereby 
produced clustering estimates similar to or slightly lower than that of IS6110 RFLP 
genotyping (Tables 2 and 3).  This implies that some MIRU-VNTR locus 
combinations could be selected as epidemiological markers to estimate the extent of 
both recent (<2-year interval) and ongoing (unrestricted interval) transmission in 
settings with a high incidence of strains with the Beijing genotype.  
 
To determine whether a correlation existed between the definitions of a strain 
according to IS6110 RFLP or MIRU-VNTR genotyping methods, the respective 
genotypes were compared.  From the results shown in Table 2 it is evident that a 
strain classified as a cluster according to IS6110 RFLP genotyping may in some 
instances be classified as unique according to the different MIRU-VNTR locus 
combinations, or vice versa.  Using a pair-wise analysis, we estimated the degree of 
matching concordance between the IS6110 RFLP and MIRU-VNTR genotyping 
methods to range between 39% and 68% depending on the locus combinations used 
(Tables 2 and 3).  The inclusion of additional MIRU-VNTR loci decreased the degree 
of matching concordance, as a result of an increased rate of divergence caused by 
more rapid evolution, with the hypervariable loci having the greatest effect.  
Conversely, the inclusion of additional loci increased the degree of mismatching 
concordance, as well as concordance between strains identified as having unique 
genotypes according to both genotyping methods (IS6110 RFLP and MIRU-VNTR).  
A consequence of more rapid evolution was the increased risk of convergent 
evolutionary events (Table 2).  
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To determine whether concordance between the respective genotyping methods could 
be improved, the analysis was repeated to allow for a genetic distance of 1, i.e., 
evolution of single MIRU-VNTR loci or single-band changes in the IS6110 pattern 
within the definition of a cluster.  The results showed that the inclusion of genetic 
distance had a significant influence on the MIRU-VNTR definition of a cluster, 
collapsing many of the genotypes (Table 2 and Supplemental data 1). This was less 
pronounced for IS6110 RFLP analysis (Table 2 and Supplemental data 1).  Matching 
concordance was improved by allowing for evolution of the MIRU-VNTR genotypes; 
however, mismatching concordance was concomitantly reduced for genotypes based 
on the 12-MIRU loci combinations.  This may be explained by the loss of 
discriminatory power as a result of the collapsing of genotypes, which is associated 
with a low rate of evolution.  In contrast, mismatching concordance was improved for 
15- and 24-MIRU-VNTR combinations due to the higher evolutionary rates of these 
markers. However, the concordance among unique genotypes remained low (Table 2).  
 
To establish which of the genotyping methods provided the most accurate description 
of ongoing transmission in the study setting, the largest group of drug-resistant 
isolates (found within sublineage 5) was selected, based on identical mutations 
conferring resistance to isoniazid, rifampin, ethambutol, and streptomycin (see 
Supplemental data 2). These isolates represent the continuing spread of a previously 
described multidrug-resistant TB outbreak (29).  A total of 35 isolates were identified 
with the katG315 AGC to ACC, rpoB531 TCG to TTG, embB306 ATG to ATA, and 
rrs513 CAG to CCG mutations, forming a single drug resistance-based cluster (Fig. 
2).  The sensitivity, specificity, and positive and negative predictive values related to 
the abilities of the different markers to identify the drug-resistant cluster are given in 
Table 4.  While the sensitivities of all the markers were high, with some of those 
based on MIRU-VNTR loci outperforming IS6110 RFLP, the specificity of all 
MIRU-VNTR markers was substantially lower than that of IS6110 RFLP.  The 
inclusion of genetic distance (single events) within the definition of a cluster appeared 
to improve the sensitivity of most of the markers but concomitantly decreased the 
specificity of the MIRU-VNTR markers.  The specificity of IS6110 was not affected 
by the inclusion of genetic distance.  Positive predictive values were not significantly 
Chapter 4 
 112 
affected by allowing for evolution of the markers; however, with the exceptions of 
IS6110, which increased, and the 24 MIRU and three hypervariable loci, which 
remained unchanged, the negative predictive values for all markers were reduced to 
zero.  
 
To determine whether MIRU-VNTR genotyping could be used as a method to 
phylogenetically group strains with the Beijing genotype, the correlation between 
MIRU-VNTR genotype and Beijing sublineage was quantified.  As sublineages 3 and 
4 and sublineages 5 and 6 were distinguished solely on the basis of IS6110 in our data 
set, these two pairs of sublineages were combined for the purposes of this analysis.  
Table 2 shows that the respective MIRU-VNTR locus combinations correctly grouped 
>96% of the isolates according to their sublineage designation, in comparison to 
100% with IS6110 RFLP genotyping.  The incorporation of genetic distance reduced 
the ability of genotyping methods based on the 12-MIRU locus combinations to 
correctly group isolates (Table 2). 
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Discussion 
IS6110 RFLP genotyping is the most widely used genotyping method for 
investigating and understanding the epidemiology of M. tuberculosis (27).  However, 
studies comparing IS6110 RFLP molecular epidemiological and contact tracing data 
have questioned the validity of the definition of transmission (4, 26).  In order to 
address these concerns MIRU-VNTR genotyping using either 15- or 24-MIRU-
VNTR loci combinations have been extensively evaluated as the new genotyping 
standard for molecular epidemiological studies of M. tuberculosis (21).  Concordance 
between MIRU-VNTR genotyping and contact tracing data was found to be superior 
to that of IS6110 RFLP in settings of low incidence (2, 18).  However, these MIRU-
VNTR locus combinations have not been fully tested in geographical regions of TB 
endemicity or within a robust M. tuberculosis phylogeny.  Our results confirm 
previous findings (2, 10, 18, 21) which suggested that MIRU-VNTR genotyping, 
using carefully selected locus combinations, could be used to estimate the extent of 
recent or ongoing transmission. The inclusion of the three hypervariable loci 
improved the discriminatory power of the MIRU-VNTR genotyping method in this 
Beijing lineage, thereby supporting a previous suggestion for their inclusion (10).  
However, the use of these loci needs further evaluation in other evolutionary lineages, 
as difficulties associated with amplification reproducibility have been reported (15, 
21, 36).  
 
We conclude that the PCR-based MIRU-VNTR genotyping method could be applied 
as an epidemiological tool to measure the performance of a TB control program over 
time in a defined geographical setting.  However, the observed concordance in the 
estimate of recent and ongoing transmission when using the IS6110 RFLP or MIRU-
VNTR genotyping methods was only coincidental.  A subsequent analysis of the 
MIRU-VNTR data, in comparison to the IS6110 RFLP genotyping data, revealed that 
the classification of a strain according to its genotype differed significantly depending 
on the genotyping method used.  Accordingly, our study showed that the degree of 
matching and mismatching concordance as well as concordance among unique strains 
was low.  This led to discordance between the transmission chains predicted by the 
respective genotyping methods.  Matching concordance increased when genetic 
distance was incorporated into the clustering calculation for all of the MIRU-VNTR 
Chapter 4 
 120 
combinations. However, this effect was offset in the case of 12-MIRU-based markers 
by the concomitant reduction in mismatching concordance, which was not the case for 
the 15- and 24-MIRU-VNTR combinations.  From this, it is apparent that the 
additional loci included in the 15- and 24-MIRU-VNTR combinations (with or 
without the addition of the hypervariable loci) improved the overall concordance of 
MIRU-VNTR with respect to IS6110 RFLP.  This may be due to these loci being 
inherently less stable and therefore more informative.  However, a caveat to the 
inclusion of genetic distance in the clustering formula is that epidemiologically 
unrelated cases may be incorrectly linked within a transmission chain.  
 
Our analysis of the drug-resistant cluster to elucidate which of the genotyping 
methods provided the most accurate reflection of the epidemiology highlighted 
shortcomings of both the IS6110 RFLP and MIRU-VNTR genotyping methods.  This 
analysis supported a previous study which demonstrated that ongoing transmission 
was characterized by the evolution of variant IS6110 RFLP genotypes while 
simultaneously preserving existing genotypes (33).  A similar observation was found 
when using the different MIRU-VNTR locus combinations.  This could be explained 
by the fact that the evolution of different loci could take place both convergently and 
divergently.  Together, these results substantiate previous findings which have 
suggested that the definition of ongoing transmission according to IS6110 RFLP or 
MIRU-VNTR genotyping should include closely related genotypes (18, 24, 35).  
However, when allowing for single MIRU-VNTR changes within the definition of a 
cluster, the MIRU-VNTR genotyping method collapsed many of the sublineage 5 
isolates into a limited number of clusters.  As a result, most of the isolates were 
grouped as resistant, giving the method a high sensitivity, but in doing so, 
compromising specificity.  In contrast, the identification of isolates within the drug-
resistant cluster was largely retained by IS6110 RFLP analysis despite the inclusion of 
genetic distance.  This suggests that IS6110 RFLP analysis in combination with 
genetic distance provides a more accurate reflection of ongoing transmission of this 
multidrug-resistant TB outbreak in this setting.  This finding is important for the 
interpretation of molecular epidemiological data in settings where contact tracing is 
extremely difficult.  However, we acknowledge that the concordance between IS6110 
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RFLP findings and transmission needs further investigation in different settings and in 
M. tuberculosis strains with different genetic backgrounds.  
 
Our results differ from previous studies (2, 18), which demonstrated a close 
correlation between IS6110 RFLP and MIRU-VNTR genotyping. These studies were 
conducted in settings in Western Europe with a low incidence of TB and where the 
TB epidemic is primarily driven by reactivation and immigration (6). In these settings, 
efficient TB control programs would largely prevent recent and ongoing transmission 
and the subsequent generation of closely related clonal variants. Thus, genetic 
diversity is predicted to be preserved. In most instances, this would imply that the 
strains cultured from TB cases would be genetically distantly related and thus would 
not share either IS6110 RFLP banding patterns or MIRU-VNTR genotypes.  
Accordingly, MIRU-VNTR genotyping would discriminate strains at a level similar 
to that of IS6110 RFLP genotyping.  In contrast, our setting of high TB incidence has 
promoted the evolution of a large number of genetically closely related strains which 
are maintained within the host population.  The genetic distance between these strains 
is often of such a nature that strains either have identical IS6110 RFLP genotypes and 
variant MIRU-VNTR genotypes or vice versa.  Accordingly, we hypothesize that the 
degree of discordance between IS6110 RFLP and MIRU-VNTR genotyping is 
dependent on the genetic distance between isolates. This is supported by the 
observation that distantly related isolates from the different Beijing sublineages have 
evolved distinct IS6110 RFLP and MIRU-VNTR genotypes.  
 
In summary, we conclude that both IS6110 RFLP and MIRU-VNTR genotyping 
methods have limitations in defining chains of transmission of Beijing genotype M. 
tuberculosis strains in this setting of high incidence. 
 
Acknowledgments 
The Harry Crossley Foundation and the European Commission 6
th
 Framework 
Program on Research Technological Development Demonstration (project no. 
037919) are thanked for financially supporting this project. 
 
Chapter 4 
 122 
Reference List 
1.  Alland, D., G. E. Kalkut, A. R. Moss, R. A. McAdam, J. A. Hahn, W.  
 Bosworth, E. Drucker, and B. R. Bloom. 1994. Transmission of tuberculosis in 
 New York City. An analysis by DNA fingerprinting and conventional 
 epidemiologic methods. N.Engl.J.Med. 330:1710-1716. 
2.  Bifani, P. J., B. B. Plikaytis, V. Kapur, K. Stockbauer, X. Pan, M. L. Lutfey, S. 
 L. Moghazeh, W. Eisner, T. M. Daniel, M. H. Kaplan, J. T. Crawford, J. M. 
 Musser, and B. N. Kreiswirth. 1996. Origin and interstate spread of a New York 
 City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275:452-
 457. 
3.  Cowan, L. S., L. Diem, T. Monson, P. Wand, D. Temporado, T. V. Oemig, and 
 J. T. Crawford. 2005. Evaluation of a two-step approach for large-scale, 
 prospective genotyping of Mycobacterium tuberculosis isolates in the United States. 
 J.Clin.Microbiol. 43:688-695. 
4.  Cruz-Ferro, E. and E. Fernandez-Nogueira. 2007. Epidemiology of tuberculosis 
 in Galicia, Spain, 1996-2005. Int.J.Tuberc.Lung Dis. 11:1073-1079. 
5.  Dahle, U. R., V. Eldholm, B. A. Winje, T. Mannsaker, and E. Heldal. 2007. 
 Impact of immigration on the molecular epidemiology of Mycobacterium 
 tuberculosis in a low-incidence country. Am.J.Respir.Crit Care Med. 176:930-935. 
6.  Gagneux, S., K. DeRiemer, T. Van, M. Kato-Maeda, B. C. de Jong, S. 
 Narayanan, M. Nicol, S. Niemann, K. Kremer, M. C. Gutierrez, M. Hilty, P. C. 
 Hopewell, and P. M. Small. 2006. Variable host-pathogen compatibility in 
 Mycobacterium tuberculosis. Proc.Natl.Acad.Sci.U.S.A 103:2869-2873. 
7.  Gibson, A., T. Brown, L. Baker, and F. Drobniewski. 2005. Can 15-locus 
 mycobacterial interspersed repetitive unit-variable-number tandem repeat analysis 
 provide insight into the evolution of Mycobacterium tuberculosis? 
 Appl.Environ.Microbiol. 71:8207-8213. 
8.  Hanekom, M., G. D. van der Spuy, E. Streicher, S. L. Ndabambi, C. R. 
 McEvoy, M. Kidd, N. Beyers, T. C. Victor, P. D. van Helden, and R. M. 
Chapter 4 
 123 
 Warren. 2007. A recently evolved sublineage of the Mycobacterium tuberculosis 
 Beijing strain family is associated with an increased ability to spread and cause 
 disease. J.Clin.Microbiol. 45:1483-1490. 
9.  Iwamoto, T., S. Yoshida, K. Suzuki, M. Tomita, R. Fujiyama, N. Tanaka, Y. 
 Kawakami, and M. Ito. 2007. Hypervariable loci that enhance the discriminatory 
 ability of newly proposed 15-loci and 24-loci variable-number tandem repeat typing 
 method on Mycobacterium tuberculosis strains predominated by the Beijing family. 
 FEMS Microbiol.Lett. 270:67-74. 
10.  Jiao, W. W., I. Mokrousov, G. Z. Sun, Y. J. Guo, A. Vyazovaya, O. Narvskaya, 
 and A. D. Shen. 2008. Evaluation of new variable-number tandem-repeat systems 
 for typing Mycobacterium tuberculosis with Beijing genotype isolates from Beijing, 
 China. J.Clin.Microbiol. 46:1045-1049. 
11.  Kam, K. M., C. W. Yip, L. W. Tse, K. L. Leung, K. L. Wong, W. M. Ko, and 
 W. S. Wong. 2006. Optimization of variable number tandem repeat typing set for 
 differentiating Mycobacterium tuberculosis strains in the Beijing family. FEMS 
 Microbiol.Lett. 256:258-265. 
12.  Kam, K. M., C. W. Yip, L. W. Tse, K. L. Wong, T. K. Lam, K. Kremer, B. K. 
 Au, and D. van Soolingen. 2005. Utility of mycobacterial interspersed repetitive 
 unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis 
 isolates of the Beijing family. J.Clin.Microbiol. 43:306-313. 
13.  Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. 
 Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. Van 
 Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium 
 tuberculosis for diagnosis and epidemiology. J.Clin.Microbiol. 35:907-914. 
14.  Kremer, K., C. Arnold, A. Cataldi, M. C. Gutierrez, W. H. Haas, S. Panaiotov, 
 R. A. Skuce, P. Supply, A. G. van der Zanden, and D. van Soolingen. 2005. 
 Discriminatory power and reproducibility of novel DNA typing methods for 
 Mycobacterium tuberculosis complex strains. J.Clin.Microbiol. 43:5628-5638. 
Chapter 4 
 124 
15.  lix-Beguec, C., M. Fauville-Dufaux, and P. Supply. 2008. Three-year population-
 based evaluation of standardized mycobacterial interspersed repetitive-unit-
 variable-number tandem-repeat typing of Mycobacterium tuberculosis. 
 J.Clin.Microbiol. 46:1398-1406. 
16.  Lopez-Calleja, A. I., M. A. Lezcano, M. A. Vitoria, M. J. Iglesias, A. Cebollada, 
 C. Lafoz, P. Gavin, L. Aristimuno, M. J. Revillo, C. Martin, and S. Samper. 
 2007. Genotyping of Mycobacterium tuberculosis over two periods: a changing 
 scenario for tuberculosis transmission. Int.J.Tuberc.Lung Dis. 11:1080-1086. 
17.  Nei, M. 1978. Estimation of Average Heterozygosity and Genetic Distance from a 
 Small Number of Individuals. Genetics 89:583-590. 
18.  Oelemann, M. C., R. Diel, V. Vatin, W. Haas, S. Rusch-Gerdes, C. Locht, S. 
 Niemann, and P. Supply. 2007. Assessment of an optimized mycobacterial 
 interspersed repetitive- unit-variable-number tandem-repeat typing system 
 combined with spoligotyping for population-based molecular epidemiology studies 
 of tuberculosis. J.Clin.Microbiol. 45:691-697. 
19.  Pretorius, G. S., P. D. van Helden, F. Sirgel, K. D. Eisenach, and T. C. Victor. 
 1995. Mutations in katG gene sequences in isoniazid-resistant clinical isolates of 
 Mycobacterium tuberculosis are rare. Antimicrob.Agents Chemother. 39:2276-
 2281. 
20.  Small, P. M., P. C. Hopewell, S. P. Singh, A. Paz, J. Parsonnet, D. C. Ruston, 
 G. F. Schecter, C. L. Daley, and G. K. Schoolnik. 1994. The epidemiology of 
 tuberculosis in San Francisco. A population-based study using conventional and 
 molecular methods. N.Engl.J.Med. 330:1703-1709. 
21.  Supply, P., C. Allix, S. Lesjean, M. Cardoso-Oelemann, S. Rusch-Gerdes, E. 
 Willery, E. Savine, H. P. de, D. H. van, S. Roring, P. Bifani, N. Kurepina, B. 
 Kreiswirth, C. Sola, N. Rastogi, V. Vatin, M. C. Gutierrez, M. Fauville, S. 
 Niemann, R. Skuce, K. Kremer, C. Locht, and S. D. van. 2006. Proposal for 
 standardization of optimized mycobacterial interspersed repetitive unit-variable-
 number tandem repeat typing of Mycobacterium tuberculosis. J.Clin.Microbiol. 
 44:4498-4510. 
Chapter 4 
 125 
22.  Supply, P., S. Lesjean, E. Savine, K. Kremer, D. van Soolingen, and C. Locht. 
 2001. Automated high-throughput genotyping for study of global epidemiology of 
 Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. 
 J.Clin.Microbiol. 39:3563-3571. 
23.  Supply, P., E. Mazars, S. Lesjean, V. Vincent, B. Gicquel, and C. Locht. 2000. 
 Variable human minisatellite-like regions in the Mycobacterium tuberculosis 
 genome. Mol.Microbiol. 36:762-771. 
24.  van der Spuy, G. D., R. M. Warren, M. Richardson, N. Beyers, M. A. Behr, 
 and P. D. van Helden. 2003. Use of genetic distance as a measure of ongoing 
 transmission of Mycobacterium tuberculosis. J.Clin.Microbiol. 41:5640-5644. 
25.  van der Zanden, A. G., E. M. Te Koppele-Vije, B. N. Vijaya, D. van Soolingen, 
 and L. M. Schouls. 2003. Use of DNA extracts from Ziehl-Neelsen-stained slides 
 for molecular detection of rifampin resistance and spoligotyping of Mycobacterium 
 tuberculosis. J.Clin.Microbiol. 41:1101-1108. 
26.  van Deutekom H., P. Supply, P. E. de Haas, E. Willery, S. P. Hoijng, C. Locht, 
 R. A. Coutinho, and S. D. van. 2005. Molecular typing of Mycobacterium 
 tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem 
 repeat analysis, a more accurate method for identifying epidemiological links 
 between patients with tuberculosis. J.Clin.Microbiol. 43:4473-4479. 
27.  van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. 
 Gicquel, P. Hermans, C. Martin, R. McAdam, and T. M. Shinnick. 1993. Strain 
 identification of Mycobacterium tuberculosis by DNA fingerprinting: 
 recommendations for a standardized methodology. J.Clin.Microbiol. 31:406-409. 
28.  van Rie, A., R. Warren, M. Richardson, T. C. Victor, R. P. Gie, D. A. Enarson, 
 N. Beyers, and P. D. van Helden. 1999. Exogenous reinfection as a cause of 
 recurrent tuberculosis after curative treatment. N.Engl.J.Med. 341:1174-1179. 
29.  van Rie, A., R. M. Warren, N. Beyers, R. P. Gie, C. N. Classen, M. Richardson, 
 S. L. Sampson, T. C. Victor, and P. D. van Helden. 1999. Transmission of a 
 multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" 
Chapter 4 
 126 
 among noninstitutionalized, human immunodeficiency virus-seronegative patients. 
 J.Infect.Dis. 180:1608-1615. 
30.  van Soolingen, D., L. Qian, P. E. de Haas, J. T. Douglas, H. Traore, F. Portaels, 
 H. Z. Qing, D. Enkhsaikan, P. Nymadawa, and J. D. van Embden. 1995. 
 Predominance of a single genotype of Mycobacterium tuberculosis in countries of 
 east Asia. J.Clin.Microbiol. 33:3234-3238. 
31.  Verver, S., R. M. Warren, Z. Munch, E. Vynnycky, P. D. van Helden, M. 
 Richardson, G. D. van der Spuy, D. A. Enarson, M. W. Borgdorff, M. A. Behr, 
 and N. Beyers. 2004. Transmission of tuberculosis in a high incidence urban 
 community in South Africa. Int.J.Epidemiol. 33:351-357. 
32.  Warren, R., M. de Kock, E. Engelke, R. Myburgh, v. P. Gey, T. Victor, and P. 
 van Helden. 2006. Safe Mycobacterium tuberculosis DNA extraction method that 
 does not compromise integrity. J.Clin.Microbiol. 44:254-256. 
33.  Warren, R. M., G. D. van der Spuy, M. Richardson, N. Beyers, C. Booysen, M. 
 A. Behr, and P. D. van Helden. 2002. Evolution of the IS6110-based restriction 
 fragment length polymorphism pattern during the transmission of Mycobacterium 
 tuberculosis. Journal of Clinical Microbiology 40:1277-1282. 
34.  Warren, R. M., T. C. Victor, E. M. Streicher, M. Richardson, G. D. van der 
 Spuy, R. Johnson, V. N. Chihota, C. Locht, P. Supply, and P. D. van Helden. 
 2004. Clonal expansion of a globally disseminated lineage of Mycobacterium 
 tuberculosis with low IS6110 copy numbers. J.Clin.Microbiol. 42:5774-5782. 
35.  Yeh, R. W., d. L. Ponce, C. B. Agasino, J. A. Hahn, C. L. Daley, P. C. 
 Hopewell, and P. M. Small. 1998. Stability of Mycobacterium tuberculosis DNA 
 genotypes. J.Infect.Dis. 177:1107-1111. 
36.  Yokoyama, E., K. Kishida, M. Uchimura, and S. Ichinohe. 2007. Improved 
 differentiation of Mycobacterium tuberculosis strains, including many Beijing 
 genotype strains, using a new combination of variable number of tandem repeats 
 loci. Infect.Genet.Evol. 7:499-508. 
 
Chapter 4 
 127 
Table S1. Cross-tabulation of marker genotypes 
The tables below show cross-tabulations of the numbers of cases classified into 
transmission chains according to IS6110 and each of the MIRU-VNTR combinations, 
allowing for evolution by single events in either marker. 
 
12-MIRU genotypes (GD=1)  IS6110- 
RFLP 
 genotypes 
GD=1 
1 2 3 Total 
1 219 1  220 
2 1   1 
3 1   1 
4 1   1 
5 4   4 
6 33   33 
7 1   1 
8 9   9 
9 8   8 
10 1   1 
11 1   1 
12 1   1 
13 1   1 
14 1   1 
15 2   2 
16 1   1 
17 2   2 
18 1   1 
19 3   3 
20 1   1 
21 4  1 5 
22 1   1 
23 1   1 
24 1   1 
25 1   1 
26 1   1 
27 2   2 
28 2   2 
29 1   1 
30 1   1 
31 2   2 
32 1   1 
33 2   2 
34 1   1 
35 1   1 
36 1   1 
37 1   1 
38 1   1 
39 1   1 
40 1   1 
Total 319 1 1 321 
Chapter 4 
 128 
12-MIRU + ETR A, B, C (GD=1)  IS6110- 
RFLP 
 genotypes 
GD=1 
1 2 3 4 Total 
1 219  1  220 
2 1    1 
3 1    1 
4 1    1 
5 4    4 
6 33    33 
7 1    1 
8 9    9 
9 8    8 
10 1    1 
11 1    1 
12 1    1 
13 1    1 
14 1    1 
15 2    2 
16 1    1 
17 2    2 
18 1    1 
19 3    3 
20 1    1 
21 4   1 5 
22 1    1 
23 1    1 
24 1    1 
25 1    1 
26 1    1 
27 2    2 
28 2    2 
29 1    1 
30  1   1 
31 2    2 
32 1    1 
33 2    2 
34 1    1 
35 1    1 
36 1    1 
37 1    1 
38 1    1 
39 1    1 
40 1    1 
Total 318 1 1 1 321 
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12-MIRU + hyper-variable loci (GD=1)  IS6110- 
RFLP 
 genotypes 
GD=1 
1 2 3 4 5 6 7 8 9 10 11 Total 
1 216  1 1 1     1  220 
2 1           1 
3 1           1 
4 1           1 
5 4           4 
6 32 1          33 
7 1           1 
8 9           9 
9 8           8 
10 1           1 
11 1           1 
12 1           1 
13 1           1 
14 1           1 
15 2           2 
16 1           1 
17 2           2 
18 1           1 
19 2        1   3 
20 1           1 
21 4          1 5 
22 1           1 
23 1           1 
24 1           1 
25 1           1 
26 1           1 
27 2           2 
28 2           2 
29 1           1 
30        1    1 
31      1 1     2 
32 1           1 
33 2           2 
34 1           1 
35 1           1 
36 1           1 
37 1           1 
38 1           1 
39 1           1 
40 1           1 
Total 311 1 1 1 1 1 1 1 1 1 1 321 
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15-MIRU-VNTR (GD-1)  IS6110- 
RFLP 
 genotypes 
GD=1 
1 2 3 4 5 6 7 8 9 10 11 Total 
1  219        1  220 
2  1          1 
3 1           1 
4 1           1 
5  4          4 
6 33           33 
7 1           1 
8 9           9 
9 8           8 
10 1           1 
11 1           1 
12 1           1 
13 1           1 
14 1           1 
15 2           2 
16 1           1 
17 2           2 
18 1           1 
19 3           3 
20 1           1 
21 4          1 5 
22         1   1 
23  1          1 
24 1           1 
25     1       1 
26      1      1 
27       2     2 
28        2    2 
29  1          1 
30    1        1 
31   2         2 
32  1          1 
33  2          2 
34 1           1 
35 1           1 
36  1          1 
37 1           1 
38  1          1 
39  1          1 
40 1           1 
Total 77 232 2 1 1 1 2 2 1 1 1 321 
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15-MIRU-VNTR + hyper-variable loci (GD=1)  IS6110- 
RFLP 
 genotypes 
GD=1 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Total 
1    216 1 1 1            1  220 
2    1                 1 
3                1     1 
4               1      1 
5    4                 4 
6 32 1                   33 
7 1                    1 
8 9                    9 
9 8                    8 
10 1                    1 
11 1                    1 
12 1                    1 
13 1                    1 
14 1                    1 
15 2                    2 
16 1                    1 
17 2                    2 
18 1                    1 
19 2             1       3 
20 1                    1 
21 4                   1 5 
22                  1   1 
23    1                 1 
24 1                    1 
25          1           1 
26           1          1 
27            2         2 
28             2        2 
29    1                 1 
30         1            1 
31        2             2 
32    1                 1 
33    2                 2 
34 1                    1 
35   1                  1 
36    1                 1 
37                 1    1 
38    1                 1 
39    1                 1 
40 1                    1 
Total 71 1 1 229 1 1 1 2 1 1 1 2 2 1 1 1 1 1 1 1 321 
 
Chapter 4 
 132 
 
24-MIRU-VNTR (GD=1)  IS6110- 
RFLP 
 genotypes 
GD=1 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Total 
1  
21
9 
           1  220 
2  1              1 
3 1               1 
4 1               1 
5  4              4 
6 33               33 
7 1               1 
8 9               9 
9 8               8 
10        1        1 
11 1               1 
12 1               1 
13 1               1 
14       1         1 
15        2        2 
16 1               1 
17 2               2 
18 1               1 
19 3               3 
20        1        1 
21         4      1 5 
22             1   1 
23  1              1 
24 1               1 
25      1          1 
26          1      1 
27           2     2 
28            2    2 
29  1              1 
30    1            1 
31   2             2 
32  1              1 
33  2              2 
34 1               1 
35 1               1 
36  1              1 
37 1               1 
38  1              1 
39  1              1 
40     1           1 
Total 67 
23
2 
2 1 1 1 1 4 4 1 2 2 1 1 1 321 
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24-MIRU-VNTR + hyper-variable loci (GD=1)  IS6110- 
RFLP 
genotypes 
GD=1 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Total 
1    216 1 1 1                   1  220 
2    1                        1 
3                      1      1 
4                     1       1 
5    4                        4 
6 32 1                          33 
7 1                           1 
8         9                   9 
9          8                  8 
10                1            1 
11 1                           1 
12 1                           1 
13 1                           1 
14               1             1 
15                2            2 
16 1                           1 
17 2                           2 
18 1                           1 
19 2            1               3 
20                1            1 
21                 4          1 5 
22                        1    1 
23    1                        1 
24                         1   1 
25              1              1 
26                  1          1 
27                   2         2 
28                    2        2 
29    1                        1 
30           1                 1 
31        2                    2 
32    1                        1 
33    2                        2 
34 1                           1 
35   1                         1 
36    1                        1 
37                       1     1 
38    1                        1 
39    1                        1 
40            1                1 
Total 43 1 1 229 1 1 1 2 9 8 1 1 1 1 1 4 4 1 2 2 1 1 1 1 1 1 1 321 
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Abstract 
Word count = 332 
Background:  The frequency and epidemiological significance of mixed Mycobacterium 
tuberculosis infections in patients with pulmonary tuberculosis is still partly unknown. 
 
Aim:  First to develop methods to identify the presence or absence of the most prominent 
phylogenetic lineages in primary cultures.  Secondly, using this genotyping data to 
understand the population structure of mixed M. tuberculosis infections in sputum specimens 
collected from pulmonary tuberculosis cases resident in a high HIV prevalent setting in South 
Africa.    
 
Method:  M. tuberculosis cultures (Mycobacterial Growth indicator Tube (MGIT) and/or 
Löwenstein-Jensen (LJ)), clinical and demographic data from pulmonary tuberculosis 
patients resident in Khayelitsha, South Africa were collected during the period April to 
October 2008 as part of a drug surveillance study.  Isolates were genotyped using an in-house 
PCR-based method which identified the most prominent phylogenetic lineages; Beijing, 
Haarlem, Low Copy Clade, S-family, and LAM.     
 
Results:  MGIT and LJ cultures were analysed from 224 patients.  Seven cultures failed to 
amplify on both media respectively.  Of the remaining cultures (n=213), 181 (85%) showed 
infection with a single strain and 32 (15%) showed the presence of more than 1 strain on both 
MGIT and LJ media.  The population structure of mixed M. tuberculosis strain genotypes 
was concordant in 62.5% of the cultures when cultured on either MGIT or LJ media. The  
remaining 37% showed discordance in either that one or both of the strain genotypes were 
absent from either the MGIT or LJ media.  Twenty-eight percent of the mixed infections were 
missed by culture on MGIT media, while 9% were missed when using LJ culture media.  
Strains of the Beijing genotype were strongly associated with mixed infections (p < 0.01).  
Mixed infection was not associated with age and sex, treatment history, smear grading or 
drug resistance.  
 
Conclusion:  Mixed infection was observed in 15% of the cultures in this study population.  
These may explain heterogeneous clinical responses to anti-tuberculosis treatment or masking 
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of drug resistance.  The growth characteristics of M. tuberculosis on different media may 
influence our ability to detect mixed infections. 
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Introduction 
Treatment failure is a significant concern to tuberculosis (TB) control programs. 
Programmatically, treatment failure is defined in patients who, while on treatment, remained 
or became smear-positive again five months or later after commencing treatment or a patient 
who was initially smear-negative before starting treatment and became smear-positive after 
the second month of treatment.  This is usually thought to result from either undetected 
primary drug-resistance or acquisition of resistance as a consequence of poor patient 
treatment adherence.  However, with the development of molecular epidemiological tools it 
has been possible to genotype strains present in a patient’s sputum to monitor any changes in 
the Mycobacterium tuberculosis population structure over time.  Evidence of mixed infection 
in a single host at a single point in time, suggesting reinfection before or during disease, was 
first observed using the phage typing method (1, 2). Subsequently, Yeh et al (1999) reported 
the first case of mixed infection using IS6110-based genotyping of M. tuberculosis (3).  This 
was followed by several other studies documenting mixed infection (4, -6).  However, the 
resolution of these methods to define the presence of a mixed infection was limited by the 
relative ratio of the two strains present in the specimen (7).  This could in part be overcome 
by the analysis of individual bacterial colonies from a single specimen (8).  Using a highly 
sensitivity PCR technique, Warren et al (2004) was able to show that 19% of the study 
participants in the given study setting were infected with both Beijing and non-Beijing strain 
genotypes (9).  In response to this finding, it was questioned whether mixed infections were 
of concern for TB control, since such infections could influence the diagnosis of drug 
resistance if a patient was infected with both a drug sensitive and a drug resistant strain.  To 
address this concern, a follow up study showed two additional mechanisms which may 
explain the emergence of drug resistance in a patient.  Firstly, the patient may be exogenously 
reinfected with a drug resistant strain while on treatment for drug susceptible TB (10).  
Secondly, the patient may have been infected with both a drug susceptible and a drug 
resistant strain prior to progression towards disease.  Subsequent treatment would select for 
the drug resistant strain leading to drug resistant TB (5, 10).   
However, the PCR-based methods used in these studies were able to analyze a small subset of 
strains only with limited ability to differentiate among the different genotypes.  Therefore, the 
true population structure of mixed infections in these study settings has remained largely 
unknown.  First this study aimed to develop methods to identify the presence or absence of 5 
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different strain genotypes (Beijing, Latin-American and Mediterranean (LAM), S-family 
(F28), Low Copy Clade (LCC) and Haarlem) in primary cultures.  Secondly, using this 
genotyping data to quantify the extent of mixed infections in a high incidence setting with a 
high prevalence of human immunodeficiency virus (HIV) co-infection and to identify risk 
factors associated with mixed infection.   
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Methods 
Study population 
During the period from April to October 2008, sputum specimens were collected from TB 
suspects resident in Khayelitsha, South Africa, where the incidence of TB is reported to be at 
least 1500/100 000 per annum and the TB/HIV co-infection rate is 70 % (City of Cape Town, 
Health Department, Statistics. 2009).  All sputum specimens were submitted for culture and 
drug susceptibility testing to the National Health Laboratory Service.  After decontamination, 
each sputum specimen was cultured on Mycobacterial Growth Indicator Tube (MGIT) liquid 
medium (Becton-Dickinson) and on Löwenstein-Jensen (LJ) solid medium. Aliquots of the 
respective cultures were boiled at 100°C to ensure sterilization and release of the M. 
tuberculosis DNA.  Drug susceptibility testing results, smear grading and patient 
demographics including sex, age, and previous history of TB were recorded at diagnosis and 
stored in a database.  This study was approved by the Ethics review board of Stellenbosch 
University.  
Genotyping by molecular techniques 
Positive primary cultures were genotyped by spoligotyping using the internationally 
standardized method (11).  Insertion sequence junctions were cloned and sequenced as 
previously described 10. Primers were designed (table 1) complimentary to the IS6110 
internal sequence and the 3’ and 5’ chromosomal flanking sequences.  M. tuberculosis 
genome sequences were amplified from a panel of M. tuberculosis strains representing the 
different genotypes present in Cape Town, South Africa.  Only primer sets that uniquely 
amplified strains representative of the LAM (12), S, LCC and Haarlem genotypes were 
selected for subsequent analysis (Table 1).  In addition, a primer set spanning the junction site 
of the Region of Difference (RD) 105 was used to specifically identify the presence of 
Beijing genotype strains (Table 1) (13).  
The sensitivity and specificity of amplification for the different primer sets was determined 
by PCR amplification of a panel of genetically related and unrelated M. tuberculosis strains 
classified according to IS6110 RFLP and spoligotyping (9).  Briefly, DNA from 40 
genetically known related and unrelated M. tuberculosis strains, representing 31 distinct 
strains, were amplified with primer sets 1 to 4 (Figure 1).  The sensitivity and specificity of 
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primer set 1 to 3 was 100% (95%CI 85 – 100%) while the sensitivity of primer set 4 was 75% 
and specificity 50% (95%CI 85 – 100%) as this primer set recognized M. tuberculosis strains 
in both the LCC and Haarlem genotypes. 
 
To determine the presence of a particular M. tuberculosis strain genotype in the selected 
cultures, DNA was PCR amplified in a total volume of 25 µl, containing 2 µl DNA template, 
1 x Q-Buffer, 1 x enzyme buffer, 3.5 mM MgCl2, 1.6 mM dNTP’s, 25 pmol of each primer 
set (Table 1) and 0.25 U HotStar Taq DNA polymerase (Qiagen, Germany).  Amplification 
was initiated by incubation at 95 ˚C for 15 min., followed by 45 cycles at 94 ˚C for 45 sec., 
62 - 65 ˚C for 45 sec., and 72 ˚C for 45 sec.  After the last cycle, the samples were incubated 
at 72 ˚C for 10 min.  PCR amplification products were electrophoretically fractionated in 2.0 
% agarose in 1 x SB pH 8.3 at 3.5V/cm for 4 hours, and visualized by staining with ethidium 
bromide.  The presence of a particular M. tuberculosis genotype was defined when the 
amplified product corresponded to the predicted product size (Table 1).   
 
To minimize the risk of laboratory cross-contamination during the PCR amplification, each 
procedure (preparation of the PCR reaction mixes, the addition of the DNA, the PCR 
amplification and the electrophoretic fractionation) was done in physically separated rooms.  
Negative controls (water) were included to control for reagent contamination. 
Statistical Methods 
The Kappa coefficient of conformance was used as a measure of conformance between the 
MGIT and LJ cultures.  Comparisons of binary responses were done using cross tabulation 
and the Chi-square test.  Comparisons of ordinal variables (eg. age) between mixed versus 
single cases were done using one-way ANOVA. 
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Results 
Study population 
During the period from April to October 2008, 614 patients enrolled in a drug surveillance 
study were diagnosed with TB by either routine smear or culture.  The average age of these 
patients was 35.4 years and included 328 (53%) male patients and 223 (36%) female patients 
(age and gender data was unavailable for 63 patients).  Primary MGIT and their 
corresponding LJ cultures were available from 224 of these cases and formed the cohort for 
subsequent analysis.  The average age of these patients in this cohort was 34.6 years and 
included 121 (54%) male patients and 88 (39%) female patients (age and sex data was 
unavailable for 15 patients).  Drug susceptibility testing was done on 199 primary cultures of 
which 119 (60%) were drug-sensitive and 50 (25%) were resistant to any drug.  The 
remaining 30 (15%) cultures were contaminated.  The patients represented in this cohort were 
not statistically different from the patients in the entire cohort according to the demographic 
measures of age, sex, previous history of tuberculosis and drug susceptibility patterns.  
Genotyping by PCR amplification 
Spoligotyping identified 188 genotypes cultured from MGIT media and 181 genotypes 
cultured from LJ media (Table 2).  PCR amplification using the five primer sets was applied 
to determine the presence of Beijing, LAM, S-family, LCC or Haarlem strain genotypes of 
244 primary MGIT and their corresponding LJ cultures.  Seven MGIT and 7 LJ cultures 
failed to amplify and were excluded from further analysis.  Table 2 shows the genotypes 
identified by the PCR-genotype method.  In total, 181 single infections were identified on 
both MGIT and LJ media, of which 180 shared the same strain genotype and 1 had a different 
strain genotype (Table 2 and Figure 2).  According to statistical analysis, concordance 
between the MGIT and LJ cultures was 0.74.  Twenty-three mixed infections were identified 
on MGIT media and 29 on LJ media (Figure 2).  The population structure of mixed infections 
on MGIT media included 14 Beijing and non-Beijing strain genotype combinations and 9 
non-Beijing strain genotype combinations (Table 3).  In addition, the population structure of 
mixed infections cultured on LJ media showed the presence of 21 Beijing and non-Beijing 
strain genotype combinations and 8 non-Beijing genotype combinations (Table 3).  
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In total, 32 (15%) mixed infections were identified by culture on MGIT and LJ media (Table 
3).  The population structure of these mixed infections included 21 Beijing and non-Beijing 
strain genotype combinations and 11 non-Beijing genotype combinations (Table 3).  Twenty 
(62.5%) of the mixed infections showed concordant genotypes on both MGIT and LJ media, 
although an additional genotype was identified on one of the cultures grown on MGIT media 
as well as on one of the cultures grown on LJ media (Table 4).  Furthermore, 11 of the mixed 
infections showed that one of the genotypes was present on both media while the other 
genotype was absent from either the MGIT or LJ media (Table 4).  The remaining mixed 
infection showed dissimilar strain genotypes on both media (Table 4).    
 
Strains of the Beijing (p < 0.01), LAM (p = 0.02), LCC (p < 0.01), Haarlem (p < 0.01) and 
“other strains” (p < 0.01) genotypes were more associated with mixed infections than strains 
of the S-family (p = 0.28) genotype.  However, strains of the Beijing genotype were 
significantly more associated with mixed infections of cultures grown on MGIT media (p < 
0.01) and LJ media (p < 0.01) than single infections grown on these 2 media.  Also, the 
Beijing strain genotype was more frequently observed in the total number of mixed infections 
grown on both MGIT and LJ media (p < 0.01).  Strains of the Haarlem genotype were more 
often observed in mixed infections when strains of the LAM and LCC genotypes were absent 
(p = 0.03).   
Clinical, demographic and drug susceptibility characteristics of study cohort  
The demographics of the 32 patients infected with more than one strain genotype were 
similar to that of the 181 patients assigned as having single infections (Table 5).  No 
significant association could be demonstrated between mixed infection and age, sex, smear 
grading or drug-resistance (Table 5). Mono-resistant (resistance to any 1 drug only), sensitive 
and multidrug- resistant (MDR) (resistance to at least isoniazid and rifampicin) isolates were 
associated with mixed infection, while poly-resistance (resistance to 2 or more drugs 
excluding MDR) was not associated with mixed infections.  However, the total number of 
poly-resistant and MDR isolates were too small to report on with any confidence (Table 5).   
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Discussion 
In this study an improved PCR-based method was used to define the population structure of 
M. tuberculosis strain genotypes in primary cultures from patients diagnosed with pulmonary 
TB who were resident in Khayelitsha, South Africa.  Using this method, it was possible to 
identify members of the Beijing, LAM, S-family, LCC and Haarlem genotypes and to 
demonstrate that 15% of sputum cultures had more than one genotype present.  This was 
significantly lower than the 57% reported in an epidemiological field site near Cape Town, 
South Africa using a PCR-based method to identify only Beijing and non-Beijing strain 
genotypes (9).  The difference could either be due to the difference in host population or the 
sensitivity of the method used to detect mixed infection.  The study by Warren et al (2004) 
was conducted in a setting where HIV/TB co-infection was low and 75% of the cases had 
smear positive disease.  In contrast, the proportion of cases with smear positive disease was 
only 55% in this study and HIV/TB co-infection was high.  The lower smear positivity rate 
implies that they are less infectious thereby decreasing the risk of multiple infections.  In 
addition, it is well established that HIV positive individuals are at a greater risk of 
progressing to disease following infection (14), thus their risk of reinfection during a short 
period of latent infection would be reduced.  Alternatively, the methodology could have 
influenced the estimate of mixed infection.  We cannot exclude the possibility that culture 
medium may have disturbed the relative abundance of the different genotypes present due to 
their different growth characteristics.  Furthermore, Warren et al (2004) used a non-
competitive PCR-based method as compared to the competitive method used in this study 
which would have influenced the sensitivity for detecting underlying strains.  Previously, it 
was estimated that the competitive method was only able to identify mixed infections at a 
ratio of 1:150, thus mixed infection with a ratio of greater than 1:150 would be missed.  Our 
estimate of mixed infection was also limited by the fact that the PCR-based method could 
only detect the presence or absence of a particular genotype and thus it was not possible to 
determine the extent of mixed infection with different strains from the same genotype. 
 
In our study, we demonstrate for the first time a broader spectrum of genotype strains using a 
PCR-based method.  Previous studies using PCR-based methods could only distinguish 
between Beijing and non-Beijing genotype strains (9).  In addition, studies using IS6110 
DNA fingerprinting to detect mixed infections were low due to the presence of low-intensity 
bands (7).  Furthermore, using this method, we were able to identify up to 4 different M. 
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tuberculosis strain genotypes in one primary culture.  Similar findings were reported in 
previous studies (15, 16) where TB is endemic in these populations.  Therefore, this 
phenomenon could be expected in high TB incidence settings where the infection pressure is 
high.  However, the implication of mixed infections involving more than two strains is 
unclear.  In contrast to our results, a study done in China using MIRU-VNTR typing, found 
43% of mixed infections had non-Beijing genotype strains while Beijing genotype strains 
were relatively seldom found in mixed infections (17).  In our study we show that strains of 
the Beijing genotype in this setting were over-represented in mixed infections of cultures 
grown on either LJ or MGIT media.  This finding may suggest that the Beijing strain 
genotype found in this setting has special properties allowing it to reinfect patients.  A 
previous study has shown that strains from a defined Beijing sublineage in different 
geographical settings may have selected for a distinct host population or that that host 
population was more vulnerable to strains from a defined Beijing sublineage (18).  In mixed 
infections, strains of the Beijing genotype occurred in combination with all other genotypes 
tested (LAM, LCC, “other strains”, S-family, Haarlem) by the PCR-based method.  Thus, we 
hypothesise that the population structure of mixed infections may reflect pathogen-pathogen 
compatibility.  Further studies are needed to determine whether certain genotypes occur 
together more frequently than other genotypes during a single disease episode, whether 
certain genotypes influence the growth of other genotypes in vivo and whether certain 
genotypes influence the rate of disease progression.   
 
Comparison of demographic data between patients infected with a single strain genotype and 
multiple strain genotypes did not identify significant differences.  In addition, there was no 
relationship between mixed infection, treatment history and drug resistance.  This differs 
from the study by Warren et al (2004) which showed that mixed infections were more 
frequently observed in retreatment cases (9).  It has been suggested that reinfection in 
recurrent TB may be explained by the fact that an ongoing TB infection may divert the 
immune response, thereby increasing the overall susceptibility to reinfection (9).  This may 
also be the case in new TB cases co-infected with HIV where the immune response is 
suboptimal.  Thus, this could explain the similar frequencies of mixed infection in both new 
and retreatment cases observed in this study. 
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The population structure of mixed M. tuberculosis strain genotypes was concordant in 62.5% 
of the cultures when cultured on either MGIT or LJ media.  The remaining 37% showed 
discordance in either that one or both of the strain genotypes were absent from either the 
MGIT or LJ media.  Twenty-eight percent of the mixed infections were missed by culture on 
MGIT media, while 9% were missed when using LJ culture media.  Previously, it has been 
suggested that the culture method could provide a “microbiological bias” and lead to a 
discrepancy in the growth of mycobacteria and therefore should be considered when 
interpreting molecular epidemiological data.  Our study supports previous reports which have 
suggested the use of a combination of both liquid and culture media for maximum recovery 
of M. tuberculosis (19, 20).  
 
In summary, this study demonstrates that mixed infections with different M. tuberculosis 
genotypes is an important epidemiological phenomenon in TB patients resident in a setting 
with one of the highest burdens of HIV and TB co-infection.  The clinical significance of 
mixed infection remains poorly understood although it has been previously shown that mixed 
infection may mask the detection of drug resistance.  In this study, only one patient was 
infected with both a drug sensitive and a drug resistant strain.  Furthermore, strains of the 
Beijing genotype were significantly associated with mixed infections which further support 
the hypothesis that strains of the Beijing genotype have evolved selective advantages 
enabling their increased dissemination.  Lastly, the study shows that the growth 
characteristics of M. tuberculosis on different media may influence our ability to detect 
mixed infections.   
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Figure 1:  Order in which primer sets were used to identify strains of the Beijing, LAM, S-
family, LCC and Haarlem genotype respectively 
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Figure 2:  Flow diagram illustrating PCR results of primary cultures grown on MGIT and LJ 
media  
 224 MGIT 
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PCR 
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217 amplified  
194 single 
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23 mixed 
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224 LJ positive 
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PCR 
amplification  
217 amplified  
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7 failed to 
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7 failed to 
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9 mixed 
infections on LJ 
only and single 
on MGIT 
20 mixed 
infections on LJ 
and MGIT 
3 mixed 
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MGIT only and 
single on LJ 
Chapter 5 
 165 
Table 1:  Primer sequences used to identify strains of the Beijing, LAM, S-family, LCC and 
Haarlem genotype respectively 
 
Primer 
Primer 
set 
Primer sequence (5’ – 3’) 
Primer 
position 
Chromosomal 
position
a
 
PCR product size 
(base pairs) 
RD105 F ACA GCG CGG GTC ATA TCA C 79385 
RD105 R AAC CAG CTC CTC GAC GCT ATC 83257 
RD105 INT 
1 
GCA ACA CCC GCT TGT CTT TG 79999 
79567 to 
83034
c
 
Beijing = 405 
Non-Beijing = 615 
Lam F
d
 TAG CCC ACC ACC ACA GCT TC 932281 
Lam R
d
 
2 
ACC ACC CTG CCT AAC CAA TTC 932141 
932204 
LAM = 205 
Non-LAM = 141 
F28/480.9 F GGC GGT GTT AGC GAT TGA A 1889015 
F28/480.9 R 
3 
CTG CGG CAA CAG ATT CCA CTA 1889250 
1889068 
S = 194 
Non-S = 236 
Rv0403cF GAC AAC GCA TGG ATC GTC C 483170 
Rv0403cR 
4 
TCA CAT CAA CAT GCG CCC 483557 
483298 
LCC = 270 
Non-LCC = 388 
Rv2336 F GGT GGC GAA AGC TTT AGC C 2610998 
Rv2336 R 
5 
TGC GCC AAA CAT GCA GTC 2610787 
2610861 
Haarlem = 279 
Non-Haarlem = 212 
Internal 
primer
b
 
 TTC AAC CAT CGC CGC CTC TAC    
 
a 
relative to the H37Rv genome sequence 21 
b 
internal primer used for primer set 2 to 4 
c
 RD105 region according to (13). 
d according to (12) 
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Table 3:  The population structure of mixed infections cultured on MGIT media and 
their corresponding LJ media as well as the population structure of the total mixed 
infections. 
MGIT culture LJ culture MGIT-LJ combinations 
LAM + “other strains” LAM + “other strains” LAM + “other strains” 
Beijing + LAM Beijing + LAM Beijing + LAM 
Beijing + LAM + LCC Beijing + LAM Beijing + LAM 
Beijing + LAM Beijing + LAM Beijing + LAM 
Beijing Beijing + LAM Beijing + LAM 
S-family + “other strains” S-family + “other strains S-family + “other strains” 
Beijing + Haarlem Beijing + Haarlem Beijing + Haarlem 
Beijing + LAM Beijing + LAM Beijing + LAM 
Beijing LAM + “other strains” LAM + “other strains” 
Beijing + LCC Beijing + LCC Beijing + LCC 
Beijing + LAM Beijing + LAM Beijing + LAM 
Beijing + Haarlem Beijing + Haarlem Beijing + Haarlem 
Beijing Beijing + LAM Beijing + LAM 
Haarlem + “other strains” Haarlem Haarlem + “other strains” 
LAM LAM + LCC LAM + LCC 
Beijing Beijing + LAM + S-family + LCC Beijing + LAM + S-family + LCC 
Beijing Beijing + LAM Beijing + LAM 
Beijing Beijing + other Beijing + other 
Beijing + LAM Beijing + LAM Beijing + LAM 
Beijing + “other strains” Beijing + LAM + S-family + LCC Beijing + “other strains” 
LCC + “other strains” LCC + “other strains” LCC + “other strains” 
LAM + Haarlem LAM + Haarlem LAM + Haarlem 
LCC + “other strains” LCC + “other strains” LCC + “other strains” 
LAM + “other strains” LAM LAM + “other strains” 
LAM + “other strains” LAM LAM + “other strains” 
Beijing + LCC Beijing + LCC Beijing + LCC 
Beijing + S-family Beijing + S-family Beijing + S-family 
Beijing Beijing + LCC Beijing + LCC 
Beijing + LAM Beijing + LAM Beijing + LAM 
Beijing Beijing + LAM + LCC Beijing + LAM + LCC 
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Beijing + Haarlem Beijing + Haarlem Beijing + Haarlem 
LAM + LCC LAM + LCC LAM + LCC 
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Table 4: Discrepant PCR amplification results of strain genotypes grown on MGIT 
media and their corresponding LJ media. 
 
MGIT LJ 
Haarlem + “other strains” Haarlem 
LAM + “other strains” LAM 
LAM + “other strains” LAM 
Beijing Beijing + LAM 
Beijing LAM + “other strains” 
Beijing Beijing + LAM 
LAM LAM + LCC 
Beijing Beijing + LAM + S-family + LCC 
Beijing Beijing + LAM 
Beijing Beijing + “other strains” 
Beijing Beijing + LCC 
Beijing Beijing + LAM + LCC 
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Table 5: Demographic and drug susceptibility data of patients infected with one or 
more M. tuberculosis strain genotypes. 
  
Demographic and 
clinical data 
All 
Mixed 
infection (%) 
(n=32) 
Single strain 
infection (%) 
(n=181) 
 
P-values 
Mean age, yr  199 33.1 yr 35 yr  
Sex  
           Male 113 16 (51.6) 97 (57.7) 
           Female 86 15 (48.4) 71 (42.3) 
p = 0.53 
Treatment history  
           New  130 21 (67.7) 109 (67.7) 
           Retreatment  62 10 (32.3) 52 (32.3) 
p = 0.99 
Smear grading  
           Negative 77 13 (41.9) 64 (38.10) 
           Positive 122 18 (58.1) 104 (61.9) 
p = 0.69 
Drug susceptibility  
   Sensitive 114 17 (70.8) 97 (70.3) 
   All resistance 50
a
 7 (29.2) 43 (30.7) 
p = 0.88 
      Mono-resistance 30 6 (25) 24 (17.4) 
     Poly-Resistance 12 0 12 (8.7) 
      MDR 6 1(4.2) 5 (3.6) 
p = 0.22 
 
a 
Two extensively drug-resistant (XDR) isolates were excluded from the table. 
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Abstract 
Drug resistance among children with culture-confirmed tuberculosis
 
(TB) provides an 
accurate measure of transmitted drug resistance
 
within the community.  We describe 
the genotype diversity in
 
children with culture-confirmed TB and investigate the 
relationship
 
between genotype and drug resistance.  A prospective study was
 
conducted from March 2003 through August 2005 at Tygerberg Children's
 
Hospital, in 
the Western Cape Province of South Africa.  All
 
children (<13 years of age) diagnosed 
with culture-confirmed
 
TB were included.  Genotype analysis and phenotypic drug 
susceptibility
 
testing were performed on the first culture-positive isolate
 
from each 
patient.  Mutation analysis was performed on all drug-resistant
 
isolates.  Spoligotyping 
was successfully performed on isolates
 
from 391/399 (98%) children diagnosed with 
culture-confirmed
 
TB.  Drug susceptibility testing was also performed on 391 isolates;
 
49 (12.5%) were resistant to isoniazid, and 20 (5.1%) of these
 
were resistant to both 
isoniazid and rifampin. Beijing was the
 
most common genotype family, identified in 
130/391 (33.2%) cases,
 
followed by LAM in 114/391 (29.2%) cases.  The presence of 
both
 
Beijing and Haarlem genotype families was significantly associated
 
with drug 
resistance (26/49 [53.1%] versus 113/342 [33.0%];
 
odds ratio, 1.7; 95% confidence 
interval, 1.0 to 2.9). The high
 
prevalence of Beijing and LAM in children with culture-
confirmed
 
TB reflects considerable transmission of these genotype families
 
within the 
community.  The overrepresentation of Beijing and
 
Haarlem genotype families in 
children with drug-resistant TB
 
demonstrates their contribution to transmitted drug 
resistance
 
and their potential importance in the emergent drug-resistant
 
TB epidemic.
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Introduction 
At a molecular level, the global tuberculosis (TB) epidemic
 
consists of multiple 
genotype-specific subepidemics.  Over time,
 
the host-pathogen interaction, as well as 
the environment, selects
 
the most "successful" genotypes within particular geographic
 
locations (10).  Different Mycobacterium tuberculosis (M. tuberculosis)
 
genotypes can 
be identified by variation in certain well-characterized
 
repeat sequences, such as the 
IS6110 transposable element and
 
the direct repeat region (33).
 
 
Host-related selective forces include variability in the immune
 
response to M. 
tuberculosis infection and the provision of anti-TB
 
chemotherapy to TB patients.  The 
immune response of the host
 
is influenced by genetic predisposition and acquired 
factors
 
(6, 10), including bacillus Calmette-Guerin (BCG) vaccination,
 
previous M. 
tuberculosis infection, exposure to environmental
 
mycobacteria, and human 
immunodeficiency virus (HIV) infection. 
 
Genotype-specific differences in the host-
pathogen interaction
 
are well documented in animal models, where infection with 
different
 
M. tuberculosis genotypes evokes markedly different immune responses
 
(14).  
In addition, BCG vaccination provides variable genotype-specific
 
protection; infection 
with strains from the Beijing genotype
 
family in particular has been associated with 
decreased protection
 
following BCG vaccination in mice (14).
 
 
The Beijing genotype family is well recognized as a distinct
 
genetic lineage, and it is 
genetically highly conserved (11),
 
although large sequence polymorphisms identify 
four monophyletic
 
subgroups (30).  It has a worldwide distribution but predominates
 
in 
certain geographic areas, particularly in parts of Asia (13,
 
31) and Russia (7). Based on 
its association with young age
 
in adult studies from Vietnam and Russia (7), 
suggesting more
 
recent spread, it has been proposed that Beijing should be regarded
 
as 
an emerging genotype family (2).
 
 
The association between drug resistance and the Beijing genotype
 
is well documented 
in adults (1, 4, 13, 23, 29, 30).  The geographic
 
variability observed in this association 
(30), the frequent
 
clustering of resistant genotypes, and their successful spread
 
within 
the Russian prison system (7, 29), suggest recent clonal
 
expansion.  This is supported 
by evidence that some strains of
 
the Beijing genotype family retain fitness despite the 
acquisition
 
of drug resistance (28).  The Haarlem genotype family has also
 
been 
Chapter 5 
 175 
associated with drug resistance and rapid clonal expansion
 
(8, 19).  The association of 
these genotype families with drug-resistant
 
outbreaks clearly demonstrates their 
epidemic potential (19,
 
21).  From a TB control point of view, it is relevant to know
 
whether specific genotype families are overrepresented among
 
drug-resistant cases and 
in particular if these resistant strains
 
are successfully transmitted within the 
community.
 
 
Children provide a valuable epidemiologic perspective, as the
 
burden of childhood TB 
reflects the level of epidemiologic control
 
achieved within a particular community 
(18).  Because children
 
usually progress to disease within 12 months of primary 
infection
 
(15, 16), genotype analysis of isolates collected from children
 
reflects current 
transmission patterns within the community
 
(35).  Children tend to develop pauci-
bacillary disease and are
 
therefore unlikely to acquire drug resistance (15, 26).  
Consequently,
 
drug resistance patterns among children with culture-confirmed
 
TB 
serve as a good indicator of transmitted (primary) drug resistance
 
within the 
community (26).
 
 
Genotype diversity, and in particular the relation between genotype
 
and drug 
resistance, are poorly documented in children.  The
 
aims of this study were to describe 
the genotype diversity in
 
children with culture-confirmed TB and to investigate the 
relationship
 
between genotype and drug resistance.
 
 
Materials and methods 
Study population and setting 
Isolates were prospectively collected from March 2003 through
 
August 2005 at 
Tygerberg Children's Hospital, a pediatric referral
 
hospital in the Western Cape 
Province of South Africa.  All children
 
(<13 years of age) diagnosed with culture-
confirmed tuberculosis
 
were included.  The Western Cape Province reported a TB 
incidence
 
of 678/100,000 in 2003 (3), and the incidence of childhood TB
 
in areas 
adjacent to Tygerberg Children's Hospital was 407/100,000
 
in the same period, 
representing 13.7% of all treated cases
 
(17).
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Laboratory procedures 
Diagnostic cultures were performed using Middlebrook 7H9 broth-based
 
Mycobacteria 
Growth Indicator Tubes (MGIT; Becton Dickinson,
 
Sparks, MD).  M. tuberculosis was 
confirmed by routine PCR-based
 
speciation of the M. tuberculosis complex (5).  The 
first culture-positive
 
isolate from each patient was sent to the regional diagnostic
 
laboratory for phenotypic drug susceptibility testing, using
 
the indirect proportional 
method.  Drug resistance was defined
 
according to international criteria ( 1% bacterial 
growth on
 
drug-containing media compared to a non-drug-containing control)
 
using 
critical concentrations of 0.2 µg/ml isoniazid (INH)
 
or 30 µg/ml rifampin (RMP) (26).  
In-house quality assurance
 
checks were performed after every batch, with external 
review
 
by the national reference TB laboratory on a quarterly basis.
  
Genotypic testing for specific mutations in the katG, inhA,
 
and rpoB genes that may 
confer resistance to INH and/or RMP
 
was performed on all isolates with phenotypic 
drug resistance.
  
DNA sequencing included the following regions: position 15 in
 
the 
inhA promoter region, codon 315 of the katG gene, and codons
 
526 and 531 of the 
rpoB gene.  An equal number of drug-sensitive
 
specimens were tested as controls.
 
 
Mycobacterial subcultures made on standard Löwenstein-Jensen
 
slants were used for 
genotyping.  Strict protocols were in place
 
to prevent cross-contamination; subcultures 
were prepared within
 
a negative-pressure extraction hood, using sterile equipment
 
and 
containers, by direct aspiration from the liquid growth
 
media.  Genotype 
determination was done using standardized spoligotyping
 
methodology (33).  Isolates 
were assigned to specific genotype
 
families according to their spoligotype signature, 
using the
 
spoldb3 database (www.pasteur-guadeloupe.fr/tb/spoldb3).  The
 
following 
internationally recognized genotype families were
 
identified: Beijing, LAM (Latin 
American and Mediterranean family),
 
X (a European clade of IS6110 low banders), 
and Haarlem (9),
 
while Family 28 was identified as a "stand alone" genotype family
 
(E. Streicher, personal communication).  Genotype families with
 
a low frequency (<10 
cases) were combined and categorized
 
as "Other."
 
 
Some isolates could not be assigned to an internationally recognized
 
genotype family, 
and these specimens were further characterized
 
by using a novel PCR-based 
technique.  PCR primers were designed
 
to identify the presence of an IS6110 insertion 
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(position 932204
 
according to the whole H37RV genome sequence), which is unique
 
to all members of the LAM family (25). DNA was PCR amplified
 
in a total volume of 
25 µl, containing 1 µl DNA
 
template, 1x Q-Buffer, 1x enzyme buffer, 3.5 mM MgCl2, 
1.6 mM
 
deoxynucleoside triphosphates, 25 pmol of each primer (LAM F,
 
TAG CCC 
ACC ACC ACA GCT TC; LAM R, ACC ACC CTG CCT AAC CAA TTC;
 
Xho1, 
TTC AAC CAT CGC CGC CTC TAC), and 0.25 U HotStarTaq DNA
 
polymerase 
(QIAGEN, Germany).  Amplification was initiated by
 
incubation at 95°C for 15 min, 
followed by 40 cycles at
 
94°C for 1 min, 62°C for 1 min, and 72°C for 1 min.
  
After 
the last cycle, isolates were incubated at 72°C for
 
10 min. PCR amplification products 
were electrophoretically
 
fractionated in 3.0% agarose in 1x Tris-borate-EDTA, pH 
8.3,
 
at 3.5 V/cm for 4 h and visualized by staining with ethidium
 
bromide.  The 
presence of a LAM strain was represented by a band
 
of 205 base pairs, while a non-
LAM strain was represented by
 
a band of 141 base pairs.  The specificity of 
amplification was
 
determined by amplification of a panel of genetically unrelated
 
and 
related strains and was shown to be 100% (95% confidence
 
interval [CI], 85 to 100%) 
compared to the gold standard of
 
IS6110 DNA fingerprinting.  To minimize the risk 
of laboratory
 
cross-contamination during PCR amplification, each procedure
 
(preparation of the PCR mixes, the addition of the DNA, the
 
PCR amplification, and 
the electrophoretic fractionation) was
 
conducted in physically separated rooms. 
Negative controls (water)
 
were included to control for reagent contamination.
  
After 
performing the LAM-specific PCR test, some isolates could
 
still not be assigned to an 
internationally recognized genotype
 
family, and these isolates were categorized as 
"unclassified."
 
 
Children were tested for human immunodeficiency virus (HIV)
 
infection, using the 
Determine HIV1/2 rapid test (Abbot, Tokyo,
 
Japan) as a screening test and an 
enzyme-linked immunosorbent
 
assay (DNA PCR in children <18 months of age) for 
confirmation.
  
The study was approved by the Ethics Committee, Faculty of Health
 
Sciences, Stellenbosch University.
 
 
Data analysis 
Descriptive statistical analysis was done with SPSS, version
 
13 (SPSS Inc., Chicago, 
IL) on anonymous unlinked data. Categorical
 
data were analyzed with the 
2
 test, 
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using Epi-Info version 6.04.
 
We report the relative proportion of different genotype 
families,
 
comparing drug-susceptible to drug-resistant isolates, and describe
 
the 
specific mutations associated with resistance.
  
Results 
During the study period, 399 children were diagnosed with culture-confirmed
 
TB. 
Patient characteristics and drug susceptibility test (DST)
 
results are reflected in Table 
1.  Spoligotyping and DST analysis
 
were performed on 391 isolates; 8 (2%) isolates 
developed bacterial
 
contamination or lost viability during drug susceptibility testing.
 
Of the isolates tested, 49 (12.5%) were resistant to INH, of
 
which 20 (5.1%) were 
resistant to both INH and RMP (multidrug
 
resistant [MDR]). No case of RMP 
monoresistance was recorded.
  
Table 1: Patient characteristics and drug susceptibility test results of children 
diagnosed with culture-confirmed tuberculosis 
Patient group and characteristic Value
a
     
 
All patients with culture-confirmed TB (n = 399)  
    Boys (no. of patients) 210 (52.6) 
  
    Age (yr)  
        Median     2 
        Range 0-12 
    HIV testing (no. of patients)  
        HIV test performed 297 (74.4) 
        HIV infected 73 (18.3) 
    DST result available (no. of patients) 391 (98.0) 
  
All patients with a DST result (n = 391)  
    Drug susceptible 342 (87.5) 
    All INH resistance 49 (12.5) 
    INH monoresistance 29 (7.4) 
    MDR 20 (5.1)  
a Values in parentheses are percentages 
Table 2 reflects the relative proportion of different genotype
 
families, comparing 
drug-susceptible to drug-resistant isolates.
 
Beijing was the most prevalent genotype 
family, identified in
 
130/391 (33.2%) isolates, followed by LAM, identified in 
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114/391
 
(29.2%) isolates.  Children infected with either the Beijing
 
or Haarlem strain 
families were more likely to have drug-resistant
 
disease compared to those infected 
with other strain families
 
(26/139 [18.7%] versus 23/252 [9.1%]; odds ratio [OR], 
2.29;
 
95% confidence interval [CI], 1.2 to 4.4).  The Beijing and Haarlem
 
families 
combined were also more prevalent in the drug-resistant
 
compared to the drug-
susceptible group (26/49 [53.1%] versus
 
113/342 [33.0%]; OR, 1.7; 95% CI, 1.0 to 
2.9).
  
 
Table 2:. Mycobacterial genotype and drug resistance in children with culture-
confirmed tuberculosis 
 
No. (%) of isolates with DST 
result available 
 
Genotype family 
designation
a
 
No. (%) of 
isolates 
Drug 
susceptible 
Drug 
resistant 
Odds ratio 
(95% CI) 
 
Beijing 130 (32.6) 105 (30.7) 22 (44.9) 1.5 (0.8-
2.6) 
 
LAM 114 (28.6) 99 (28.9) 13 (26.5) 0.9 (0.4-
1.8) 
 
X 25 (6.3) 22 (6.4) 3 (6.1) 1.0 (0.2-
3.5) 
 
Family 28 25 (6.3) 24 (7.1) 1 (2.0) 0.3 (0.0-
1.8) 
 
Haarlem 12 (3.0) 8 (2.3) 4 (8.2) 3.7 (0.8-
14.5) 
 
Other 7 (2.0) 7 (2.0) 0   
Unclassified 78 (19.5) 71 (20.8) 5 (10.3) 0.4 (0.1-
1.1) 
 
Not done 8 (2.0) 6 (1.8) 1 (2.0) 1.2 (0.0-
9.9) 
 
Total 399 (100.0) 342 (100) 49 (100)   
 
a
 Other, all genotype families with a frequency of less than 10 cases; X, European clade of IS6110 low 
banders, identified by spoligotyping (9); unclassified, no internationally recognized genotype family 
assigned, based on the spoldb3 spoligotype database (9), and negative for the LAM-specific PCR test. 
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Table 3 reflects specific mutations in the inhA promoter region
 
and in the katG gene. 
Resistance mutations were detected in
 
31/49 (64.6%) isolates with phenotypic INH 
resistance.  The two
 
most common mutations detected were –15 in the inhA promoter
 
region (18/49; 36.7%) and 315ACC in the katG gene (16/49; 32.7%).
  
Among Beijing 
isolates, the –15 inhA promoter region mutation
 
occurred most frequently (13/22; 
59.1%) and was exclusively
 
detected in the Beijing 220 subgroup.  The Beijing 220 
subgroup
 
is a well-recognized drug-resistant strain in the Western Cape
 
Province (T. 
C. Victor, personal communication).  Mutations found
 
in the MDR isolates included –
15 in the inhA promoter
 
region (7/20; 35%) as well as 315ACC (10/20; 50%) and 
315ACA
 
in the katG gene (1/20; 5%).  No INH resistance-associated mutation
 
was 
detected in 2/20 (10%) MDR isolates, using the limited mutation
 
analysis described, 
and no multiple mutations were detected
 
in the same isolate.  No resistance-associated 
mutations, either
 
for INH or RMP, were identified in any of the drug-sensitive
 
control 
isolates.
 
 
Table 3:. Specific resistance mutations in children with INH-resistant tuberculosis 
No. of strains with resistance 
mutation: 
 
Genotype family 
designation
a
 
inhA 
–15 
katG 
315ACA 
katG 
315ACC 
No. of wild-
type strains 
Total no. 
of strains 
 
Beijing 13 0 5 4 22   
LAM 3 0 4 6 13   
X 0 1 1 1 3   
Family 28 1 0 0 0 1   
Haarlem 0 0 3 1 4   
Other 0 0 0 0 0   
Unclassified 0 0 3 2 5   
Not done 1 0 0 0 1   
Total 18 1 16 14 49   
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a
 Other, all genotype families with a frequency of less than 10 cases; X, European clade of IS6110 low 
banders, identified by spoligotyping (9); unclassified, no internationally recognized genotype family 
assigned, based on the spoldb3 spoligotype database (9), and negative for the LAM-specific PCR test. 
Table 4 reflects specific mutations in the rpoB gene in children
 
with RMP-resistant 
TB.  Resistance mutations were detected in
 
all isolates with phenotypic RMP 
resistance.  The most common
 
rpoB gene mutation was 531TTG (13/20; 65%).  This 
mutation was
 
identified in all (8/8) multidrug-resistant Beijing isolates.
 
 
Table 4: Specific rpoB mutations in children with MDR
a
 tuberculosis 
No. of strains with 
resistance mutation: 
 
Genotype family 
designation
b
 
526 531 CAG 
531 
TTG 
No. of wild-
type strains 
Total no. 
of strains 
 
Beijing 0 0 8 0 8   
LAM 1 1 3 0 5   
X 0 0 1 0 1   
Family 28 1 0 0 0 1   
Haarlem 0 0 2 0 2   
Other 0 0 0 0 0   
Unclassified 2 0 1 0 3   
Total 4 1 15 0 20   
 
a MDR, multidrug resistant (resistant to both INH and rifampin); all rifampin-resistant isolates 
were resistant to isoniazid as well. 
b Other, all genotype families with a frequency of less than 10 cases; X, European clade of 
IS6110 low banders, identified by spoligotyping (9); unclassified, no internationally 
recognized genotype family assigned, based on the spolDB3 spoligotype database (9), and 
negative for the LAM-specific PCR test. 
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Discussion 
To our knowledge this is the first report of genotype diversity
 
in relation to phenotypic 
and genotypic drug resistance in children
 
with TB, and it represents one of the largest 
cohorts of children
 
with DST results reported to date.  As such, the report provides
 
an 
estimate of genotype-specific transmission patterns at the
 
community level, both for 
drug-susceptible and drug-resistant
 
organisms.  The association found between 
Beijing and Haarlem
 
genotype families and drug-resistant TB is consistent with 
previous
 
reports on adults (4, 7, 8, 19, 23, 29).
 
 
The predominance of specific mutations such as the –15
 
inhA promoter region 
mutation and the 531TTG rpoB mutation in
 
the Beijing genotype family is an 
interesting observation.  The
 
frequency with which these specific mutations were 
detected
 
may reflect random mutation and subsequent clonal expansion.
  
Alternatively, 
certain genotype families may preferentially
 
develop resistance mutations at particular 
locations in so-called
 
mutation hotspots.  Unique polymorphisms in the genes 
involved
 
in DNA repair (mut genes) have been demonstrated in the Beijing
 
genotype 
family, which may explain the ability of this clonal
 
family to rapidly adapt to selective 
pressure (24); however,
 
functional correlates of the "mutator phenotype" hypothesis
 
have not been demonstrated.
  
In a comparative RMP resistance study, Beijing 
genotypes did
 
not acquire rpoB mutations more rapidly than the reference H37Rv
 
strain (34).  However, the Beijing genotype family is not a homogeneous
 
group and 
demonstrates a deeper population structure than previously
 
appreciated (30).  
Therefore, the reported comparable acquisition
 
of RMP resistance may not necessarily 
apply to the Beijing genotype
 
family as a whole.  In addition, the ability to acquire 
INH resistance
 
may be the most important step in the acquisition of MDR disease.
 
RMP monoresistance is rare.  Due to the exceptional early bactericidal
 
activity of INH 
(20), the development of monoresistance to INH
 
is probably a more relevant event in 
the acquisition of multidrug
 
resistance.  In this regard, the specific –15 inhA promoter
 
region mutation, documented in children infected with the particular
 
Beijing 220 
subgroup, is of particular interest and warrants
 
further investigation.  The substantial 
pool of INH monoresistant
 
isolates identified may represent a source of future MDR 
disease
 
(27).
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Similar to a recent report from an adjacent study setting in
 
Cape Town, South Africa 
(22), this study demonstrates that Beijing
 
is the dominant genotype family in children 
with culture-confirmed
 
TB.  An important finding is that the prevalence of the Beijing
 
genotype in children seems to differ from that described in
 
adults from the same 
geographic area.  LAM (which includes Family
 
11) has been reported as the dominant 
genotype family among
 
adults in Cape Town (32).  This discrepancy may reflect an 
important
 
"age-shift," similar to adult data from Vietnam (2), indicating
 
emergence of 
the Beijing genotype family in the Western Cape
 
Province of South Africa.  However, 
the validity of comparisons
 
with adult data is limited, as adult and child data were not
 
collected from the same geographic area or the same period of
 
time.
  
In Vietnam, the 
prevalence of the Beijing genotype family was
 
found to be associated with the 
presence of a BCG scar (2). 
 
Although this was not significant after  
correcting for the cohort
 
effect (2), it lends preliminary support to observations in
 
animal studies that BCG provides less efficient protection against
 
Beijing (14). This 
may provide a selective advantage to the
 
Beijing genotype family in countries with 
universal BCG vaccination
 
policies, such as South Africa.
 
 
This study has several limitations.  Limiting selection bias
 
presents a huge challenge 
when studying children with culture-confirmed
 
TB, as culture confirmation is rarely 
achieved at the primary
 
health care level, and hospital-based studies are inherently
 
limited by selection bias.  However, a recent report that compared
 
drug resistance 
patterns between hospital- and community-recruited
 
children from the same cohort 
found no significant differences
 
between the two groups (26).
 
 
When investigating genotype diversity, an important consideration
 
that is often 
overlooked is the potential selection bias imposed
 
by the variable culturability of 
different genotypes.  If particular
 
genotypes are easier to culture in vitro, particularly 
in children
 
with pauci-bacillary disease, this may introduce a significant
 
bias.  In vivo 
data demonstrate that variation in strain-specific
 
culturability is a reality that requires 
further exploration
 
(12).  Finally, the spoligotype fingerprint of the Beijing genotype
 
family is short and distinct.  Therefore, the probability of
 
losing the spoligotype 
fingerprint of other strains through
 
mutational events is greater.  As a result, most of 
the unclassified
 
strains would represent non-Beijing genotypes.  We used a novel
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PCR-based test to reduce the number of unclassified isolates,
 
and during analysis, all 
unclassified strains were regarded
 
as non-Beijing to limit potential bias.
 
 
In conclusion, the high prevalence of Beijing and LAM in children
 
with culture-
confirmed TB reflects considerable transmission
 
of these genotype families within the 
community. The overrepresentation
 
of Beijing and Haarlem genotype families in 
children with drug-resistant
 
TB demonstrate their contribution to transmitted drug 
resistance
 
and their potential importance in the emergent drug-resistant
 
TB epidemic.
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Abstract 
Word count = 199 
 
Background:  Molecular epidemiological and murine infection model studies have 
suggested that distinct Mycobacterium tuberculosis genotypes evolved unique 
pathogenic characteristics. 
 
Aim:  Clinical and demographic parameters of new tuberculosis (TB) patients 
infected with Beijing and non-Beijing genotype strains were compared to identify 
genotype-specific pathogenic characteristics. 
 
Methods:  Clinical and demographic data were collected from new pulmonary 
tuberculosis patients that were prospectively recruited at 5 health care clinics in Cape 
Town, South Africa over a period of 24 months as part of a longitudinal cohort study.  
Chest radiographs were read, scored and recorded in a database.  M. tuberculosis 
strains were genotyped according to IS6110 DNA fingerprinting and spoligotyping.   
 
Results:  Patients infected with a Beijing genotype strain were more likely to have a 
higher bacillary load as measured by their sputum smear gradation (p = 0.008).  
Review of the chest radiographs showed a weak association between pleural TB 
(pleural fluid and pleural fibrosis) and the non-Beijing genotype (p = 0.03).  All of the 
other clinical and demographic parameters analyzed were not associated with a 
defined M. tuberculosis genotype.  
 
Conclusion:  This study showed that Beijing genotype strains were associated with an 
increased bacterial load in sputum samples thereby enhancing the transmissibility of 
this genotype.  
 
Introduction  
Molecular epidemiological studies have shown that the tuberculosis (TB) epidemic is 
composed of subsets of smaller sub-epidemics which consist of various genetically 
related and unrelated Mycobacterium tuberculosis genotypes.  Subsequent studies 
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have found that the Beijing genotype occurs worldwide and has been associated with 
numerous TB outbreaks (1, 2).  In addition, the Beijing strain genotype has been 
associated with drug resistance (3), the ability to evade the protective effect of the 
BCG vaccine (4), treatment failure and relapse (5, 6) and to cause more severe forms 
of disease (7).  Based on these findings, many studies attempted to determine whether 
a correlation exists between the M. tuberculosis genotype and clinical presentation.  In 
the murine infection model Beijing genotype strains were more frequently associated 
with increased growth rate, bacterial load and time to death and severe lung pathology 
of infected mice (8, 9).  These findings were attributed to the ability of the Beijing 
strain genotype to induce a non-protective Th2-type immune response characterized 
by increased levels of IL-4 and IgE and decreased levels of IL-2 and IFN-γ (8).  In 
humans, the interaction between M. tuberculosis genotypes and the immune response 
is not well established although certain clinical and demographic parameters 
(extrapulmonary disease, febrile response, human immunodificiency virus (HIV) 
status and young age) have been associated with the Beijing genotype (7, 10, 11, 12). 
Interestingly, the association between the Beijing genotype and transmission has not 
been linked to the clinical parameter of sputum smear gradation (7, 10, 13, 14).  
Recent studies from The Gambia and South Africa suggest that the Beijing and non-
Beijing genotype strains are equally infectious (15, 16), although, infection with 
Beijing genotype strains was more likely to progress towards disease, possibly as a 
result of immune modulation (15, 17).   
 
A limited number of studies have attempted to use chest radiography to demonstrate 
an association between lung pathology and the genotype of the M. tuberculosis strain 
causing disease (10, 13, 18, 19).  However these finding have not been consistent.  
Studies done in Indonesia (10), the Netherlands (18) and Taiwan (13) found no 
significant differences between chest radiograph findings and these two groups of 
patients.  In contrast, a subsequent study done in Russia (19) showed that TB caused 
by a Beijing genotype strain was more commonly associated with advanced 
radiological abnormalities (multiple lung zones with fibrotic changes and widespread 
cavitations) than strains with a non-Beijing genotype.   
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In this study we compared clinical and demographic data of newly diagnosed TB 
patients infected with Beijing and non-Beijing genotype strains in order to determine 
whether a correlation existed between clinical presentation and the genotype of the M. 
tuberculosis strain causing disease.  
 
Methods 
Sputum specimens were collected from pulmonary TB patients that were 
prospectively recruited at 5 health care clinics in Cape Town, South Africa over a 
period of 24 months as part of a longitudinal cohort study.  Patients were excluded for 
the following reasons:  multidrug-resistant (MDR) TB, positive HIV status, co-
infection with nontuberculous mycobacteria (NTM), co-morbid diseases or history of 
previous TB.  Sputum smear and culture, radiological findings, drug susceptibility test 
results and patient demographics including gender and age were recorded at diagnosis 
and stored in a database.  Strains were genotyped by IS6110 DNA fingerprinting (20) 
and spoligotyping (21) using internationally standardized methods.   
 
Chest radiographs were read and scored using a modified version of the recently 
described chest radiograph reading and recording system (CRRS) (22).  This system 
provides for the collection of data on the most significant forms of lung disease for 
which radiology is a useful screening method.  Chest radiographs were read by a 
single reader with clinical experience in chest radiology and who was blinded to the 
genotypic data.  Chest radiographs were evaluated according to film quality (optimal, 
suboptimal and unreadable) and the presence or absence of abnormalities associated 
with TB.  Abnormalities recorded included parenchymal (large (>1cm) and small 
(<1cm) opacities, cavities), pleural (pleural fluid/ fibrosis), central structure (hilar and 
mediastinal lymphadenopathy) and other (bronchiectasis, hyperinflation) 
abnormalities.  Relationships between the occurrences of various chest radiograph 
findings and Beijing/non-Beijing genotype cases were tested using cross tabulation 
and the Fisher exact test. 
 
This study was approved by the Ethics review board of Stellenbosch University.  
Permission for the study was also granted by the Director of Health, City of Cape 
Town, and the local health committees representing the communities.   
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Results 
Two hundred and seventy-four HIV-uninfected, new pulmonary TB patients were 
enrolled in the study.  Complete clinical and demographic data as well as good quality 
chest radiographs were available from 241 of these patients.  The patients represented 
in this cohort were not statistically different from the patients in the entire cohort 
according to the demographic measures of age, gender, smear grading and drug 
susceptibility patterns.  Eighty-five (35%) of the patients were infected with a Beijing 
genotype strain, while the remaining 156 (65%) patients were infected with a non-
Beijing genotype strain.  Comparison of clinical and demographic data showed that 
patients infected with a Beijing genotype strain were more likely to have a higher 
bacillary load as measured by their sputum smear gradation (p = 0.008; Table 1). 
Analysis of the chest radiographs showed a weak association between extrapulmonary 
TB (pleural fluid and pleural fibrosis) and the non-Beijing genotype (p = 0.03; Table 
2).  All of the other clinical and demographic parameters were not associated with a 
defined M. tuberculosis genotype. 
 
Discussion 
This study showed that the clinical and demographic characteristics of patients 
infected with either a Beijing genotype strain or a non-Beijing genotype strain are 
very similar with the exception that the bacterial load was significantly higher in 
patients infected with a Beijing genotype strain.  This suggests that these patients are 
more infectious leading to ongoing transmission in this setting.  This supports a recent 
finding which showed that the proportion of TB cases with a Beijing genotype strain 
was increasing significantly over time (23, 24).  Van der Spuy et al (2009) showed a 
weak association between smear-positive disease and the Beijing genotype but 
suggested that other factors were required to explain the growth rate in the number of 
cases with a Beijing genotype strain (23).  The association between smear gradation 
and extent of disease suggests that Beijing genotype strains cause more extensive 
disease, however, this was not supported by macroscopic lung pathology according to 
the chest radiograph analysis as no statistical difference could be found for the 
expected abnormalities (cavitations, consolidation and infiltration) associated with 
smear positivity (25) and the genotype of the strain causing disease.  This can in part 
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be explained by the fact that the majority of cases included in the study cohort had 
smear-positive disease and advanced radiological pathology suggestive of diagnostic 
delay.  Both diagnostic delay and the extent of disease may mask subtle pathological 
differences associated with the genotype of the strain causing disease.  Thus, in these 
patients a relationship between bacterial load and lung pathology may not be evident.  
 
In this study, the non-Beijing genotype was weakly associated with chest radiograph 
abnormalities consistent with pleural TB as defined by the presence of pleural fluid or 
pleural fibrosis.  This suggests that non-Beijing genotype strains may cause more 
disseminated disease than strains of the Beijing genotype in the study setting.  
However, we acknowledge that we were unable to show that these patients had other 
extrapulmonary manifestations (i.e. skeletal, central nervous system) beyond the 
pleura since the clinical investigation in this study was limited to pulmonary and 
pleural TB.  In general our findings concurred with previous studies which failed to 
demonstrate an association between the Beijing genotype and radiological features (7, 
13, 26 27).  However, our findings differed from the study done by Drobniewski et al 
(2005) who showed that strains of the Beijing genotype were associated with more 
advanced disease as defined by amongst others fibrotic changes (19).  These 
conflicting findings could be attributed to the population structure of the Beijing 
genotype strains in the different study settings as well as host population genetics (28, 
29).  Previously it was suggested that strains from the different Beijing sublineages 
may have evolved unique pathogenic characteristics (29).  
 
We acknowledge that this study was limited by the fact that only one reader’s 
observation was compared with the genotypic data. However, this is in agreement 
with a previous study (18) and inter-reader agreement has been shown to be limited 
(30).   
 
In conclusion, this study supports the notion that the Beijing genotype may influence 
the clinical presentation of disease in certain host populations.  However, we conclude 
that the resolution of the chest radiograph may be insufficient in patients with 
prolonged diagnostic delay to identify minor differences in pathology associated with 
a defined bacterial genotype.  
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Table 1:  Clinical and demographic of patients according to the genotype of the M. 
tuberculosis strain causing disease. 
 Characteristics of cohort Beijing (n=85) (%) Non-Beijing (n = 
156) (%) 
p-values 
Age 33.7 33.1 p = 0.7 
Gender  
      Male  52 (35.6) 94 (64.4) 
      Female 33 (34.7) 62 (65.3) 
p = 0.7 
Drug susceptibility  
      Sensitive 76 (36) 133 (64) 
      INH mono-resistance 6 (25) 18 (75) 
p = 0.25 
Smear gradation  
      Low (negative/1+) 39 (29) 98 (71) 
      High (2+/3+) 46 (45) 56 (55) 
p = 0.008 
Chest radiograph 
abnormalities
a
 
 
     Yes 84 (35.0) 156 (65) 
     No 1 (100) 0 
p = 0.35 
 
a 
see Table 2
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Table 2:  Chest radiograph abnormalities of TB patients infected with either strains of 
the Beijing genotype or strains of the non-Beijing genotype. 
 
Chest radiograph findings 
Beijing 
(n = 85) 
(%) 
Non-Beijing 
(n = 156) 
(%) 
p-values 
Abnormalities consistent with TB    
        Yes 84 (35.3) 154 (64.7) 
        No 1 (33.3) 2 (66.7) 
p = 0.72 
A. Pulmonary TB 
     Parenchymal abnormalities 
   
     Yes 
     No 
82 (34.6) 
3 (75.0) 
155 (65.4) 
1 (25.0) 
p = 0.13 
• Cavity    
           Yes 80 (35.2) 147 (64.8) 
            No 5 (35.7) 9 (64.3) 
p = 0.58 
• Small opacities (< 1cm) 
o Number of lobes involved 
   
                         1 lobe 4 (33.3) 8 (66.7) 
                         >1 lobe 81 (35.4) 148 (64.6) 
p = 0.58 
o Extent of disease    
                         unilateral 30 (33.7) 59 (66.3) 
                         bilateral 55 (36.2) 97 (63.8) 
p = 0.40 
• Large opacities (> 1cm) 
o Number of lobes involved 
   
                         1 lobe 73 (35.1) 135 (64.9) 
                         >1 lobe 12 (36.4) 21 (63.6) 
p = 0.52 
o Extent of disease    
                        unilateral 82 (35.0) 152 (65.0) 
                        bilateral 3 (42.9) 4 (57.1) 
p = 0.47 
     Central structure abnormalities    
     Yes 82 (35.7) 148 (64.3) 
      No 3 (27.3) 8 (72.7) 
p = 0.41 
• Enlarged hilar lymph nodes    
            Yes 6 (28.6) 15 (71.4) 
            No 79 (35.9) 141 (64.1) 
p = 0.34 
• Enlarged mediastinal lymph nodes    
            Yes 2 (100.0) 0 p = 0.12 
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            No 83 (34.7) 156 (65.3) 
     Other lung abnormalities    
• Hyperinflation    
            Yes 20 (34.5) 38 (65.5) 
            No 65 (35.5) 118 (64.5) 
p = 0.51 
• Bronchiectasis    
            Yes 9 (27.3) 24 (72.7) 
            No 76 (36.5) 132 (63.5) 
p = 0.20 
   B. Pleural TB 
     Pleural abnormalities    
     Yes 54 (32.9) 110 (67.1) 
     No 31 (40.3) 46 (59.7) 
p = 0.17 
• Pleural fluid/fibrosis     
           Yes 18 (25.7) 52 (74.3) 
           No 67 (39.2) 104 (60.8) 
p = 0.03 
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Conclusion 
Tuberculosis (TB) has been a major concern to those providing health care since the 
dawn of recorded human history.  The specific approach to TB control has been based 
on prevention and treatment of infection by means of vaccination (primary 
prevention), decrease the development of active disease in individuals already 
infected by means of preventative therapy (secondary prevention) and eradication of 
the bacilli in individuals with active disease by means of curative chemotherapy 
(active treatment).  However, evidence shows that BCG vaccine protection ranges 
from 0 to 80% and antimicrobial agents have encouraged the evolution of resistant 
bacteria often resulting in treatment failure.  To address these limitations in TB 
control, the focus of research has been on the development of new vaccines and anti-
TB drugs.  However, this has been done without a good understanding of the genetic 
background of the strains of Mycobacterium tuberculosis and the population structure 
of these strains in different geographical settings.  
 
The development of molecular epidemiological tools has allowed the focus of 
research to turn towards understanding the M. tuberculosis genome in order to 
amongst others, determine the influence of genetic strain variation on disease 
presentation and outcome (association of different bacterial strains with drug 
resistance, treatment failure, clustering, and the BCG vaccine).   
 
The Beijing strain genotype has been extensively studied (as discussed in Chapter 1) 
in different geographical settings because of their worldwide occurrence and 
association with major TB outbreaks.  It has been suggested that strains with the 
Beijing genotype have the ability to evade the protective effect of the BCG vaccine, to 
transmit more readily, to cause more severe forms of disease, to elicit a non-protective 
host immune response and to acquire drug resistance.  In Chapter 2, we described the 
phylogeny of the Beijing lineage and showed that the pathogenic characteristics of the 
Beijing lineage are not conserved but rather that strains within the different 
sublineages have evolved unique pathogenic characteristics.  The most pathogenic 
strains, as measured by their frequency of occurrence, were associated with the 
accumulation of deletions thus, suggesting that evolution has influenced the ability of 
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strains to transmit and cause disease.  Strains with the least genomic changes (termed 
“atypical Beijing strains) were less frequently found to transmit than the more 
recently evolved strains (termed “typical” Beijing strains).  Analysis of drug 
resistance data showed that the frequency of occurrence of the drug resistance 
phenotype was not associated with the most recently evolved sublineage.  
Interestingly, we showed in another setting that the “atypical” Beijing strains, which 
according to current dogma are attenuated in their ability to transmit, were over-
represented.  Transmission was linked to HIV co-infection supporting the concept that 
less fit strains are able to spread and cause disease in vulnerable host populations 
causing further concerns for TB control.   
 
In Chapter 3, the characteristics of the Beijing strain genotype i.e. ability to transmit 
and cause disease were further investigated.  We found a strong association between 
prevalence of a specific sublineage and the host population in which the strains were 
isolated.  From this we concluded that either the strains had evolved unique properties 
which allowed rapid spread in their respective host populations or that the immunity 
of the respective host populations was unable to prevent progression to disease and 
subsequent spread.  The findings from the above chapters have important implications 
for TB control as it is evident that Beijing genotype strains from the most recently 
evolved sublineage are highly pathogenic in their ability to spread and cause disease.  
Greater vigilance is needed to prevent the spread of these strains and it is thus 
suggested that screening of contacts be intensified as well as the implementation of 
rapid diagnostic tools.   
 
The evolution of the Beijing genotype was further explored in Chapter 4 using 
Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat which 
is based on a PCR amplification of a combination of minisatellite-like variable-
number repeat regions scattered around the bacterial genome.  The ability of these 
markers to identify transmission of Beijing genotype strains in Cape Town, South 
Africa was similar to that of IS6110 DNA fingerprinting.  However, comparison of 
the MIRU-VNTR loci combinations and IS6110 DNA fingerprints showed 
discordance between the two methods.  This implies that these chromosomal markers 
evolve independently and at different rates.  Their use as molecular epidemiological 
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tools is defined by the incidence of TB in the study setting and the role of immigration 
in introducing new strains into the study population.  
 
Treatment failure, a significant concern for TB control, has been associated with 
strains of the Beijing genotype as well as with mixed infections where a drug-resistant 
and a drug-sensitive strain are present in a single primary culture of a TB case.  In 
Chapter 5, using an improved PCR-based method, we were able to identify, for the 
first time, 5 prominent strain genotypes (Beijing, LAM, S-family, LCC and Haarlem) 
in primary cultures and quantify the extent of mixed infections in a high incidence 
setting with a high prevalence of HIV co-infection.  In this study we found a low 
incidence of mixed infections, however, one patient presented with both a drug-
sensitive and a drug-resistant strain underscoring the importance of detecting mixed 
infections in order to assure successful treatment and limiting TB transmission.  
Furthermore, we found that strains of the Beijing genotype were associated with 
mixed infections, which further supports the hypothesis that strains of the Beijing 
genotype have evolved selective advantages enabling their increased dissemination. 
 
Genotype-specific characteristics were further explored in chapter 6 by comparing 
clinical and demographic data of patients infected with Beijing and non-Beijing 
genotype strains.  We found that strains of the Beijing genotype were associated with 
increased bacillary load in sputum of TB cases supporting the hypothesis that these 
strains transmit more readily.  However, this association could not be confirmed by 
lung pathology according to chest radiographs.  This contradicts the hypothesis that 
the Beijing genotype cause more severe forms of disease.  However, the severity of 
disease may be masked by diagnostic delay (either due to prolonged patient seeking 
behaviour or time consuming diagnostic tools) as most of these patients were highly 
infectious (smear-positive) and had extensive disease according to chest radiography.  
This demonstrates the need to educate the human population on the signs and 
symptoms of TB to ensure that suspects seek medical advice earlier.  
 
Collectively, these studies show the importance of improving TB control and 
enhancing our understanding of the influence of different M. tuberculosis genotypes 
on clinical presentation.  The identification of unique pathogenic characteristics 
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associated with the Beijing genotype could be useful for future vaccine and drug 
development.  Our findings show that these Beijing genotype strains could be adapted 
to a certain host population and thus, future vaccines should target bacterial 
populations that are prevalent in a specific geographical setting (individualized rather 
than generalized preventative therapy).  In addition, new generation drugs should 
target virulence factors in different M. tuberculosis strains.   
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s 
is
o
la
te
d
 f
ro
m
 n
ew
 a
n
d
 
re
tr
ea
tm
en
t 
P
T
B
 p
ts
 d
u
ri
n
g
 t
h
e 
n
at
io
n
al
 s
u
rv
e
y
 o
f 
d
ru
g
 r
es
is
ta
n
ce
 
ca
rr
ie
d
 o
u
t 
in
 P
ar
ag
u
a
y
; 
re
p
re
se
n
ts
 7
7
%
 o
f 
st
ra
in
s 
c
o
m
p
o
si
n
g
 t
h
e 
d
ru
g
 r
es
is
ta
n
ce
 s
u
rv
e
y
. 
1
/2
2
0
 (
0
.5
%
) 
V
en
ez
u
el
a 
A
rt
is
ti
m
u
ñ
o
 e
t 
a
l,
 2
0
0
6
 
1
9
9
8
-1
9
9
9
 
5
5
6
 i
so
la
te
s 
w
er
e 
c
o
ll
ec
te
d
 f
ro
m
 n
ew
 a
n
d
 r
et
re
at
m
e
n
t 
sm
ea
r-
p
o
si
ti
v
e 
P
T
B
 p
at
ie
n
ts
 e
n
ro
ll
e
d
 i
n
 a
 d
ru
g
 s
u
rv
e
y
 i
n
 2
3
 p
ro
v
in
ce
s 
in
 
0
 
S
u
p
p
le
m
en
ta
l 
T
a
b
le
s 
 
2
2
6
V
en
ez
u
e
la
  
V
en
ez
u
el
a 
A
rt
is
ti
m
u
ñ
o
 e
t 
a
l,
 2
0
0
7
 
2
0
0
0
-2
0
0
4
 
3
6
 M
D
R
 i
so
la
te
s 
w
er
e 
o
b
ta
in
ed
 f
ro
m
 s
m
ea
r-
p
o
si
ti
v
e 
T
B
 c
a
se
s 
d
ia
g
n
o
se
d
 b
y
 t
h
e 
V
en
ez
u
el
a
n
 N
at
io
n
al
 T
B
 P
ro
g
ra
m
 
2
 (
6
%
) 
C
o
lo
m
b
ia
 (
B
u
en
av
e
n
tu
ra
0
 
L
as
er
so
n
 e
t 
a
l,
 2
0
0
0
 
1
9
9
7
-1
9
9
8
 
2
4
 a
n
d
 4
0
 i
so
la
te
s 
fr
o
m
 t
re
at
m
en
t 
fa
il
u
re
 p
at
ie
n
ts
 i
d
en
ti
fi
ed
 t
h
ro
u
g
h
 
p
as
si
v
e 
a
n
d
 a
ct
iv
e 
su
rv
ei
ll
an
c
e 
re
sp
ec
ti
v
el
y
 a
t 
9
 l
o
ca
l 
h
ea
lt
h
 p
o
st
s 
an
d
 1
 c
en
tr
al
 h
o
sp
it
al
 a
n
d
 7
3
 i
so
la
te
s 
fr
o
m
 n
ew
 T
B
 c
as
es
 w
er
e 
an
al
y
se
d
 
1
1
/1
1
1
 (
1
0
%
) 
P
er
u
, 
A
rg
e
n
ti
n
a,
 B
ra
zi
l,
 
P
ar
ag
u
a
y
, 
C
h
il
e,
 
C
o
lo
m
b
ia
, 
E
cu
a
d
o
r 
R
it
ac
c
o
 e
t 
a
l,
 2
0
0
8
 
1
9
9
7
-2
0
0
3
 
1
2
0
2
 i
so
la
te
s 
w
er
e 
c
o
ll
ec
te
d
 f
ro
m
 s
m
ea
r 
p
o
si
ti
v
e 
P
T
B
 c
as
es
 f
ro
m
 7
 
c
o
u
n
tr
ie
s 
o
f 
S
o
u
th
 A
m
er
ic
a 
as
 p
ar
t 
o
f 
su
rv
e
y
s 
fo
r 
ev
al
u
at
io
n
 o
f 
d
ru
g
 r
es
is
ta
n
t 
o
r 
p
at
ie
n
ts
 w
it
h
 l
ab
o
ra
to
ry
-c
o
n
fi
rm
ed
 d
ia
g
n
o
si
s 
o
f 
M
D
R
-T
B
 
1
9
/1
2
0
2
 (
1
.6
%
) 
A
rg
en
ti
n
a 
an
d
 C
o
lo
m
b
ia
 
O
la
n
o
 e
t 
a
l,
 2
0
0
7
 
2
0
0
3
-2
0
0
4
 
9
2
 a
n
d
 2
5
 i
so
la
te
s 
w
er
e 
c
o
ll
ec
te
d
 f
ro
m
 A
rg
e
n
ti
n
a 
an
d
 C
o
lo
m
b
ia
 
re
sp
ec
ti
v
el
y
 t
o
 t
e
st
 t
h
e 
as
so
ci
a
ti
o
n
 b
et
w
ee
n
 m
u
ta
ti
o
n
s 
in
 s
p
e
ci
fi
c 
D
N
A
 r
ep
ai
r 
g
e
n
es
 a
n
d
 M
D
R
. 
2
/1
1
7
 (
1
.7
%
) 
O
T
H
E
R
 
R
u
ss
ia
, 
E
u
ro
p
e 
an
d
 E
as
t 
A
si
a 
M
o
k
ro
u
so
v
 e
t 
a
l,
 2
0
0
6
 
2
0
0
2
-2
0
0
5
 
8
6
6
 i
so
la
te
s 
w
er
e 
c
o
ll
ec
te
d
 r
e
p
re
se
n
ti
n
g
 R
u
ss
ia
, 
C
h
in
a,
 V
ie
tn
am
 
an
d
 B
u
lg
ar
ia
 w
h
er
e 
th
e 
B
ei
ji
n
g
 g
e
n
o
ty
p
e 
is
 e
n
d
em
ic
. 
 T
h
e 
c
o
ll
ec
ti
o
n
s 
fr
o
m
 f
ir
st
 3
 c
o
u
n
tr
ie
s 
w
er
e 
c
o
n
v
e
n
ie
n
ce
 s
am
p
le
s 
w
h
er
ea
s 
th
o
se
 f
ro
m
 B
u
lg
ar
ia
 w
er
e 
ra
n
d
o
m
ly
 s
e
le
ct
ed
 
4
0
8
/8
6
6
 (
4
7
%
) 
T
e
x
as
 a
n
d
 M
ex
ic
o
 
Q
u
it
u
g
u
a 
et
 a
l,
 2
0
0
2
 
1
9
9
2
-2
0
0
0
 
T
o
ta
l 
o
f 
9
1
9
 d
ru
g
 r
e
si
st
a
n
t 
is
o
la
te
s 
fr
o
m
 6
0
6
 a
n
d
 3
1
3
 p
at
ie
n
ts
 
re
si
d
in
g
 i
n
 T
e
x
as
 a
n
d
 M
ex
ic
o
 r
es
p
ec
ti
v
el
y
 w
er
e 
c
o
ll
ec
te
d
 
1
4
5
/9
1
9
 (
1
6
%
) 
  
S
u
p
p
le
m
en
ta
l 
T
a
b
le
s 
 
2
2
7
T
a
b
le
 2
 
 
C
O
U
N
T
R
Y
 
P
U
B
L
IC
A
T
IO
N
 
In
ci
d
en
ce
 o
f 
a
ll
 
T
B
 c
a
se
s 
–
 
W
H
O
, 
2
0
0
6
 
(r
a
te
/1
0
0
 0
0
0
) 
H
IV
 
p
re
v
a
le
n
ce
 i
n
 
in
ci
d
en
t 
T
B
 
ca
se
s 
(%
) 
A
ss
o
ci
a
ti
o
n
  
b
et
w
ee
n
 
B
ei
ji
n
g
 a
n
d
 
d
ru
g
 d
ru
g
 
re
si
st
a
n
ce
 
C
O
M
M
E
N
T
S
 
A
F
R
IC
A
 
K
en
y
a 
(N
ai
ro
b
i)
 
G
it
h
u
i 
et
 a
l,
 2
0
0
3
 
3
8
4
 
5
2
 
n
o
 
3
%
 o
f 
B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
d
ru
g
 r
es
is
ta
n
t 
o
f 
w
h
ic
h
 a
ll
 w
er
e 
M
D
R
 
v
er
su
s 
4
2
%
 o
f 
n
o
n
-B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
d
ru
g
 r
e
si
st
a
n
t 
o
f 
w
h
ic
h
 
4
0
%
 h
ad
 M
D
R
; 
C
A
S
 f
am
il
y
 a
ss
o
ci
at
ed
 w
it
h
 d
ru
g
 r
es
is
ta
n
ce
 i
n
 
th
is
 s
tu
d
y
 
M
al
aw
i 
(K
ar
o
n
g
a 
D
is
tr
ic
t)
 
G
ly
n
n
 e
t 
a
l,
 2
0
0
5
 
3
7
7
 
7
0
 
n
o
 
A
ll
 B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
d
ru
g
 s
en
si
ti
v
e 
S
en
e
g
al
 
N
ia
n
g
 e
t 
a
l,
 1
9
9
9
 
2
7
0
 
3
 
n
o
t 
a
v
ai
la
b
le
 
N
o
 d
if
fe
re
n
ce
 c
o
u
ld
 b
e 
o
b
se
rv
ed
 b
et
w
ee
n
 t
h
e 
p
ro
fi
le
s 
o
f 
se
n
si
ti
v
e 
an
d
 d
ru
g
 r
es
is
ta
n
t 
T
B
 s
tr
ai
n
s 
S
ie
rr
a 
L
e
o
n
e 
H
o
m
o
lk
a 
et
 a
l,
 2
0
0
8
 
5
1
7
 
5
 
y
e
s 
A
ll
 4
 i
so
la
te
s 
w
it
h
 B
ei
ji
n
g
 g
en
o
ty
p
e 
w
er
e 
d
ru
g
 r
e
si
st
a
n
t 
(3
=
M
D
R
) 
T
an
za
n
ia
 
K
ib
ik
i 
et
 a
l,
 2
0
0
7
 
3
1
2
 
1
8
 
n
o
 
A
ll
 B
ei
ji
n
g
 i
so
la
te
s 
w
er
e 
d
ru
g
 s
en
si
ti
v
e 
U
g
a
n
d
a 
(K
am
p
a
la
) 
A
si
im
w
e 
et
 a
l,
 2
0
0
8
 
3
5
5
 
1
6
 
n
o
 
3
 o
u
t 
o
f 
4
 i
s 
d
ru
g
 s
e
n
si
ti
v
e 
S
o
u
th
 A
fr
ic
a 
(C
ap
e 
T
o
w
n
) 
V
an
 R
ie
 e
t 
a
l,
 2
0
0
1
 
9
4
0
 
4
4
 
y
e
s 
A
ll
 d
ru
g
 r
es
is
ta
n
t 
B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
M
D
R
 w
h
er
ea
s 
o
n
ly
 5
0
%
 
o
f 
d
ru
g
 r
es
is
ta
n
t 
n
o
n
-B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
M
D
R
 
S
o
u
th
 A
fr
ic
a 
(C
ap
e 
T
o
w
n
) 
V
an
 R
ie
 e
t 
a
l,
 1
9
9
9
 
y
e
s 
1
7
/2
1
 M
D
R
 c
as
es
 i
d
e
n
ti
fi
ed
 w
er
e 
in
fe
ct
ed
 w
it
h
 a
 B
ei
ji
n
g
 
g
en
o
ty
p
e 
S
o
u
th
 A
fr
ic
a 
(W
es
te
rn
 a
n
d
 
E
as
te
rn
 C
a
p
e)
 
S
tr
au
ss
 e
t 
a
l,
 2
0
0
7
 
9
4
0
 
4
4
 
y
e
s 
n
sS
N
P
s 
at
 c
o
d
o
n
 5
1
6
 (
G
A
C
-G
T
C
) 
w
a
s 
as
so
ci
at
e
d
 w
it
h
 a
ty
p
ic
al
 
B
ei
ji
n
g
 s
tr
ai
n
s 
fr
o
m
 t
h
e 
W
es
te
rn
 C
ap
e 
an
d
 n
sS
N
P
s 
at
 c
o
d
o
n
 5
3
3
 
w
as
 a
ss
o
ci
at
ed
 w
it
h
 t
y
p
ic
a
l 
B
e
ij
in
g
 s
tr
ai
n
s 
fr
o
m
 t
h
e 
E
as
te
rn
 
S
u
p
p
le
m
en
ta
l 
T
a
b
le
s 
 
2
2
8
C
ap
e 
S
o
u
th
 A
fr
ic
a 
(B
O
K
S
) 
S
tr
ei
ch
er
 e
t 
a
l,
 2
0
0
4
 
y
e
s 
B
ei
ji
n
g
 a
n
d
 L
C
C
 w
er
e 
m
o
st
 p
re
v
a
le
n
t 
d
ru
g
 r
es
is
ta
n
t 
is
o
la
te
s 
Z
im
b
ab
w
e 
E
as
te
rb
ro
o
k
 e
t 
a
l,
 2
0
0
4
 
5
5
7
 
4
3
 
n
o
 
O
n
ly
 4
 B
ei
ji
n
g
 i
so
la
te
s 
w
er
e 
fo
u
n
d
 i
n
 s
tu
d
y
 s
et
ti
n
g
; 
al
l 
w
er
e
 
d
ru
g
 s
e
n
si
ti
v
e 
C
E
N
T
R
A
L
 A
M
E
R
IC
A
 
C
u
b
a 
D
ia
z 
et
 a
l,
 1
9
9
8
 
9
 
0
 
y
e
s 
1
1
/2
0
 d
ru
g
 r
es
is
ta
n
t 
ca
se
s 
w
er
e 
in
fe
ct
ed
 w
it
h
 a
 B
e
ij
in
g
 g
en
o
ty
p
e 
E
U
R
O
P
E
 
A
u
st
ri
a 
S
ta
u
ff
er
 e
t 
a
l,
 2
0
0
0
 
1
3
 
5
 
n
o
 
1
5
/1
7
 M
D
R
 i
so
la
te
s 
h
a
d
 u
n
iq
u
e 
sp
o
li
g
o
ty
p
e 
p
at
te
rn
s;
 2
/1
7
 w
er
e 
B
ei
ji
n
g
 
A
ze
rb
ai
ja
n
 
P
fy
ff
er
 e
t 
a
l,
 2
0
0
1
 
7
7
 
1
 
y
e
s 
6
3
%
 o
f 
d
ru
g
 r
es
is
ta
n
t 
ca
se
s 
w
er
e 
in
fe
ct
ed
 w
it
h
 B
ei
ji
n
g
 s
tr
ai
n
 o
f 
w
h
ic
h
 6
8
%
 w
er
e 
M
D
R
 v
er
su
s 
2
0
 a
n
d
 4
6
%
 r
es
p
ec
ti
v
el
y
 f
o
r 
c
as
es
 
in
fe
ct
ed
 w
it
h
 n
o
n
-B
ei
ji
n
g
 s
tr
ai
n
; 
M
D
R
 w
as
 a
ss
o
ci
a
te
d
 w
it
h
 t
h
e 
B
ei
ji
n
g
 g
e
n
o
ty
p
e 
G
er
m
an
y
 
D
ie
l 
et
 a
l,
 2
0
0
2
 
n
o
 
M
a
jo
ri
ty
 o
f 
is
o
la
te
s 
an
al
y
se
d
 (
4
0
1
/4
2
3
) 
w
er
e 
d
ru
g
 s
en
si
ti
v
e;
 
re
m
ai
n
in
g
 d
ru
g
 r
es
is
ta
n
t 
is
o
la
te
s 
w
er
e 
m
o
st
ly
 f
ro
m
 u
n
cl
u
st
er
ed
 
st
ra
in
s 
G
er
m
an
y
 
H
il
le
m
a
n
 e
t 
a
l,
 2
0
0
5
 
6
 
2
 
y
e
s 
- 
G
er
m
an
y
 
K
u
b
ic
a 
et
 a
l,
 2
0
0
4
 
6
 
2
 
y
e
s 
F
o
u
n
d
 a
 r
em
ar
k
ab
ly
 h
ig
h
 r
at
e 
o
f 
B
ei
ji
n
g
 g
e
n
o
ty
p
e 
(3
8
.8
%
) 
am
o
n
g
 M
D
R
-T
B
 s
tr
ai
n
s 
fr
o
m
 G
er
m
an
y
, 
w
it
h
 a
n
 a
n
n
u
al
 i
n
cr
ea
se
 
d
u
ri
n
g
 t
h
e 
st
u
d
y
 p
er
io
d
 
E
st
o
n
ia
 
K
ru
u
n
er
 e
t 
a
l,
 2
0
0
1
 
3
9
 
1
8
 
y
e
s 
8
7
.5
%
 o
f 
al
l 
M
D
R
 i
so
la
te
s,
 6
7
.2
%
 o
f 
al
l 
is
o
la
te
s 
w
it
h
 a
n
y
 d
ru
g
 
re
si
st
a
n
ce
 b
u
t 
o
n
ly
 1
2
%
 o
f 
d
ru
g
 s
e
n
si
ti
v
e 
ca
se
s 
w
er
e 
in
fe
ct
ed
 
w
it
h
 t
h
e 
B
ei
ji
n
g
 g
en
o
ty
p
e 
F
in
la
n
d
 
P
u
u
st
in
en
 e
t 
a
l,
 2
0
0
3
 
n
o
 
2
/4
 w
er
e 
d
ru
g
 s
e
n
si
ti
v
e;
 1
 w
as
 I
N
H
 m
o
n
o
-r
es
is
ta
n
t;
 1
 w
as
 
re
si
st
a
n
t 
to
 I
N
H
, 
R
if
, 
S
tr
ep
 a
n
d
 E
M
B
 
F
in
la
n
d
 
M
ar
ti
ll
a 
et
 a
l,
 2
0
0
7
 
5
 
1
 
n
o
 
O
n
ly
 8
.8
%
 o
f 
d
ru
g
 r
es
is
ta
n
t 
is
o
la
te
s 
w
er
e 
d
u
e 
to
 B
ei
ji
n
g
 s
tr
ai
n
s 
S
u
p
p
le
m
en
ta
l 
T
a
b
le
s 
 
2
2
9
U
n
it
ed
-K
in
g
d
o
m
 (
S
co
tl
a
n
d
) 
F
a
n
g
 e
t 
a
l,
 1
9
9
9
 
1
5
 
4
 
y
e
s 
2
/2
 B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
d
ru
g
 r
es
is
ta
n
t 
It
al
y
 
L
ar
i 
et
 a
l,
 2
0
0
7
 
n
o
 
O
n
ly
 o
n
e 
p
at
ie
n
t 
(f
ro
m
 f
o
rm
er
 S
o
v
ie
t 
U
n
io
n
) 
w
as
 M
D
R
 w
it
h
 n
o
 
su
b
st
a
n
ti
al
 r
es
is
ta
n
ce
 t
o
 a
n
y
 o
th
er
 a
n
ti
-T
B
 d
ru
g
s 
w
as
 o
b
se
rv
e
d
 
am
o
n
g
 t
h
e 
B
ei
ji
n
g
 s
tr
ai
n
s 
It
al
y
 (
T
u
sc
a
n
y
) 
R
in
d
i 
et
 a
l,
 2
0
0
8
 
7
 
7
 
n
o
 
p
ro
p
o
rt
io
n
 o
f 
is
o
la
te
s 
re
si
st
an
t 
to
 a
n
y
 1
st
-l
in
e 
d
ru
g
s 
w
a
s 
n
o
t 
d
if
fe
re
n
t 
fr
o
m
 t
h
a
t 
o
f 
n
o
n
-B
ei
ji
n
g
 s
tr
ai
n
s 
is
o
la
te
d
 i
n
 t
h
e 
sa
m
e 
st
u
d
y
 p
er
io
d
 
L
at
v
ia
 
T
ra
ce
v
sk
a 
et
 a
l,
 2
0
0
3
 
5
7
 
4
 
y
e
s 
B
ei
ji
n
g
 g
e
n
o
ty
p
e 
n
o
t 
p
ar
ti
cu
la
rl
y 
c
o
m
m
o
n
 a
m
o
n
g
 d
ru
g
 s
en
si
ti
v
e 
is
o
la
te
s 
in
 L
a
tv
ia
 
P
o
la
n
d
 
S
aj
d
u
d
a 
et
 a
l,
 2
0
0
4
 
2
5
 
0
 
y
e
s 
5
7
%
 o
f 
B
e
ij
in
g
 s
tr
ai
n
s 
w
er
e 
M
D
R
 
P
o
rt
u
g
al
 
P
er
d
ig
ão
 e
t 
a
l,
 2
0
0
8
 
3
2
 
1
4
 
n
o
 
S
tr
ai
n
s 
b
el
o
n
g
in
g
 t
o
 f
a
m
il
y
 L
is
b
o
a 
ar
e 
re
sp
o
n
si
b
le
 f
o
r 
th
e 
m
aj
o
ri
ty
 o
f 
M
D
R
-T
B
 c
as
es
. 
5
3
%
 o
f 
th
es
e 
w
er
e 
X
D
R
 
R
u
ss
ia
 
M
o
k
ro
u
so
v
 e
t 
a
l,
 2
0
0
3
 
y
e
s 
- 
R
u
ss
ia
 (
A
rc
h
a
n
g
el
 O
b
la
st
) 
T
o
u
n
g
o
u
ss
o
v
a 
et
 a
l,
 
2
0
0
2
 
y
e
s 
4
1
/5
3
 i
s 
d
ru
g
 r
es
is
ta
n
t 
o
f 
w
h
ic
h
 2
3
 i
s 
M
D
R
; 
re
si
st
an
ce
 t
o
 R
if
 a
n
d
 
S
M
 s
ig
n
if
ic
a
n
tl
y
 a
ss
o
ci
a
te
d
 w
it
h
 B
e
ij
in
g
 s
tr
ai
n
s 
b
u
t 
n
o
t 
fo
r 
E
M
B
 
an
d
 I
N
H
 
R
u
ss
ia
 (
A
rc
h
a
n
g
el
 p
ri
so
n
) 
T
o
u
n
g
o
u
ss
o
v
a 
et
 a
l,
 
2
0
0
3
 
y
e
s 
8
5
%
 o
f 
d
ru
g
 r
es
is
ta
n
t 
st
ra
in
s 
w
er
e 
p
ar
t 
o
f 
th
e 
B
ei
ji
n
g
 s
tr
ai
n
 
fa
m
il
y
; 
 B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
m
o
re
 o
ft
en
 M
D
R
 t
h
an
 w
er
e 
th
e 
n
o
n
-B
ei
ji
n
g
 b
u
t 
d
if
fe
re
n
ce
 n
o
t 
si
g
n
if
ic
an
t 
(d
id
 n
o
t 
fi
n
d
 a
 h
ig
h
er
 
ra
te
 o
f 
M
D
R
 p
h
en
o
ty
p
e 
in
 t
h
e 
B
ei
ji
n
g
 i
so
la
te
s 
R
u
ss
ia
 (
A
rc
h
a
n
g
el
 O
b
la
st
) 
T
o
u
n
g
o
u
ss
o
v
a 
et
 a
l,
 
2
0
0
5
 
y
e
s 
8
0
%
 o
f 
M
D
R
 i
so
la
te
s 
w
er
e 
in
fe
ct
ed
 w
it
h
 a
 B
ei
ji
n
g
 s
tr
ai
n
; 
sp
re
ad
 
o
f 
B
ei
ji
n
g
 i
n
 A
rc
h
an
g
el
 i
s 
as
so
ci
at
e
d
 w
it
h
 h
ig
h
 r
at
e
s 
o
f 
d
ru
g
 R
 t
o
 
fi
rs
t-
li
n
e 
d
ru
g
s.
  
H
o
w
e
v
er
, 
n
o
 a
ss
o
ci
at
io
n
 w
a
s 
fo
u
n
d
 f
o
r 
se
c
o
n
d
-
li
n
e 
d
ru
g
s;
 r
es
is
ta
n
ce
 t
o
 c
ap
re
o
m
y
c
in
 l
es
s 
c
o
m
m
o
n
 i
n
 B
e
ij
in
g
 
st
ra
in
s 
(3
3
%
 v
s 
7
1
%
) 
R
u
ss
ia
 (
T
u
la
 R
eg
io
n
) 
Ig
n
at
o
v
a 
et
 a
l,
 2
0
0
6
 
1
0
7
 
4
 
y
e
s 
7
6
.3
%
 o
f 
d
ru
g
 r
es
is
ta
n
t 
B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
M
D
R
 
S
u
p
p
le
m
en
ta
l 
T
a
b
le
s 
 
2
3
0
R
u
ss
ia
 (
S
am
ar
a 
re
g
io
n
) 
D
ro
b
n
ie
w
sk
i 
et
 a
l,
 2
0
0
5
 
y
e
s 
D
ru
g
 r
es
is
ta
n
t 
w
er
e 
si
g
n
if
ic
an
tl
y
 h
ig
h
er
, 
p
ar
ti
c
u
la
rl
y
 f
o
r 
M
D
R
-
T
B
 a
m
o
n
g
 t
h
o
se
 i
n
fe
ct
ed
 w
it
h
 t
h
e 
B
ei
ji
n
g
 g
e
n
o
ty
p
e;
 R
es
is
ta
n
ce
 
to
 I
N
H
, 
R
if
, 
M
D
R
, 
S
M
 a
n
d
 E
M
B
 2
-f
o
ld
 h
ig
h
er
 i
n
 B
ei
ji
n
g
 v
er
su
s 
n
o
n
-B
ei
ji
n
g
 i
n
fe
ct
ed
 p
at
ie
n
ts
 
R
u
ss
ia
 (
S
am
ar
a 
re
g
io
n
) 
B
al
ab
o
n
o
v
a 
et
 a
l,
 2
0
0
6
 
y
e
s 
D
ru
g
 r
es
is
ta
n
ce
, 
in
cl
u
d
in
g
 M
D
R
, 
w
as
 t
w
ic
e 
h
ig
h
er
 a
m
o
n
g
 t
h
e 
B
ei
ji
n
g
 s
tr
ai
n
 f
a
m
il
y
 
R
u
ss
ia
 (
S
t.
 P
et
er
sb
u
rg
) 
N
ar
v
sk
a
y
a 
et
 a
l,
 2
0
0
2
 
y
e
s 
N
o
 e
v
id
e
n
ce
 o
f 
tr
an
sm
is
si
o
n
 f
o
r 
th
e 
n
o
n
-B
ei
ji
n
g
 M
D
R
 i
so
la
te
s 
w
as
 f
o
u
n
d
 
R
u
ss
ia
 
M
o
k
ro
u
so
v
 e
t 
a
l,
 2
0
0
2
 
y
e
s 
M
a
jo
ri
ty
 o
f 
d
ru
g
 r
e
si
st
a
n
t 
st
ra
in
s 
fr
o
m
 n
e
w
ly
 d
ia
g
n
o
se
d
 p
at
ie
n
ts
 
b
el
o
n
g
ed
 t
o
 t
h
e 
B
ei
ji
n
g
 g
en
o
ty
p
e 
R
u
ss
ia
 (
S
er
p
u
k
h
o
v
 p
ri
so
n
) 
S
h
e
m
y
a
k
in
 e
t 
a
l,
 2
0
0
4
 
y
e
s 
P
re
d
o
m
in
a
n
ce
 t
o
g
et
h
er
 w
it
h
 t
h
e 
L
A
M
 f
am
il
y
 a
m
o
n
g
 d
ru
g
 
re
si
st
a
n
t 
is
o
la
te
s 
d
er
iv
ed
 f
ro
m
 p
ri
so
n
 i
n
m
at
es
 
R
u
ss
ia
 (
A
rc
h
a
n
g
el
 O
b
la
st
) 
T
o
u
n
g
o
u
ss
o
v
a 
et
 a
l,
 
2
0
0
4
 
y
e
s 
A
ll
 d
ru
g
 r
es
is
ta
n
t 
B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
M
D
R
 w
h
er
ea
s 
o
n
ly
 6
0
%
 
o
f 
d
ru
g
 R
 n
o
n
-B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
M
D
R
 
R
u
ss
ia
 (
U
k
ra
in
e)
 
N
ik
o
la
y
ev
sk
y
y
 e
t 
a
l,
 
2
0
0
6
 
y
e
s 
D
ru
g
 s
en
si
ti
v
it
y
 m
o
re
 c
o
m
m
o
n
 i
n
 n
o
n
-B
ei
ji
n
g
 s
tr
ai
n
s;
 
p
re
v
al
e
n
ce
 o
f 
m
u
ta
ti
o
n
s 
as
so
ci
at
ed
 w
it
h
 a
ll
 t
y
p
es
 o
f 
re
si
st
a
n
ce
 
w
as
 s
ig
n
if
ic
an
tl
y
 h
ig
h
er
 a
m
o
n
g
 B
ei
ji
n
g
 s
tr
ai
n
s 
w
it
h
 s
tr
o
n
g
e
st
 
as
so
ci
at
io
n
 w
it
h
 M
D
R
 
R
u
ss
ia
 
M
o
k
ro
u
so
v
 e
t 
a
l,
 2
0
0
2
 
y
e
s 
6
8
%
 o
f 
M
D
R
 i
so
la
te
s 
w
er
e 
in
fe
ct
ed
 w
it
h
 a
 B
ei
ji
n
g
 s
tr
ai
n
; 
th
e
y
 
ac
q
u
ir
e
d
 t
h
e 
m
u
ta
ti
o
n
 T
C
G
5
2
1
-T
T
G
 m
o
re
 r
ea
d
il
y
 w
it
h
in
 t
h
e 
rp
o
B
 g
e
n
e 
R
u
ss
ia
 (
K
al
in
in
g
ra
d
) 
M
o
k
ro
u
so
v
 e
t 
a
l,
 2
0
0
8
 
y
e
s 
B
ei
ji
n
g
 s
tr
ai
n
s 
m
a
d
e 
1
.6
%
 o
f 
al
l 
d
ru
g
 s
e
n
si
ti
v
e 
is
o
la
te
s 
a
n
d
 2
8
 
o
u
t 
o
f 
3
0
 M
D
R
 c
as
es
; 
re
m
ar
k
ab
ly
 s
tr
o
n
g
 a
ss
o
ci
at
io
n
 o
f 
M
D
R
 a
s 
w
el
l 
as
 o
f 
an
y
 d
ru
g
 r
es
is
ta
n
ce
 w
as
 o
b
se
rv
ed
 f
o
r 
th
e 
B
e
ij
in
g
 
g
en
o
ty
p
e 
R
u
ss
ia
 
N
ar
v
sk
ai
a 
et
 a
l,
 2
0
0
2
 
y
e
s 
B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
sh
o
w
n
 t
o
 c
au
se
 m
o
re
 s
e
v
er
e 
u
n
ar
re
st
ed
 
c
o
u
rs
e 
o
f 
d
ru
g
 r
es
is
ta
n
t 
fi
b
ro
-c
av
er
n
o
u
s 
T
B
 
R
u
ss
ia
 (
U
ra
l 
re
g
io
n
) 
K
o
v
al
e
v
 e
t 
a
l,
 2
0
0
5
 
1
0
7
 
4
 
y
e
s 
1
9
 o
u
t 
o
f 
th
e 
2
3
 M
D
R
 i
so
la
te
s 
b
el
o
n
g
 t
o
 s
tr
ai
n
s 
w
it
h
 t
h
e 
B
ei
ji
n
g
 
g
en
o
ty
p
e
; 
B
ei
ji
n
g
 d
ru
g
 r
es
is
ta
n
t 
is
o
la
te
s 
w
er
e 
tw
ic
e 
as
 f
re
q
u
en
t 
S
u
p
p
le
m
en
ta
l 
T
a
b
le
s 
 
2
3
1
as
 i
n
 o
th
er
 g
ro
u
p
s 
R
u
ss
ia
 (
M
o
sc
o
w
) 
L
ip
in
 e
t 
a
l,
 2
0
0
7
 
y
e
s 
4
2
.4
 a
n
d
 4
5
.6
%
 o
f 
is
o
la
te
s 
w
er
e 
in
fe
ct
ed
 w
it
h
 B
e
ij
in
g
 a
n
d
 L
A
M
 
g
en
o
ty
p
e
s 
re
sp
ec
ti
v
el
y
 
S
w
ed
e
n
 
G
h
eb
re
m
ic
h
ae
l 
et
 a
l,
 
2
0
0
8
 
n
o
 
T
e
n
 o
f 
th
e 
4
6
 M
D
R
 i
so
la
te
s 
a
n
d
 t
h
e 
X
D
R
 i
so
la
te
 w
er
e 
o
f 
th
e 
B
ei
ji
n
g
 l
in
ea
g
e 
S
w
ed
e
n
 
B
ru
d
e
y
 e
t 
a
l,
 2
0
0
4
 
6
 
3
 
n
o
 
3
/1
1
 B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
re
si
st
an
t;
 n
o
n
e 
w
er
e 
M
D
R
 
S
p
ai
n
 
S
am
p
er
 e
t 
a
l,
 2
0
0
5
 
n
o
 
N
o
n
-B
ei
ji
n
g
 s
tr
ai
n
s 
m
ad
e 
o
u
t 
9
4
%
 o
f 
al
l 
M
D
R
 i
so
la
te
s 
st
u
d
ie
d
. 
T
h
e 
“B
”-
st
ra
in
 w
as
 t
h
e 
m
o
st
 f
re
q
u
en
tl
y
 i
so
la
te
d
 M
D
R
 s
tr
ai
n
 i
n
 
th
is
 s
tu
d
y
 
S
p
ai
n
 (
G
ra
n
 C
an
ar
ia
 I
sl
a
n
d
) 
C
am
in
er
o
 e
t 
a
l,
 2
0
0
1
 
n
o
 
A
ll
 B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
d
ru
g
 s
en
is
it
v
e 
o
f 
w
h
ic
h
 2
 d
e
v
el
o
p
e
d
 
M
D
R
 d
u
ri
n
g
 t
re
at
m
en
t 
S
p
ai
n
 (
E
lc
h
e)
 
G
ar
ci
a-
P
ac
h
o
n
 e
t 
a
l,
 
2
0
0
7
 
n
o
 
O
n
ly
 1
 B
ei
ji
n
g
 s
tr
ai
n
 w
a
s 
fo
u
n
d
 d
u
ri
n
g
 s
tu
d
y
 p
er
io
d
 
S
p
ai
n
 (
M
ad
ri
d
) 
D
e 
V
ie
d
m
a 
et
 a
l,
 2
0
0
6
 
3
0
 
 
9
 
n
o
 
A
ll
 i
so
la
te
s 
ex
ce
p
t 
fo
r 
1
 w
er
e 
d
ru
g
 s
e
n
si
ti
v
e 
T
u
rk
e
y
 
D
u
rm
az
 e
t 
a
l,
 2
0
0
7
 
n
o
 
D
es
p
it
e 
h
ig
h
 M
D
R
 r
at
es
 (
5
9
%
) 
an
d
 1
4
%
 o
f 
st
ra
in
s 
w
er
e 
IN
H
 
m
o
n
o
- 
re
si
st
an
ce
, 
o
n
ly
 1
 B
ei
ji
n
g
 s
tr
ai
n
 w
er
e 
fo
u
n
d
 
T
u
rk
e
y
 (
Is
ta
n
b
u
l)
 
K
o
k
sa
la
n
 e
t 
a
l,
 2
0
0
6
 
2
9
 
- 
y
e
s 
S
ig
n
if
ic
an
t 
as
so
ci
at
io
n
 b
e
tw
ee
n
 R
if
 r
es
is
ta
n
ce
 a
n
d
 B
ei
ji
n
g
 
st
ra
in
s 
F
A
R
-E
A
S
T
 A
S
IA
 
C
h
in
a 
(B
ei
ji
n
g
) 
M
o
k
ro
u
so
v
 e
t 
a
l,
 2
0
0
6
 
y
e
s 
R
if
, 
P
Z
A
, 
M
D
R
 a
n
d
 H
R
Z
 p
at
te
rn
s 
w
er
e 
si
g
n
if
ic
an
tl
y
 a
ss
o
c
ia
te
d
 
w
it
h
 t
h
e 
o
ld
 B
ei
ji
n
g
 s
tr
ai
n
s;
 S
M
 w
ea
k
ly
 a
ss
o
ci
at
ed
 w
it
h
 n
e
w
 
B
ei
ji
n
g
 s
tr
ai
n
s 
C
h
in
a 
(B
ei
ji
n
g
) 
W
ei
-W
ei
 e
t 
a
l,
 2
0
0
7
 
9
9
 
0
.3
 
y
e
s 
N
o
 s
ig
n
if
ic
an
t 
d
if
fe
re
n
ce
 b
et
w
ee
n
 m
o
d
er
n
 a
n
d
 a
n
ci
e
n
t 
B
ei
ji
n
g
 
st
ra
in
s 
re
g
ar
d
in
g
 p
re
v
al
en
ce
 o
f 
rp
o
B
 a
n
d
 k
a
tG
 m
u
ta
ti
o
n
 h
o
w
ev
er
 
th
e 
p
ro
p
o
rt
io
n
 o
f 
rp
o
B
 m
u
ta
n
ts
 w
er
e 
sl
ig
h
tl
y
 h
ig
h
er
 i
n
 t
h
e 
m
o
d
er
n
 s
tr
ai
n
s 
w
h
il
e 
ka
tG
 S
3
1
5
T
 w
er
e 
h
ig
h
er
 i
n
 a
n
ci
e
n
t 
st
ra
in
s 
S
u
p
p
le
m
en
ta
l 
T
a
b
le
s 
 
2
3
2
C
h
in
a 
(B
ei
ji
n
g
, 
S
h
an
g
h
ai
, 
T
ia
n
ji
n
) 
L
i 
et
 a
l,
 2
0
0
5
 
y
e
s 
B
ei
ji
n
g
 s
tr
ai
n
s 
si
g
n
if
ic
an
tl
y
 m
o
re
 r
es
is
ta
n
t 
to
 a
n
ti
-T
B
 d
ru
g
s 
u
si
n
g
  
X
2
 te
st
 b
u
t 
n
o
t 
w
it
h
 m
u
lt
iv
ar
ia
te
 a
n
al
y
si
s 
C
h
in
a 
(H
o
n
g
 K
o
n
g
) 
C
h
a
n
 e
t 
a
l,
 2
0
0
1
 
n
o
 
N
o
 s
ig
n
if
ic
an
t 
as
so
ci
at
io
n
 b
et
w
ee
n
 B
ei
ji
n
g
 a
n
d
 i
n
d
iv
id
u
al
 f
ir
st
-
li
n
e 
an
ti
-T
B
 d
ru
g
s 
al
th
o
u
g
h
 t
h
er
e 
w
as
 a
 t
en
d
e
n
c
y
 f
o
r 
B
ei
ji
n
g
 t
o
 
b
e 
as
so
ci
at
ed
 w
it
h
 I
N
H
 s
e
n
si
ti
v
e 
st
ra
in
s 
C
h
in
a 
(T
ia
n
ji
n
) 
C
h
ai
 e
t 
a
l,
 2
0
0
7
 
n
o
 
- 
C
h
in
a 
(T
ib
e
t)
 
S
h
i 
et
 a
l,
 2
0
0
7
 
n
o
 
B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
n
o
t 
si
g
n
if
ic
an
tl
y
 a
ss
o
ci
at
e
d
 w
it
h
 d
ru
g
 
re
si
st
a
n
ce
 t
o
 a
ll
 o
f 
th
e 
4
 d
ru
g
s 
In
d
o
n
e
si
a 
(J
a
k
ar
ta
) 
V
an
 C
re
v
el
 e
t 
a
l,
 2
0
0
1
 
n
o
 
- 
In
d
o
n
e
si
a 
( 
W
e
st
 J
a
v
a 
an
d
 
T
im
o
r)
 
P
ar
w
at
i 
et
 a
l,
 2
0
0
8
 
2
3
4
 
1
 
n
o
 
D
ru
g
 r
es
is
ta
n
ce
 p
at
te
rn
s 
o
f 
B
e
ij
in
g
 a
n
d
 n
o
n
-B
ei
ji
n
g
 i
so
la
te
s 
w
er
e 
n
o
t 
si
g
n
if
ic
a
n
tl
y
 d
if
fe
re
n
t;
 n
o
 a
ss
o
ci
at
io
n
 f
o
u
n
d
 b
et
w
ee
n
 
B
ei
ji
n
g
 s
tr
ai
n
s 
an
d
 d
ru
g
 r
es
is
ta
n
ce
 
Ja
p
an
 
M
il
le
t 
et
 a
l,
 2
0
0
7
 
2
2
 
0
 
n
o
t 
a
v
ai
la
b
le
 
N
ei
th
er
 B
ei
ji
n
g
 n
o
r 
n
o
n
-B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
as
so
ci
at
e
d
 w
it
h
 
M
D
R
; 
to
ta
l 
d
ru
g
 r
e
si
st
a
n
ce
 =
 1
6
%
 
K
o
re
a 
P
ar
k
 e
t 
a
l,
 2
0
0
5
 
8
8
 
1
 
y
e
s 
P
ro
p
o
rt
io
n
 o
f 
B
ei
ji
n
g
 s
tr
ai
n
s 
w
er
e 
si
g
n
if
ic
an
tl
y
 h
ig
h
er
 a
m
o
n
g
 
M
D
R
 i
so
la
te
s 
th
an
 a
m
o
n
g
 d
ru
g
 s
e
n
si
ti
v
e 
st
ra
in
s 
S
in
g
a
p
o
re
 
S
u
n
 e
t 
a
l,
 2
0
0
7
 
2
6
 
3
 
y
e
s 
R
if
, 
S
M
 a
n
d
 M
D
R
 i
so
la
te
s 
m
o
re
 c
o
m
m
o
n
 i
n
 B
ei
ji
n
g
 g
en
o
ty
p
e;
 
IN
H
 a
n
d
 E
M
B
 r
es
is
ta
n
ce
 n
o
t 
as
so
ci
at
ed
 w
it
h
 a
n
y
 g
e
n
o
ty
p
e 
T
h
ai
la
n
d
 (
B
an
g
k
o
k
) 
P
ro
d
in
g
er
 e
t 
a
l,
 2
0
0
1
 
1
4
2
 
1
1
 
n
o
 
O
v
er
al
l 
d
ru
g
 r
e
si
st
a
n
ce
 t
o
 s
in
g
le
 d
ru
g
s 
a
n
d
 M
D
R
 w
er
e 
n
o
t 
as
so
ci
at
ed
 w
it
h
 B
ei
ji
n
g
 
T
ai
w
a
n
 
Jo
u
 e
t 
a
l,
 2
0
0
5
 
- 
- 
y
e
s 
P
re
v
al
en
ce
 o
f 
d
ru
g
 r
es
is
ta
n
ce
 w
er
e 
h
ig
h
er
 a
m
o
n
g
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